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INTRODUCTION 
Since the early 1900s, much of the research,6n boVine brucellosis 
has been'directed toward the development of an effective immunizing 
product, The results of these studies with various experimental vaccines 
have determined strain 19 to possess the best combination of, 1) stable 
low pathogenicity, 2) relatively high immunogenicity, and 3) moderate 
antigenicity (,54, 69, 86), 
Consequently, in 1941, strain 19 vaccine became part of the USDA, 
Bureau of Animal Industries' (BAI) control Program and has been the only 
official vaccine used in this country since that time, A dose containing 
8 X 109 to 12 X 109 living cells per ml (in a 5 ml dose) given subcuta-
neously was recommended (18), however, many vaccinated adult animals 
became r'eactors on diagnostic tests, A large proportion of animals vac-
cinated at four to eight months of age became negative within 13 months 
after vaccination (18), For these reasons, in the 1940s the BAI limited 
vaccination with strain 19 to calves between four and eight months of 
age and to adults only under certain conditions. 
From the 1940s to the 1970s, ,a gradual shift in herd management 
t!)ward large commercial dairies created a serious problem in establishing 
a successful brucellosis eradication program,in these herds, A study 
conducted in calves, using reduced dosages of strain 19, indicated that 
the protection from l/20th of a standard dose was comparable to that 
conferred by the standard dose and the problem of persisting vaccination 
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titers was reduced (70). Field studies w~e initiated in 1975 to eval-
uate strain 19 vaccination of adult cattle with various dosages and by 
different routes of administration. The use of the l/20th dose of st~ain 
19 in adult cattle appeared to give results comparable to those obtained 
in·calves. As a result of these studies, the use of.a reduced dose of 
strain 19 vaccine was approved1 , with certain restrictions, in adult 
female cattle in herds where a high prevalence of infection was reported. 
While field studies indicated that reduced doses of vaccine admin-
istered to adult cows might be of value in controlling brucellosis in 
infected herds, .accurate data concerning the optimum dose that provides 
adequate protection with little to no stimulation of diagnostically 
' 
significant levels of antibodies was not provided, To gather such in-
formation it would be necessary to conduct vaccination trials under the 
best possible controlled conditions. 
Therefore, this study was initiated to determine, under controlled 
conditions, the. Va.ccinal titer patterns and the immunity produced by the 
standard dose and four different reduced dosages of strain 19. The 
. . 
study was. designed to eiiminate. as many variable~ as possible and pro-
vide additional baseline data to aid in interpreting the antibody titers 
produced by reduced dosages. The cattle purchased for the study met 
strict nonexposiire, age, pregnancy, and health requirements. Systematic 
1usnA, Animal and ~lant Health Inspection Service, Veterinary 
Services, 1977. 
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serum, milk, vaginal swab and tissue collection schedules were developed 
and followed, including the cultural examination of tissues at the 
termination of the study. 
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LITERATURE REVIEW 
. History 
Since 1897, the yea:r Professor Bernard Bang (7) and his associate 
Stribolt, announced their discovery of the causal agent of "contagious 
abortion" 'in cattle, a concentrated effort has been made to find a 
method which would provide immunity to this costly disease. Bang sug-
gested, in 1897, that artificial immunization was a possibility. Later, 
in 1906, Bang (8) reported on experiments using both living and killed 
suspensions of Brucella abortus as immunizing agents in cattle, sheep,. 
and goats, His results with living vaccines were encouraging. 
Since then, vaccination methods, dosages, and types of vaccines 
have received much attention by many investigators. McFadyean and 
Stockman (66), in 1909, injected single, massive doses of live~· abortus 
subcutaneously into virgin heifers and produced an active immunity. 
A great controversy developed among resea:rchers over the use of 
vaccination in cattle. Some felt that vaccinating infected, as well as 
noninfected cattle, with the virulent organism produced an effective 
immunity (82, 83), Others explained the beneficial results were ac-
counted for by a saturation-tolerance (22). Huddleson reported that a 
nonvirulent, highly agglutinogenic strain of Brucella would produce a 
good immunity without the hazards that followed the use of extremely 
virulent vaccines (41). 
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A considerable volume of research on various vaccines has accumu-
latOO. over the yea.rs, These ·efforts have been directed primarily toward 
the production of an effective, durable immunity, In addition to the 
goal of finding the most effective vaccination procedure, the problem 
of persisting agglutination titers in vaccinated animals became a major 
disadvantage in ~he use of vaccine. 
Buck and Creech (17) studied the length of time that live ~. abortus 
remained in the animal." A study was conducted in which two-thirds of 
the cattle in a large infected herd were vaccinated and the remaining 
one-third were used as controls. Their analysis indicated that heifers, 
which had a negative serological titer at the time of vaccination, had 
5% fewer abortions during the first calving season and 7% fewer abor-
tions dtiring the second calving season than did the control cattle. A 
second more controlled and defined study was conducted on eight heifers 
and five cows, A 20 cc dose. containing approximately one billion organ-
isms per cc of live ~. abortus was given, As a result, they observed 
that even though marked serological reactions were produced in suscep-
tible heifers by the injections, the titers declined in four to five 
months. 
Hart and Traum (38) reported on work using four strains of £!. abor-
tus (A, 80, 101, and a commercial strain) as vaccines, Suspensions con~ 
taining 11 billion live organisms per ml were prepared and each animal 
was given 20 ml subcutaneously, The vaccine prevented abortions and 
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in addition, it was shown that organisms were shed prior to the devel-
opment of a detectable agglutinin response. This pointed out the lim~ 
i"i:,ations of interpreting a negative agglutination test as an indication 
that the animals were free from infection,. It was further observed that 
cattle had persi~tent titers of 1:100 or higher for several months to 
one year following injection at this dosage level, 
Buck (16) vaccinated 18 heifer calves in order to determine the 
duration of immunity. Twelve were vaccinated subcutaneously with 20 cc 
of live~. abortus·and the remaining six calves were used as controls. 
Three.different lots of va~cine were prepared and used. One lot con-
taining strains ~, 10, and 11 was administered to each of six animals ; 
strain 88 was administered to three animals; and strain 19 was adminis-
tered to three animals, Buck found that all three vaccine lots produced 
similar results. He felt that ''medium virulence" strains such as ~· 
abortus strain 19 should be used in place of the highly virulent strains. 
He concluded that the subcutaneous administration ·of the vaccine provided 
adequate immunity during the first pregnancy without producing sterility,· 
In 1933, Cotton and Buck (22) reported on the comparative virulence 
of three different strains of~. abortus (11, 19, and 484), when admin-
istered to guinea pigs and cattle. The results indicated that strains 
11 and 19 did not infect the udders of nonpregnant. cows and that all 
three strains were similar in.their ability to produce immunity. other 
investigators (29, 63, 85) searched for additional low virulence strains 
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that might ·be even more immunogenic. McEwen and Priestley found that a 
live vaccine prepared from a rough strain.of:!?_, abortus 45/20 provided 
adequate immuirl.ty, but that it tended to revert t.o its virulent smooth 
form. 
Manthei et al. (57) and McDiarmid (60) compared the immune response 
in cattle vaccinated with varying doses of~. abortus strain 19 by the 
intradermal and subcutaneous routes. Manthei found that the maximum 
agglutinin titers were similar in animals inoculated with either 5 ml 
subcutaneously or 0.2 ml intradermally, and that the serological re-
sponse from the 0,2 ml dose was considerably lower than the other two 
dosages, McDi~d (60), however, failed to see any significant differ-
ences in the serological titers for these different dosages or routes. 
Both investigators found the degree of post-vaccinal agglutinin response 
was not related to the degree of immunity to brucellosis in cattle vac-
cinated with strain 19. The degree of inununity against brucellosis was 
·similar in· all the groups of vaccinated cattle. 
In 1973, Worthington et al. (93) studied the persistence of anti-
body titers in vaccinated cattle. One hundred twenty-eight pregnant 
cows were vaccinated with 100 X 109 viable :!?_, abortus strain 19 organisms 
and blood samples were collected and tested at monthly intervals for two 
years using the following procedures; the complement fixation (CF), 
mercaptoethanol (ME), rivanol (RIV), Coombs, and tube agglutination 
tests. The agglutination tests became positive during the first month 
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following vaccination and the titers persisted at levels above 64 I,U, 
in most of the cattle for over two years, The CF, RIV, and ME titers 
peaked one month post vaccination, then declined rapidly and became 
negative after five months, Seventy-five percent of the cattle remained 
negative on the CF test for the 18 month period of observation, whereas 
25% had occasionally low titers, Application of the CF test six months 
following vaccination made it possible to determine whether the persist-
ent agglutination titers were due to vaccination or natural infection 
in 90% of the cattle, 
IIi 1976, Plommet and Fensterbank (77), and again in 1979, 
Fensterbank and Plommet (32), investigated a new route of vaccination, 
the conjunctiva! route, traditionally used as the site for challenge, 
In the first study, they used 74 heifers, 7-12 months old, and divided 
them into four groups; an unvaccinated control. group; a second group 
vaccinated subcutaneously with 9 X io10 B. abortus strain 19; a third 
group vaccinated subcutaneously with 9 X io10 strain 19, then revacci-
nated by the conjunctiva! route six to eight months later with 5 X ~o9 
strain 19 organisms; and a fourth group vaccinated twice by the conjunc-
tival route with the same dose and time intervals as in the third group. 
Following:challenge with~. abortus strain 544, the average degree of 
infection per group, as determined by culturing techniques, was signifi-
cantly lower in the vaccine groups as compared to the Control Group. 
Groups 3 and 4 had a significantly lower degree of infection than the 
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group vaccinated subcutaneously, The second group developed agglutinin 
titers i.n which the geometric mean reached l500 I. U, in l5 days post 
vaccination and receded to less· than 30 I.U. seven months later. All 
cattle in Group 2 were negative 60 weeks post vac~ination, The third 
group developed agglutinin titers similar to Group 2 until the booster 
vaccination was given by the conjunctival rout.e. This caused a rise· in 
titers for two months; however, the titers receded and became negative 
at about the same time period as the cattle in Group 2. ' The mean agglu-
tination titers of Group 4 did not reach 30 I.U. after the first vacci-
nation. Following the second vaccination, some titers were positive for 
a maximum of eight weeks with the group mean agglutinin titer of JO I. U. 
lasting for one week. Plommet and Fensterbank felt the conjunctival 
route of vaccination could be used to vaccinate cattle at any age with-
out serious interference in routine diagnostic tests. 
Afte:z; a lapse of approximately JO years, adult vaccination has been 
reinstated in the southern United States as an immunizing procedure. 
Nicoletti et al. (74, 75) studied adult vaccination using various dosages 
and routes of administration of the strain l9 vaccine in large infected 
dairy herds. The serological tests used included the standard tube 
agglutination (STT), mercaptoethanol (ME), rivanol (RIV), card, and com-
plement fi:xation (CF), The CF test became negative before the aggluti-
nation tests following vaccination. They concluded that a 0,2 ml dose 
of strain l9 given subcutaneously provided an adequate protection without 
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creating a persistent titer problem and that the CF. test proved to be 
superior to other tests in correctly identifying culture positive cattle. 
One of the hazards occasionally encountered with adult vaccination 
is vaccine induced abortion. Several reports of abortion following vac-
cination of cows in late gestation occur in the literature. Haring (35) 
induced uterine infection and abortion with strain 19 in one cow vacci-
nated during advanced gestation. Strain 19 was isolated from one heifer 
out of 40, which McDiarmid (60) vaccinated at approximately two months 
gestation. Mant.hei (52) reported.strain 19 caused one abortion in 76 
pregnant cattle inoculated with 5 ml of vaccine subcutaneously and one 
abortion in 27 pregnant cattle inoculated with a 0.2 ml of strain 19 
intraderrnally, Deem and Cross ( 25) recovered organisms similar to . strain 
19 from two aborted fetuses collected fro'm two herds containing a total 
of 116 cows vaccinated in late gestation following known exposure to 
brucellosis reactors. 
Others (30, 68, 92) have reported abortions following vaccination 
of pregnant cows but could not prove that these.abortions were due to 
strain 19 infection. The majority of abortions reported in pregnant 
cattle vaccinated with strain 19 have occurred in cattle vaccinated in 
late gestation. 
Mode of Transmission 
The transmission of ~. abortus is primarily by ingestion of food 
or water contaminated directly or indirectly with infectious material 
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such as uterine discharge, aborted fetus or placenta, The organism may 
invade the surface of mucous inembranes. Other means of spreading the 
organism include venereal and dam to offspring transmission (48), Bru-
cel1osis in man, caused by~. abortus, is primarily transmitted by han-
dling infected cattle or ingestion of food products such as milk or 
meat (58, 67), 
Diagnosis of Bovine Brucellosis 
The diagnosis of brucellosis is primarily accomplished by serolog-
ical tests and direct cultural examination of milk or tissue samples (2), 
Other diagnostic procedures include animal inoculation (2) and skin 
tests (44), The isolation and identification of~. abortus provides· 
the best evidence that infection is present (2), Milk, placenta, vagi-
nal mucous, fetal stomach contents, fetal lung, fetal spleen, meconium, 
and occasionally blood are cultured from live cows in order to isolate 
Brucellil. (2), Tissues collected from cattle at slaughter are also cul-
tured for isolation of Brucella. These include, in order of importance 
as sources of Brucella; the supramammary lymph nodes, internal iliac 
lymph nodes, lumbar lymph nodes, parotid lymph nodes, spleen, uterus·, and 
mammary tissues (2), 
It is not always possible to isolate Brucella from infected cattle; 
therefore, the serological and milk antibody tests have been important 
in diagnosis, The tube agglutination and complement fixation tests were 
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first used in diagnosis of brucellosis (40, 84), In 1926, Huddleson et 
al. described the rapid plate' agglutination test (43), The Brucella 
Ring test, used for detecting agglutinins in milk, was first reported 
in 1937 and used in field studies in the late 1940s (79), The acidified 
plate antigen (APA) test, reported by Roepke et al. (80) in 1956, uses 
acetic, lactic, or tartaric acid to reduce the pH of the serum-antigen 
. mixture between the ranges of three to four, This low pH inhibits non-
specific agglutination reactions. 
In the early 1960s, Anderson et al, (4) developed the rivanol pre-
cipitation pl~te agglutination test (Rivanol test), A J% solution of 
rivanol and serum are mixed in equal quantities and centrifuged. The 
nonspecific (high molecular weight) agglutinins precipitate with the 
proteins; whereas, the specific (low molecular weight) agglutinins re-
main in the supernatant which is used for testing. 
The card and mercaptoethanol (ME} tests were developed in 1964 (3, 
76). The low pH of the buffered antigen used in the card test inhibits 
nonspe0ific agglutination reactions; whereas, the ME test utilizes 0.05 
molar mercaptoethanol to inacti·vate the IgM class of antibodies, 
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MATERIALS AND MEI'HODS 
Brucella Organisms 
Vaccine inoculum preparation 
A lot of lyophilized vaccine was prepared, as previously described, 
from "Original Seed"1 using liquid.medium, sodium carboxymethyl-cellu-
lose method for separating the cells and a lyophilizing stabilizer (2, 5). 
The original fill volume of single dose vials was 2 ml. It had previ-
ously been determined that after restoration of the vaccine to the orig-
i:tla.l fill volume it could be stored at 4° C for several days with only 
a slight decrease in viability, 2 
Four days before vaccination of the animals, 20 vials of vaccine 
were restored to 2 ml volumes and the contents were then pooled and a 
viability count conducted, The results of the count indicated the pool 
contained 22 X 109 viable organisms per ml. On the day of vaccination, 
this concentrate was diluted in phosphate buffered saline pH 6.4 to make 
five lots of vaccine containing 78 X 109 , 5,0 X 109 , 9,2 X 108 , .1.4 X 108 , 
and 2,3 X 107 viable organisms/dose respectively as determined by via-
bility counts post-dilution. After the vaccination was completed, a 
viability count was again made on an uliused portion of each lot.of vac-
cine and no appre·ciable difference was found between. the two counts. 
1usDA, original stock culture of ~· abortus strain 19 prepared by 
the Reagents Section, Scientific Services Laboratory, National Veterinary 
Services Laboratories, Ames, IA, 
'1i. D, Angus, unpublished data, Ames, IA. 
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Challenge inoculum preparation 
The challenge inoculum was prepared from a lyophilized culture of 
~. abortus strain 2308, the USDA . l Challenge Strain. Prior to lyophili-
zation, the culture had been passaged in guinea pigs and recovered. 
After the recovery from guinea pigs, the culture was passaged on arti-
ficial medium a minimum bf.times in·order to prepare it for lyophilization, 
The lyophilized culture was restored using sterile distilled water 
and then plated onto tryptose agar containing 5% bovine serum, The in-
oculated plates were incubated at 37° C for 96 hours and examined under 
a broad field dissecting microscope using a reflected light source, An 
area of typically smoo.th colonies was selected and inoculum was trans-
ferred to tryptose agar slants, The slants were incubated at. 37° C for 
24 hours after which the growth was washed from the surface of the agar 
using phosphate buffered saline, pH 6.4 (PBS). The density of the cell 
suspension was adjusted to give 66% light transmittance at a wave length 
2 of 600 nm ..on a B & L Spectronic 20 spectrophotometer, then a l :2000 
dilution was made using PBS and duplicate viable counts were made using 
standard procedures (86), The viability count conducted on the day of 
challenge indicated the inoculum contained 8.27 X 105 organisms per ml, 
1Prepared by the Reagents Section, Scientific Services Laboratory, 
National Veterinary Services Laboratories, Ames, IA, · 
2 Bausch & Lomb, Inc,, Rochester, NY, 
:r' 
,.· 
1.5 
Serological Procedures 
Six serological tests were used to evaluate the antibody response 
to vaccination and challenge, The test procedures are described below. 
Tube agglutination test 
Tube agglutination test antigen was a 4 • .5% {by volume) stock sus-
pension of ~. abortus strain 1119-3. When used in the laboratory, the 
stock antigen was diluted at 1:100 with saline containing 0 • .5% phenol, 
Serum quantities of 0,08, 0,04, 0,02, 0,01, and 0,00.5 ml were measured 
into five separate test tubes and 2,0 ml of diluted antigen added to 
each tube, This resulted in dilutions of 1:2.5, 1:.50, 1:100, 1:200, and 
1:400 1 respectively. The tubes were incubated at 37° C for 48 hours and 
read for clearing and agglutination against a dull black background, 
with light coming from behind the tubes, When the serum samples were 
positive at the 1:400 dilution, additional doubling dilutions, up to 
1:1280, were made to determine the end point titer. Ea.ch dilution was 
read.as positive, incomplete, or negative (89). 
Plate agglutination test 
The plate test has been standardized so that, by using the same 
quantities of serum as in the tube test, the results obtained are com-
parable to the results of the tube test, The antigen contained 11,0% 
{by volume) of B, abortus strain 1119-3 and was stained with a mixture of 
crystal violet and brilliant green, One dxop (0.03 ml) of antigen was 
added to each quantity of serum {0,08, O,o4, 0,02, 0,01, and 0.00.5 ml) 
on a plate, mixed, rotated, and then incubated at room temperature for 
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eight minutes.· The plate was rotated for four rotations immediately 
after mixing and after four and eight minutes of incubation. Immediately 
after the final rotation of the plate, the test was read against·a black 
background with indirect lighting (89), Each dilution was read as pas-
itive,.incomplete,. or negative. 
Rivanol precipitation test 
In the rivanol precipitation-plate agglutination test·, equal q_uan~ 
ti ties of serum and 1. 0% solution of rivanol 1 were mixed and centrifuged 
for five minutes.. The· supernatant was tested by placing fiv.e q_uantities 
(0.08, 0.04, 0,02, 0.01, and 0,005 ml) on a glass plate (such as the 
Minnesota test box) and one drop (0.03. ml) of rivanol antigen (prepared 
as outlined in the Diagnostic Reagents Manual 65-C (88)) was added to 
each q_uantity of supernatant and mixed. The results were read after the. 
mixture on a plate was incubated at room temperature for 12 minutes. 
The plate was rotated four times at the beginning of incubation, after 
six minutes, and after 12 minutes incubation (just prior to reading). 
The results using five q_uantities of serum were considered comparable to 
dilutions of 1:25, 1:50, 1:100, 1:200, and 1:400, respectively, and the 
reaction of each dilution was read as negative, incomplete, or positive 
(90). 
Mercaptoethanol test 
The mercaptoethanol test (ME test) was performed similar to the 
standard tube test except that rather than adding 2 ml of a 1:100 dilution 
~oussel Corporation, New York, NY. 
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of the concentrated tube antigen, 1 ml of 0.1 molar mercaptoethanol and 
1 ml of a 1:50 dilution of the concentrated tube antigen were added 
(maldng a final ME concentration of 0.05 M). Phenol was not used as a 
preservative, as it caused cloudiness in the test suspension, The period 
of incubation and the reading of the results are the same as described 
for the tube test (90), 
Complement fixation test1 
Serum samples were diluted 1 :10 with veronal buffer (VE) and heated 
at 56° C for 30 minutes to inactivate resident complement, Tubes were 
placed in racks to provide for dilution of the serum up to 1:1280 in a 
doubling dilution scheme, The first tube for each sample was used as a 
serum control containing 0,5 ml inactivated serum and 1.0 ml complement. 
The second tube was the first test dilution (1:10) and contained 0.5 ml 
inactivated serum, 0,5 ml antigen (Brucella tube test antigen diluted 
1:500) and 1.0 ml complement, Remaining tubes were the same as tube 2 
except that the serum had been serially diluted in VB to provide for 
ti tra ti on .of the anti body activity. The racks of tubes were shaken and 
placed at 4° C overnight to allow for antigen-antibody reaction and 
fixation of the complement. 
Following the reaction period, 1.0 ml of sensitized RBC's were added 
to· each tube. The racks were shaken and then incubated in a waterbath 
for 30 minutes at 37° C and then read. No hemolysis indicated a "++++" 
1 . . 
Conducted by the Serology and General Bacteriology Section, 
Diagnostic Bacteriology Laboratory, National Veterinary Services Labo-
ratories, Ames, IA. 
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titer with 10o% fixation, Twenty-five percent hemolysis was read as a 
"+++" titer with 75% fixation, Fifty percent hemolysis was read as a 
"++" titer with 5o% fixation, and 75% hemolysis indicated a "+" titer 
with 25% fixation (40), 
The card test was conducted on disposable, waxed cardboard sheets 
with ten teardrop indentations.1 Equal ~uantities (0.03 ml) of serum and 
antigen were placed in an indentation and mixed, F.ach mixture was 
spread over.the entire surface of the indentation, The card was then 
' 2 ' 
rocked for four minutes on a card test rocker and the results were read 
immediately. The presence of an agglutiria.tion reaction indicated a 
positive test (90). 
Experimental Animals 
For this study 135 female beef cattle, li to 2 years of age, were 
purchased from two Nebraska ranches. Prior to purchase, the cows were 
examined and found to be free of any clinical signs of disease. Blood 
samples were taken from each animal and the serum was tested for Brucella 
antibodies using the card, tube, plate, rivanol, mercaptoethanol, and. 
complement fixation tests. The cattle were all serologically negative 
for brucellosis on all tests, In addition, they were certified by the 
owners as unvaccinated for or having no known exposure to brucellosis, 
1 Hynson, Wescott & Dunning, Baltimore, MD. 
2.retracon Assn. Inc., Norman, OK. 
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The cows were transported to Ames, Iowa and unloaded into an isolated 
cattle pen, Six days later, nine bulls were placed with the cattle for 
nine weeks (three estrus periods) , The bulls were from an Iowa bull 
testing farm, They had no history of contact with Brucella, either from 
vaccination or exposure. Blood samples were drawn and subjected to the 
same tests as described above and were found to be negative, One week 
following removal of the bulls, each cow was examined for pregnancy, 
Ninety-five pregnant animals were randomly selected and transported to 
medium security animal housing facilities at the National Veterinary 
Ser\/ices Laboratories (NVSL) for the vaccination-challenge phase of the 
study. The remaining 40 animals were transported to other animal housing 
facilities at NVSL and used for the vaccination-nonchallenge phase of the 
study, Any animals, which were diagnosed as being nonpregnant during the 
first examination, were reexamined 45 days later. 
The 95 pregnant cows used in the vaccination-challenge phase of the 
study _were housed separately in individual indoor stalls, Each animal 
had a separate headgate for restraint, separate feed containers, and 
separate water bowls. The cows were maintained in these stalls for the 
duration of the study. Great care was used to minimize contact between 
animals, caretakers, and equipment, 
All personnel were required to wear rubber boots, coveralls, rubber 
gloves, and face shields, Boots and gloves were disinfected in a solu~1 
tion of Microbac1 in water, after exiting from a stall and prior to the 
1Professional Products Division, Economics Laboratories, Inc,, 
St. Paul, MN, 
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entry into other stalls or feed areas. The animals were bedded with 
wood shavings, The pens were scraped clean once every two days. The 
animals were fed a maintenance ration, supplemented with alfalfa hay or 
hay cubes. 
The 40 cows used in the vaccination-nonchallenge phase were housed 
together in an open, dry lot with a loafing shed for shelter, 
Vaccination Phase 
Vaccination-challenge groups 
Following serological testing and pregnancy examination (see Table 
2), 9.5 pregnant animals were randomly assigned to six groups and vacci-
nated subcutaneously with B. abortus strain 19 vaccine as shown in Table 1. 
Table 1. Dosage schedule for vaccination-challenge groups 
Group 
VC-1 
VC-2 
VC-J 
VC-4 
VC-5 
Control 
No. 
animals 
15 
15 
15 
15 
15 
20 
Vaccine dosage 
Volume 
5 ml (standard dose) 
2 ml (6.4% of std. dose) 
2 ml (1.2% of std. dose) 
2 ml (0,18% of std, dose) 
2 ml (0,03% of std, dose) 
none 
No. viable organisms 
78,0 x 109 
5,0 x 109 
9,2 x 108 
1.4 x 108 
2.J x 107 
none 
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Table 2. Weekly chronology of principal procedures performed with· 
reference to vaccination 
Date 
9-15-77 
9-16-77 
9-22-77 
11-24-77 
11-(28-29)-77 
12-6-77 
12-13-77 
12-20-77 
12-27-77 
1-3-78 
1-10-78 
1-17-78 
1-24-78 
1-31-78 
2-7-78 
2-21-78 
3-7-78 
. 3-21-78 
4-4-78 
Time interval 
from vaccination 
week -12 
week -3 
week -2 
week -1 
week O 
week 1 
week 2 
week 3 
week 4 
week 5 
week 6 
week 7 
week 8 
week 10 
week 12 
week 14 
week 16 
Blood sample 
collected 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
Comments 
135 cows examined indi-
vidually for clinical 
signs of disease 
135 cows delivered to 
sit·e 
9 bulls added to herd 
bulls removed 
pregnancy examination 
vaccinate 5 groups with 
different dosages 
reexamination of non-
pregnant cows 
challenge 95 animals 
22 
T<r:ble 2. (Continued) 
1Ja. te Time i nterval Blood sample Comments from vaccination collected 
4-11-78 week 17 yes 
4-18 -78 week 18 yes 
4- 25-78 week 19 yes 
a. 
20 5- 2-78 week yes 
5-9-78 week 21 yes 
5-16-78 week 22 yes 
5- 2)- 78 week 23 yes 
a week 24 5- J0-78 yes 
6-6-78 week 25 yes 
6-lJ-78 week 26 yes 
6- 20-78 week 27 yes 
a week 28 6- 27-78 yes 
i -11-78 week JO yes 
a week 32 7-25-78 yes 
8 -8 -78 week J4 yes 
8 -22-7s1' week J6 yes last week that all cattle 
were sampled 
9-5- 78 week J8 yes 
a week If{) 9-19-78 yes 
8-22 to 10-15 Cattle wer e sold for sla.~hter a.nu tissues collectea 
aForty nonchallenged animals bled at one month intervals after 
challenge of the other 95 animals . 
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A blood sample was collected from each animal and serological tests 
(tube , card , mercaptoethanol , rivanol, plate , and complement fixation) 
were conducted at one week intervals for the first ei ght weeks after 
vaccination and at biwee~y intervals for the next eight weeks (Weeks 
9-16) . 
Vaccination-nonchallenge groups 
The remaining 40 animals were randomly assigned to five groups of 
eight animals/group and vaccinated subcutaneously according to the sched-
ule in Table 3. All but three animals were pregnant. For 16 weeks post 
vaccination , the bl ood sampling and testing followed the same schedul e 
as for the vaccination-challenge groups ; however, these animals were not 
challenged. Blood samples wer e collected and tested at four week inter-
vals for Weeks 17-36 post-vaccination . 
Table J . uosage s chedule for vaccination-nonchallenge groups 
Vacci ne Dosage 
Group No , a.nimals 
Vol ume No . viabl e organisms 
V-1 8 5 ml (standard dose) 78.0 x 109 
V-2 8 2 ml ( 6 , 4 ;~ of std . dose) 5 . 0 x 109 
V-J 7 2 ml (1. 2% of std . uose) 9.2 x 108 
V-4 8 2 ml (0 . 18% of std . uose) 1.4 x 108 
V- 5 f3 2 ml (o . oy& of stu . dose) 2 . J /,. 107 
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When parturition occurred, the placental membranes, swabs of vagi-
nal mucus and quarter milk samples from each ani~l. were cultured for 
1 Brucella. Thereafter, quarter milk samples .were cultured at two week 
intervals from animals which strain 19 was isolated or with serologic 
evidence of persistent infection with strain 19. Tissues were collected 
1 from each animal at slaughter and cultured for ~. abortus. 
Challenge Phase 
Challenge procedure 
Sixteen weeks after vaccination, 75 vaccinates and 20 nonvaccinates 
were exposed by inoculating 1 ml containing 8.27 X 105 viable organisms 
of~. abortus strain 2308 into the conjunctival sacs of each animal, 
Half the dose was· placed into each eye and the eyelids were .. held shut 
and massaged gently for one minute to allow time for absorption. 
Post-challenge examinations 
The post-challenge antibody response of each animal was determined 
using the serological procedures previously mentioned. When parturition 
or abortion occurred, the aborted fetus, placental membrane, swabs. of 
vaginal mucus, and quarter milk samples from each animal were cultured1 
for~. abortus. 
Milk samples were collected and cultured1 from the cows from which 
1vaginal mucus, ffiilk, and tissues taken from cows at slaughter were 
cultured by the Mycobacteria and Brucella Section, Diagnostic Bacteriology 
Laboratory, NVSL, Ames, IA, and fetal tissues and placental membranes were 
cultured by the Reagents Section, Scientific Services Laboratory, NVSL, 
Ames, IA, 
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~. abortus was not isolated; at two week intervals until Brucella or-
ganisms were isolated or until completion of the study. If isolations 
were made, the milk samples were collected and cultured until three neg-
ative weekly samples were collected, 
Samples of the vaginal mucus were collected weekly from each animal 
following challenge and on the day of calving or abortion. Animals 
which remained negative for Brucella on culture for three continuous 
weeks, following calving or abortion, were not swabbed for the remainder 
1 of the study. Vaginal. swabs were collected and cultured at weekly 
intervals from each vaginal swab culture positive animal until negative 
results were obtained for three consecutive weeks. 
Cattle that became serologically.negative and those from which 
~. abortus was isolated were the first animals to be sent to slaughter 
following Week 36, Tissues (supramammary, retropharyngeal, iliac and 
lumbar lymph nodes and a section of the spleen, uterus and each quarter 
of the udder) were collected at slaughter from each animal and cultured2 
for Brucella. 
Cultural Procedures 
Bacteriologic culture mediums 
The two mediums used to isolate the Brucella organisms by direct in-
oculation were designated.No. 2 and No. 3 as described by Nelson et al. 
(73). 
1Amy.Armbrust, Masters Thesis, ISU, 1979.(6). 
~issues were cultured by the Mycobacteria and Brucella Section, 
Diagnostic Bacteriology Laboratory, NVSL, Ames, .IA. 
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Medium No. ~ (serum tryptose agar with antibiotics) Medium No. 2 
contained 41 gm o:f Formula 00641 in one liter o:f water. A:fte± steriliza-
tion the medium was cooled to 50° C and immediately prior to dispensing 
the medium into petri dishes, 50 ml o:f sterile bovine serum with 1,800 
units o:f polymixi.n B, 7,500 units o:f l:iacitracin, and 30 mg o:f cyclohexa-
mide2 were added to enrich the medium and aid in preventing the growth 
o:f contaminates. 
Medium No. J. (serum tryptose agar with antibiotics and crystal 
violet) Medium No. 3 was prepared in the same manner as No, 2 except 
that 4 ml o:f 1:2600 solution o:f crystal violet was added to each liter 
o:f medium just prior to sterilization, 
Milk sample collection 
Samples q:f milk from each quarter o:f'the udder were collected di-
rectly into sterile whirl-pak bags,3 Prior to collection the udder was 
washed with a H2o and Betadine
4 solution. To :further reduce contamina-
tion, disin:fected rubber gloves were worn while milking, The samples 
were placed in insulated containers and taken directly to the laboratory. 
Twenty milliliters o:f milk :from each quarter sample were pipetted into a 
sterile tube and centrifuged at approximately 5,000 X g :for 15 minutes, 
The cream and sediment :from each sample was inoculated onto separate 
1Di:fco Laboratories, Detroit, MI. 
2
Aeti-Dione, Calbiochem, Los Angeles, CA. 
3Arthur H, Thomas Co., Philadelphia, PA. 
4Purdue Frederick Co. , Norwalk, CT, 
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plates of Medium No. 2 and No .• 3, The plates were incubated in air at 
0 . 
37 G for a maximum of seven days and examined for the growth of Bru-
cella-like colonies. 
Tissue sample collection 
The tissues obtained from each animal at slaughter were collected · 
as aseptically as possible, placed in sterile whirl-pak bags, identi-
fied, and placed in insulated containers with dry ice. The frozen tis-
sues were stored at -20° G and processed within three months following 
collection. 
The methods described by Nelson et al. (73) were used to prepare 
and culture the tissue samples, A section of tissue was cleaned of all 
exterior fat, dipped in 95% ethyl alcohol and flamed. The tissue was 
incised with a sterile scalpel. Multiple cuts were made to increase the 
expo·sed surface area and then it was applied directly to the surface of 
the medium. Two plates, one containing Medium No,·· 2 and one containing 
Medium No. 3, were inoculated using this procedure, The plates were 
incubated at 37° G in an air environment and examined periodically for 
Brucella-like colonies for a maXimum of seven days in an air environment. 
Vaginal mucus collection 
Samples of vaginal mucus were aseptically collected on sterile dis-
posable Kalayon guarded culture instruments,1 placed in sterile labeled 
tubes and transported in insulated containers to the laboratory. The 
culture procedure and results are described and reported elsewhere by 
Armbrust ( 6) • 
1w. A, Butler, Columbus, OH, 
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Identification and verification of Brucella isolates 
The colonies which developed on selectiv.e mediums were isolated for 
study and those which had characteristics of Brucella were subjected to 
the established procedures (91) for accurate identification of the Bru-
cellae, Antigenic and biochemical tests were conducted on each Brucella 
strain isolated following the procedures reported by Alton et al. (2). 
In order to ·distinguish between vaccination and challenge strains, the 
following differential characteristics were determined as described by 
Brown et al. (15), 
Table 4, Tests for differentiation of ;!!, abortus strain 19 and 2308 
Medium containing 
Thionin blue 1/50;000 
Penicillin 5 units/ml 
Erythritol 1 mg/ml 
Strain 19 
a 
~ndicates no growth in the presence of these factors. 
b Indicates growth in the presence of these factors, 
Reading and Interpretation of Serologic Results 
Strain 2308 
'b 
+ 
+ 
+ 
The card test results are based on the presence or absence of an 
agglutination reaction and are read as positive or negative. Therefore, 
the graphs depicting the card test results represent,. as a percentage, 
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the total number of cows that were positive during each week. 
·The agglutination tests (tube, plate, ME, and rivanol) are con-
ducted with serum dilutions of 1:25, 1:50, 1:100, 1:200, etc. After 
incubation, each serum dilution was read for clearing and agglutination. 
The highest dilution showing complete or incomplete agglutination was 
recorded as a positive. test·. Therefore, the graphs depicting these test 
results present the dilutions along the y-axis. Each dilution numbered 
is positive (i.e. +25) while halfway between the positive dilutions is 
an incomplete positive (i.e. I.SO). 
The CF test was conducted with serum dilutions of 1:10, 1:20, 1:40, 
1:80; etc.. After incubation, each serum dilution was read and the degree 
of hemolysis was recorded. A "+" indicates 25% of the Red Blood Cells 
(RBC's) are hemolyzed. A "++" indicates 5o% are hemolyzed, a "+++" 
indicates 75% are hemolyzed, and a "++++" indicates 10o% of the RBC's 
are hemolyzed. Therefore, the graphs depicting the CF test results have 
the dilutions listed along the y~axis. 
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RESULTS 
The results are divided into four sections: 1) the antibody re-
sponses of the vaccination-nonchallenge groups, 2) the antibody responses 
of the vaccination-challenge groups and the nonvaccination-challenge 
control group, 3) a comparison cif the results of the tube and mercap-
toethanol tests is made to depict the difference between the IgG and IgM 
response for each group of cattle, and 4) pertinent clinical observations 
and individual serologic and cultural results 
Vaccination-Nonchallenge Phase 
The antibody levels in blood samples collected weekly or biweekly 
from each cow were determined using six serological tests and the results 
are presented in graphic form. 
Card test results 
Figure 1 displays the antibody.response of.the five vaccination-
nonchallenge groups (eight animals/group) as judged by the card test. 
The card test is read as a positive or negative; therefore, the graph 
represents the percentage of cows that were positive on the test, by week, 
for 36 weeks following vaccination. 
Group V-1 received the standard dose of :!?_. abortus strain 19 vaccine 
(78 X 109 organisms). These cattle became positive on the card test 
one week following vaccination and remained positive until after Week 
18. One animal became negative during Week 20. On Week 22, all of the 
Figure 1. Retsults of biweekly and monthly card tests for the five vaccination-nonchallenge 
groups following !!_, abortus strain 19 vaccination 
Group V-1 (+) received 78 X 109 organisms (8 animals per group) 
Group V-2 (*)received 5 X 109 organisms (8.animals per group) 
Group V-3 (#) received. 9.2 X 108 organisms (7 animals per group) 
Group V-4 (fil) received 1,4' X 108 organisms (8 animals per group) 
Group V-5 (X) received 2,3 X 107 organisms (8 animals per group) 
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cattle were positive but decreased to 75% positive during Weeks 24-32. 
Thereafter, the percentage of. positive cattle declined to 37fo by Week 
36. 
Cattle in Group V-2 received a vaccine dose of 5 X 109 organisms. 
All animals were positive on the card test after one week and remained 
positive until Week 6. After the sixth week, the percent positive de-
clined rapidly until Week 12; where only 25% of the cattle were positive 
(2 animals), The card test reactions tended to remain at about 25% pos-
itive from the 12th to the 32nd week, however,·there was some fluctua-
tion. For example, at the 20th week only 2'J/o were positive (1 animal) 
and at Week 24, 37% reacted (3 animals), All animals were negative by 
the 36th week. 
Group V-3 cattle (9.2 X 108 ~· abortus strain 19 organisms) were 
over· 85%.positive during Weeks 1 and 2, and all were positive during . . 
Weeks, 3 and 4. Thereafter, the percentage of positive reactions de-
clined sharply until Week 12 when 12% of the cattle (1 animal) remained 
positive until Week J6, One additional animal became positive during 
Week J2. 
The percentage of positive reactions in the Group V--4 cattle 
(1.4 X io8 ~· abortus strain 19 organisms) peaked at 75% by Week 4, 
then declined until all cattle were negative on the card test by the 
seventh week. Group V-5 received 2.3 X 107 ~. abortus strain 19 
organisms, which was the lowest dosage used. Only 25%· (2 animals) were 
positive by Week 3 and they reverted to negative by Week 8. 
The percentage of cattle responding on the card test and the per-
sistence of antibodies as detected by the card test were directly corre-
lated with the dosage of vaccine given. The highest dosage group re-
mained over 35% positive by Week 36, whereas Groups V-2 and V-3 were 
almost negative by Week 36. The lowest two dosages were negative by 
Week 8. 
Tube test results 
The serologic results for the groups of vaccination-nonchallenge 
cows on the tube test are presented in Figures 2-6. The graphs repre-
sent the geometric mean titer of each group. The titer range for each 
sampling date is also depicted. All animals in the vaccina"\:-ion-nonchal-
lenge groups responded. to the vaccine as evidenced by positive reactions 
in the tube test. The antibody titers in a11· cows were highest during 
Week 2. The overall trend of the titers was similar for each group, 
regardless of the dosage of vaccine given. The major difference between 
the .five vaccine groups was the degree of antibody response, which cor-
related with the dose of vaccine. 
Figure 2 displays the tube test results for Group V~l. The range 
of titers for each week is included and was approximately two to four 
dilutions. The highest individual titer was a positive at 1.:3200 (+3200) 
during Week 2 while the lowest titer, that week, was an incomplete pos-
itive at 1:800 (1800). The maximum geometric mean titer was a positive 
.. 
Figure 2. Results of biweekly tube' tests for Group V-1 (vaccination-
nonchailenge) following B. abortus strain 19 vaccination with 
5 ml containing 78 X lOrorganisms (8 animals per. group),-
Figure 3.• Results of 'biweekly tube tests for Group V-2 (vaccination-
nohchallenge) following~. abortus strain 19 vaccination with 
2 ml containing 5 X 10'.1 organisms (8 animals per group) 
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at a 1:1600 (+1600) during Week 2. The mean titer gradually receded 
to a positive at a 1:100 (+100) between Weeks 24.and 36, 
Group V-2 (Figure 3) had mean titers that were lower than Group V-1 
with the maximum titer being a +400, This mean titer then receded fol-
lowing Week 2 until Week 16 when it was an 150. It fluctuated slightly 
at that level through·Week 36, 
The range in titers (approximately four dilutions) was greatest for 
Group V-2 during the first seven weeks. After Week 7, the ·range was 
approximately two dilutions. The highest individual titer was a +1600 
during Week 3, 
The mean titers for Group V-3 (Figure 4) were similar to those in 
Group V-2; however, the range of individual titers was considerably dif-
ferent. The range for Group v~3 varied between three to four dilutions 
during the entire study, except for Week 16 when the range was approxi-
mately one dilution. The highest individual titer was a +1600 during 
Weeks 1 and 2. By Week 10 the titers began to decline to an I50 and 
remained at that level through Week 36, 
Figure 5 shows the mean titers for Group V4. The maximum mean 
titer was a +100. During Week 8 the mean titer receded to. a +25, there-
after, it fell below the +25 dilution. The range was five dilutions 
during the first week but decreased to one or two dilutions (-25 to +50) 
during the last 16 weeks. 
Group V-5 (Figure 6) had the lowest mean titer response, with the 
Figure 4. 
Figure 5, 
Results of biweekly tube tests for Group V-3 (vaccination-
nonchallenge) following B. abortus strain 19 vacqination with 
2 ml containing 9.2 X 108" .organisms (7 animals per group) 
Results of biweekly tube tests for Group·v~4 (vaccination- · 
nonchallenge) following B. abortus strain 19 vaccination with· 
2 ml containing 1.4 X 108" organisms (8 animals per group) 
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Figure 6, Results of biweekly tube tests for Group V-5 (vaccination-
nonchallenge) following B. abortus strain 19 vaccination with 
2 ml containing 2.3 X 107 organisms (8 animals per group} 
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maximum being a +50 during the second week. The mean titer receded to 
almost negative at a 1:25 dilution during. Weeks 8-14, increased.to a +25 
during Weeks 26-32, then decreased to an I25 on Week 36, 
The greatest rarige in titers among individual animals was five di-
lutions durj_ng Week 3 (-25 to ;400). However, there was a variation of 
only one to two dilutions. from Week 5 through Week 28, One animal's 
titer increased from ah I50 during Week 28 to a '1400 during Week 32 1 
then decreased to an IlOO during Weeks 36 and 40. 
Plate test results 
The highest dilution used in th~ plate test was a 1:400, which con-
forms With established procedures. The serologic results for the groups 
of vaccinated-nonchallenged cows on the plate test were similar in each 
group when compared with the corresponding ·tube titers, exoept that the 
geometric mean plate titer was.lower than the tube titer because the 
plate titers were not conducted at the highest reacting dilutions, 
Therefore, the plate test results are not presented in the graphs, In-
dividual animal plate test results are included in the Appendix, 
Mercaptoethanol test results 
Figures 7-11 depict the geometric mean serologic. results for the 
five vaccination-nonchallenge groups of cows on the mercaptoethanol (ME) 
test. The maximum mean antibody titers occurred during Week 3 for the 
four higher dosage groups and at Week 4 for the lowest dosage group, 
The general titer patterns were similar for each group. The major 
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difference between the five vaccine groups was 'the degree and persist-
ence of the antibody response. 
Figure 7 shows the ME test .results :fbr Group V-1. During Week 1 
there was no response, which differed from the tube test results. A 
peak titer of a i400 was reached during Week 3; it gradually declined 
to a -25 by Week 36. The range of individual titers fluctuated from 
over five dilutions during Week 2 ( +50 to I3200) to half a dilution 
during Week 4 (+200 to I400). The range increased again to four dilu-
tions (I25 to -+400) by Week 16 then gradually declined to two dilutions 
(-25 to +50) at Week 32. 
Group V-2 (Figure 8) had mean ME titers that were significantly 
lower (99% probability)
1 
than Group V-1. Although all of the cows in 
this group responded to the vaccine, there was no response during the 
first week, A peak mean titer of an IlOO was reached during Week 3, The 
titer declined rapidly and was negative at a 1:25 by Week 12, One ani-
.mal reacted at an I25 during Week 16. The highest individual titer was 
.. 
a -+400. The range in individual titers was five dilutions ( +25 to i400) 
during Week J, but decreased rapidly as did the group mean titer. 
The m.ean titer response for Group V-3 (Figure 9) was similar to 
Group V-2; however, the peak titer was only an I50 during Week 3 and re-
turned to a -25 by Week 12. One cow in this group failed to respond, 
Figure 10 shows the antibody response produced by Group V-4 on the 
1i>earson chi-square was used to determine significance level.·· 
Figure 7, Results of biweekly mercaptoethanol tests for Group V-1 
(vaccination-nonchallenge) following B. abortus strain 19 
vaccination with 5 ml containing 78 x-109 organisms (8 
animals per group) 
Figure 8. Results of biweekly mercaptoethanol tests for Group V-2 
(vaccination-nonchallenge) following l!l_, ~bortus st:ml.in h9 
vaccination with 2 ml containing 5 X 109 brganisms (8 
animals per group) 
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Figure 9, 
Figure 10, 
Results of biweekly mercaptoethanol tests for Group V-3 
(vaccination-nonchallenge) following B. abortus strain 19 
vaccination with 2 ml containing 9,2 X 108 organisms 
(7 animals per group) 
Results of biweekly mercaptoethanol tests for Group V-4 
(vaccination-nonchallenge) following~. abortus strain 19 
vaccination with 2 ml containing 1.4 X 108 organisms 
(8 animals per group) 
ISDO 
15BOD .... 
j:: '"IOD 
·~ 2DD 
I.ti 
Cl a IDD 
m 5:'0 
3200 
.ISDD 
a: BOD ..... .... 
j:: '"IDD 
~ 2DD 
I§ 
cl 100 
m 5:'0 
47 
F" l GURE: 51 
0 2 Lt 6 B l D 12 I Ll I 6 I B 20 22 21.f 26 28 3D 32 31..t 36 
HE:E:IC PDST-VRCCINRTIDN 
F" I GURE I El 
25:' Jltl. 
D 2 Lt 6 BID 12 Iii 16 IB2D222'"1262B3D323"136. 
WEDC PDST-VRCCINATIDN 
48 
ME test. The highest titer was a +25, which occ=ed in three cows dur-
ing Weeks 3 and 5, Group V-5 had only one cow respond at a +25 during 
Week 4 and one at a I25 during Week 5 (Figure 11). 
Rivanol test results 
Antibody responses evaluated on the rivanol (RIV) test are pre-
sented in Figures 12-16. The response pattern of each group is similar 
to the ME test results. However, endpoint titers were not determined at 
dilutions greater than a 1:400, This affected the geometric mean results 
in Group V-1 for eight weeks and Group V-2 for two weeks, 
Group V-1 (Figure 12) showed a re~ponse the first week following 
vaccination but did not reach the peak mean titer (1400) until Week 4, 
The mean titer decreased more slowly than did the ME titer but was nega-
tive at a 1:25 dilution by Week 36, A range in individual titers of one 
to two dilutions increased after Week 10 (IlOO to "'400) to over four 
dilutions from Weeks 12 to 20 (-25 to 1400). The range gradually de-
clined to one-half dilution (-25 to 125) by Week 36, 
Figure 13 (Group V-2) shows there was no response at Week l, How-
ever by Week 2 a +100 peak mean titer was reached and persisted until 
Week 4, then gradually declined, The mean titer became negative by Week 
20; whereas, the mean ME test titer was negative by Week 12. The range 
of titers (a "'400 individual titer was reached during Weeks 3 and 4) 
was over three dilutions during Weeks 3-8 and decreased to half a 
dilution by Week 16 ( -25 to 125) • 
Figure 11, Results of biweekly mercaptoethanol tests for. Group V-5 
(vaccination-nonchallenge) following fl., abortus strain 19 
vaccination with 2 ml containing 2.3 X 107 organisms 
(8 animals per .. group). 
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Figure 12. Results of biweekly rivanol tests for Group V-1 (vaccination-
nonchallenge) following B, abortus strain 19 vaccination with 
5 ml containing 78 X lOrorganisms (8 animals per gro{ip) 
Figure lJ, Results of biweekly rivanol tests for Group V-2 ('vaccination-
nonchallenge) following~· abortus strain 19 vaccination with 
2 ml containing 5 X 10~ organisms (8 animals per group) 
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Group V-3 (Figure 14) had a response during the first week which 
peaked at a -t-50 during Weeks 2 to 4, The mean titer gradually declined 
until Week 14 when it was almost negative at a 1:25 dilution. The range 
of titers was from a -25 to an I400. Two cows had titers which fluc-
tuated from a -25 to an I50 on Weeks 16 and 18, 
Figure 15 shows the mean antibody response for Group V-4. Only 
. four of the eight cows in the group responded to the vaccine, The high-
est individual titer was an I50 during Wee~ 3 and 4, The maximum mean 
titer was an I50 and all animals were negative by Week 8. 
Two of the eight.cows in Group V-5 (Figilre 16) responded to the 
vaccine with titers of an I25 during Weeks 2 to 5, 
Complement fixation test results 
The complement fixation (CF) test results are depicted in Figures 
17-21. The CF test uses doubling dilutions from a 1:10 to a 1:1280, 
and the results are recorded as the degree of fixation in the highest 
reacting dilution (25% fixation (1-:t-), 5a% fixation (2-t-), 75% fixation 
(3-:1-), and 10(]'/, fixation (4-t-)), The general trend for each group re-
sponse is similar as with the other tests used, with each higher dosage 
giving a greater response. The peak titers were reached during Week 3, 
Figure 17 shows the CF antibody response for Group V-1. The max-
imum mean titer was a 25% fixation at the 1:160 dilution (l-:t-160). The 
mean titer gradually decreased until it became negative at a 1:10 dilu-
tion (-10) on Week 32, A range of approximately four dilutions occurred 
until Week 18, it then decreased to three dilutions (-10 to 4-140), 
Figure 14. Results of biweekly rivanol tests for Group V-3 (vaccination-
nonchallenge) following·B, abortus strain 19 vaccination with 
2 ml containing 9.2 X·lOB' organisms(? animals per group) 
Figure 15. Results of biweekly rivanol tests for Group V-4 (vaccination-
nonchallenge) following B. abortus strain 19 vaccination with 
;e .ml" .ciontaining 1.4 X lQtl organisms (8 animals per group) 
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Figure 16. Results of biweekly rivanol tests for Group V-5 (vaccination-
nonchallenge) following B. abortus strain 19 vaccination with 
2 ml containing 2.3 X 107 organisms (8 animals per group) 
32DD 
ISDD 
D: sec. 
t.I ..... 
;: "ICC 
~ 2DD 
LEI 
Cl 
El ICC 
a:: 
t.I 
111 S:D 
57 
F'IEiURE: . IS 
III! 
D 2 "I S 8 ID 12 ILi IS 182D222"126283D323"136. 
WEEK PDST-VflCCINflTIDN 
Figure 17, 
Figure 18, 
Results of biweekly complement fixation tests for Group V-1 
(vaccination-nonchallenge) following fl., abortus strain 19 
vaccination with 5 ml containing 78 X 109 organisms 
(8 animals per group) 
Results of biweekly complement fixation tests for Group V-2 
(vaccination-nonchallenge) following fl., abortus strain 19 
vaccination with 2 ml containing 5 X 109 organisms 
(8 animals per group) 
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The Group V-2 (Figure 18) CF antibody response was much lower than 
Group V-1, The peak mean titer was 75% fixation at a 1:40 (3i40), The 
highest individual titer was a 2+80, All cattle were negative at a 1:10 
dilution by the 12th week. 
Group V-3 (Figure 19) had a lower mean titer (4+10) than Group V-2; 
however, the highest individual titer (2+80) was the same. All animals 
were negative at a 1:10 dilution by Week 12. Two cows failed to produce 
antibodies detectable by the CF test. 
Figure 20 shows the antibody response for Group V-4. Only half of 
the cows (4) showed a response, with the highest response being a 2+20 
during the third week, Group V-5 (Figure 21) had only two out of eight 
animals respond on the CF test for two to four weeks. The highest indi-
vidual titer was a 3+20, 
Table 5 and 6 summarize, by group, the antibody responses to ~· 
abortus strain 19 vaccine for the tube, ME, rivanol, CF, and card tests. 
Table 5, Summary, by group, of the peak antibody response and duration 
of response to the B, abortus strain 19 vaccine for the card 
test -
Group Test Highest percent positive Duration of positive response 
V-1 Carda 100}6 positive 37% positive at Week 36 
V-2 Card 10o% positive Negative by Week 36 
V-3 Card 100}6 positive 11J% positive at Week 36 
V-4 Card 75% positive Negative by Week 7 
V-5 Card 25% positive Negative by Week 8 
~he card test is read.as either positive or negative, 
Figure 19. 
<. 
Figure 20. 
Results of biweekly complement fixation tests for Group V-3 
(vaccination-nonchallenge) following ll.. abortus strain 19 
vaccination with 2 ml containing 9,2 X 108 organisms 
(? animals per group) 
Results of biweekly complement fixation tests ior Group V-4 
(vaccination-nonchallenge) following Jl., abortus strain 19 
vaccination with 2 ml containing 1,4 X 108 organisms .. 
(8 animals per group) 
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Figure 21. Results of biweekly complement fixation tests for Group V-5 
(vaccination-nonchallenge) following R. abortus strain 19 
vaccination with 2 ml containing 2.J X 107 organisms 
(8 animals per group) 
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Table 6. Summary, by group, of the peak antibody response and duration 
of response to ~. abortus strain 19 vaccine for the tube, ME, 
rivanol, and CF tests 
Group Test Highest mean titer Duration of group mean titer 
V-1 Tube a +1600 +100 at Week 36 
V-2 " .+400 I50 at Week 36 
V-3 " +400 I50 at Week 36 
V-4 " +100 I25 at Week 36 
V-5 " +50 I25 at Week 36 
V-1 MEb IBOO Negative by Week 36 
V-2 " IlOO " " " 12 
V-3 " I50 " " " 12 
V-4 " I25 " " " 6 
V-5 " '<I25 " " " 6 
V-1 RIVc I400 Negative by Week 36 
V-2 " +100 " " " 22 
V-3 " +50 " " " 22 
V-4 " I25 " " " 8 
V-5 " <125 " " " 6 
V-1 cF'1 1+160 Negative by Week 34 
V-2 " 2+160 " " " 12 
V-3 " 1+20 " " " 12 
V-4 " 1+10 " " " 5 
V-5 " 2+10 " " " 7 
a+50 = negative; IlOO to I200 = suspect; +200 or> =reactor. 
bNot an official test. 
c . 
~+50 = reactor; <+50 = negative.·· 
t\1+40 =reactor; 2+10 to 4.+20 = suspect; <2+10 = negative. 
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Vaccination-Challenge Phase 
The serological responses for the five vaccination-challenge groups 
(15 animals/group) were basically the same as those in the vaccination-
nonchallenge groups through Week 16. During Week 16 the five vaccina-
tion-challenge groups and a nonvaccinated control group (20 animals) 
5 were instilled into the conjunctival sac with 8.27 X 10 ~. abortus 
strain 2308 organisms. 
Card test results 
Figure 22A displays the antibody response for the five vaccine dos-
age groups and the nonvaccinated controls as detected by the card test, 
All of the animals in Group VC-1 were positive on the card test one week 
after vaccination and remained positive through Week 14, During Weeks 
16-34. over 9CJ% of the cattle remained positive (one cow had an inter-
mittent response for six weeks). At Week 36 the percentage of positive 
cattle declined to less than 8CJ%, 
More than 9CJ% of the cows in Group VC-2 were positive on the card 
test after two weeks, and all were positive by the fourth week. The 
percent of reactions declined rapidly to about 3CJ% between Weeks· 4 and 
14 and stabilized at that level until Week 26. Between Weeks 26-36 
there were some fluctuations due to three animals ·titers. Thirty-five 
percent of the cattle were still positive during Week 36, 
Over 9CJ% of the cows in Group VC-3 were positive during Weeks 2-4, 
Thereafter, the percentage declined sharply and all were negative by 
Figilre 22A. Results of biweekly and monthly card tests for the five vaccination-challenge groups 
following ~. abortus strain 19 -vaccination (Week o) and challenged with 8,27 X 105 
B. abortus strain 2308 organisms (Week 16) 
- Group VC-1 (+ received 78 X 109 organisms (14 animals per group) 
Group VC-2 (* received 5 X 109 organisms (15 animals per group) 
Group VC-3 (# received 9.2 X 10~ organisms (14 animals per group) 
Group VC-4 ( received 1.4 X 10 organisms (15 animals per group) 
Group VC-5 (!( received 2.3 X 107 organisms (15 animals per group) 
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Week 10. After this group was challenged, one· animal (7%) became pos-
itive during Weeks 19-26. The number of animals with positive responses 
then increased to 6(J}b during Week JO, but decline_d again to 7% by Week 
J6. Brucella abortus strain 2J08 was isolated from two of the cows in 
this group, 
The percent of card test positive reactions in the cows from Group 
VC-4 _reached 6(J}b by Weeks J and 4, tt;en declined until all catt],e were 
negative by Week 14 (seven weeks after being challenged)". One animal 
(7%) had an agglutination response at Week 2J. Approxl.mately 20% (J 
animals) were positive during Week JO, then the percentage declined to 
7% by Week J6, Brucella abortus strain 2J08 was isolated from one cow 
in Group VC-4, Twenty-five percent of the cattle in Group VC-5 (Figure 
22A) were positive by Week J, but reverted to negative by Week 8 and 
remained negative through Week J6. 
Figure 22B displays the card test responses of the vaccination-
challenge control group, Isolations of )1. abortus strain 2J08 were made 
from three cows in this group. All animals remained negative on the 
card test until three weeks following challenge (Week 19). Fifteen per-
cent of the animals were positive on Week 19 and JfJJb were positive dur-
ing Weeks 22-26. Only lfJJb of the animals were positive between Weeks 
J2-J6. 
Tube test results 
The results of the tube test for the groups of vaccinated and non-
vaccinated cows are presented.in Figures 2J-2?. As depicted in the 
Figure 22B. Results of biweekly and monthly card tests for the nonvaccination-challenge 
Control Group (20 animals per group) preceding and following challenge during 
Week 16 with 8.27 X 105 B. abortus strain 2308 organisms 
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vaccination-nonchallenge groups, the maximum antibody titers occurred in 
all cows during Week 2. The major difference among the five vaccine 
groups during Weeks.O-l6 was.the degree and persistence of the antibody 
response for each group. 
Figure 23 contains the tube test results for Group VC-l, The range 
of titers for each week was approximately three dilutions. The highest 
individual titer was a ~00 during Week 2, while the lowest titer· that 
week was an IBOO, The maximum geometric mean titer was a +l600 during 
Week 2, but the titer gradually receded to a +200 by Week 12. Following 
Week 24, the mean titer increased minimally through Week 32. One in-
dividual titer increased after challenge from an IBOO (Week 26) to a 
+1600 (Week 32), but then receded to an.IBOO by Week 36, 
The mean tube test titers for Group VC-2 (Figure 24) were lower 
than Group VC-1 with the maximum being a -1400 on Week 2. The mean titer 
then receded until Week 14 when it was positive at a +50 and remained 
at that level through Week 26. Between Weeks 28-36 the mean titer 
gradually increased to an IlOO, The variation of responses of individ-
ual animals was observed to be greater in Group VC-2 than in Group VC-1, 
The mean tube titers were lower for Group VC-3·(Figure 25) than for 
the previous two groups, The highest mean titer was a +200 (Week 2) 
which receded to a +25 by Week 14, Following Week 17 the mean titer 
began to gradually increase until Week 30 when the titer peaked at an 
IlOO. The mean titer decreased slightly by Week 36, Following Week 16 
Figure 23. 
Figure 24. 
Results of biweekly tube tests for Group VC-1 (vaccination-
challenge) following vaccination with78 X 109 B, abortus 
strain 19 organisms and challenged with B, abortus strain 
2308 during Week 16 (14 animals per group) 
Results of biweekly tube tests for Group VC-2 (vaccination-
challenge) following vaccination with 5 X 109 ~· abortus 
strain 19 organisms and challenged with B, abortus strain 
2308 during Week 16 (15 animals per group) 
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until Week 36 the range of titers increased to ov_er eight dilutions 
(-25 to 16400). Brucella abortus strain 2308 was isolated from two of 
the cows at the time of abortion or calving. 
Figure 26 shows the mean tube test results for Group VC-4. The 
maxi.mum mean titer prior to challenge was a +100. By Week 14 the mean 
titer had receded to an 125. During the first ten weeks, 12 out of the 
15 cows responded to the vaccine, The individual titers ranged from an 
125 to a ?400 during Week 2. At the time the cows were challenged the 
highest titer was a +50. Following the challenge during Week 16, the 
mean titer increased slightly·to an 150 by Week 34. One of three cows 
which responded to the challenge had a titer which increased to a +1600 
by Week 36. She aborted and~. abortus strain 2308 was isolated from 
the fetus. 
Group VC-5 (Figure 27) showed the lowest mean titer response, with 
the maxi.mum being an incomplete positive at a 1:50 during Week 4. The 
mean titer receded to almost negative at a 1:25 during Weeks 14 and 17, 
and increased minimally to an 125 during Weeks 18-36. As in Group VC-4, 
some animals had a minimal response (125) to the vaccine; however, six 
cows had titers of a +50 to an 1400. After challenge, the titer of the 
three cows increased to a +50 and a +100. Five cows did not respond to 
the challenge and seven cows maintained fluctuating titers between·a 
--25 and an 150. 
The tube test results for the nonvaccinated control group (C) are 
Figure 25. Results of biweekly tube tests for Group VC-3 Cvaccination-
challenge) following vaccination with 9.2 X 108 B, abortus 
strain 19 organisms and challenged with B, abort~s strain 
2308 during Week 16 (14 animals per group) 
Figure 26. Results of biweekly tube tests for Group VC-4 (vaccination-
challenge) following vaccination with 1.4 X 108 ;§_, abortus 
strain 19 organisms and challenged with B, abortus strain 
2308 during Week 16 (15 animals per groilp) 
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Figure 27 . Results of biweekly tube tests for Group VC-5 (vaccination-
challenge) following vaccination with 2 . J X 10? B. abortus 
strain 19 organisms and challenged with B. abortus strain 
2J08 during Week 16 (15 animals per group) 
Figure 28 . Results of biweekly tube tests for the Control Group 
(nonvaccination-challenge) following challenge with ~ · abortus 
strain 2J08 during Week 16 ( 20 animals per group) 
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shown in Figure 28. Nine of the cattle had fluctuating titers prior to 
challenge that ranged from a -25 to a +25. The highest individual titer 
was an 150. After being challenged with B, abortus strain 2308 1 19 of 
the 20 animals had a detectable increase in antibody response (+25 to 
+1600), Those that had been negative at the 1:25 dilution before chal-
lenge (10 cows) developed titers between a +25 and a +100 after chal-
lenge, Brucella abortus strain 2308 was isolated from the lymph nodes 
of one of these cows, Two cows that had intermittent 125 responses 
before challenge developed titers of an 150 to an 1100, three to five 
weeks after challenge, Five cows had a maximum pre-challenge titer of. 
a +25; one maintained a titer of an 125; two developed responses of a 
+50; one developed a titer of.a +200 and one a titer of a +1600 fol-
lowing challenge (;!!_. abortus strain 2308 was isolated from the' cow with 
the +1600 titer). 
Three cows developed nonspecific titers of an 150 during the two 
wee!';.s before challenge. After challenge, ·one cow maintained a titer of 
a +25; one developed a response. of a +100 for three weeks; the third 
cow developed a peak titer of a +800 two weeks following abortion and 
isolation of :!)_, abortus strain 2308, 
Plate test results 
As indicated before, the highest plate test dilution used was a 
1:400 1 which is one dilution higher than that used in routine test pro-
cedures, The plate titers were similar for each vaccine group when 
81 
compared with the corresponding tube test titers, except that the geo-
metric mean plate· titers were lower because dilutions above a 1:400 were 
not used. Therefore, the plate test results are not presented, but ·are 
included in the Appendix. 
Mercaptoethanol test results 
Figures 29-34 depict the geometric mean antibody responses on the 
ME test for the five vaccination-challenge groups and the contr.ols, All 
of the cows failed to respond on the ME test during the first week. Fol-
lowing vaccination, Groups VC-1. and VC-2 developed higher overall anti-
body responses with longer duration of titers on the ME test than the 
three lower dosage groups, 
·Group VC-l·(Figure 29) developed.a maximum mean titer of a -!400 
during Week 2. The mean titer declined during Weeks 4-23. Twelve to 
16 weeks following the challenge the mean titer increased from a -25 to 
a +25. The range in individual titers during the first week was from 
an I25 to an !6400 (8 · dilutioni). Seven of 15 cows had a minimal sero-
logical response to the challenge, with titers increasing from a -25 to 
a maximum of either a +25 or a +50. 
Cows in Group VC-2 (Figure 30) had a maximum mean titer of a +50 
during Week 4. Only three of the 15 cows had detectable antibody re-
sponses·.following challenge (I25 to I50), indicating the challenge had 
little effect, as measured by the ME test, 
Group VC-3 (Figure 31) had a minimal antibody response following 
vaccination. ·The highest individual titer was a +50. The mean titer 
Figure 29. 
Figure 30, 
Results of biweekly mercaptoethanol tests for Group VC-1 
(vaccination-challenge) following vaccination with 78 X 109 
~. abortus strain 19 organisms and challenged with !!_. abortus 
strain 2308 during Week 16 (14 animals per group) · 
Results of biweekly mercaptoethanol tests for Group VC-2 9 (vaccination-challenge) following vaccination with 5 X 10 
B, abortus strain 19 organisms and challenged with B, abortus 
ztrain 2308 during Week 16 (15 animals per group) . -
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Figure 31. 
Figure 32. 
Results of biweekly mercaptoethanol tests for Group VC-3 
8 (vaccination-challenge) following vaccination with 9.2 X 10 
~. abortus strain 19 organisms and challenged with~. abortus 
strain 2308 during Week 16 (14 animals per group) 
Results of.biweekly mercaptoethanol tests for Group VC-4 8 (vaccination-challenge) following vaccination with 1.4 X 10 
~. abortus strain 19 organisms and challenged with.~. abortus 
strain 2308 during Week 16 (15 animals per group) 
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was a +50. The mean titer following vaccination was below the I25 level 
and lasted only foux weeks (Weeks 2-6), Following challenge only two 
cows (Nos. 67 and 69) responded on the ME test. Their titers increased 
from a -25 to as high as a ~l2,800 by Week 26. Isolations of !!_, abortus 
strain 2308 were made from these two cows. The individual serological. 
results for these two animals are presented in Figuxes 56 and 58. 
Figuxe 32 (Group VC-4) had a response to vaccination similar to 
Group VC-3, Ten out of l5 cows in Group VC-4 had no response on the 
ME ~est during the study. Two animals responded to vaccination, with 
one cow developing a titer of a +200 duxing Week }; both animals were 
negative at a l:25 dilution by Week lO. One cow developed a post-chal-
lenge titer of a +l600 by Week 36, All the other cows remained negative. 
Brucella abortus strain 2308 was isolated from two cows in this group. 
The only response in Group vc-5· on the ME test were two cows which 
developed a I25 titer for one week each. 
The Control Group (Figuxe 34) remained serologically negative on, 
the ME test throughout the study, except for two cows. The individual 
titers of those cows reached an I800 and a +l600, Individual results 
for these two animals are shown in Figuxes 53 and 54, 
Rivanol test results 
Figuxes 35-40 display the results of the rivanol test for each vac-
cination-challenge group and the controls, The results of the rivanol 
test for each group were similar to those reported for the ME test, and 
therefore, will not be presented in detail.· 
87 
Complement fixation test results 
The complement fixation (CF) test results are·depicted in Figures 
41-46. In Group VC-1 (Figure 41) the maximum mean titer of a J-180 was 
reached during Week 4, then declined to negative at a 1:10.dilution by 
Week 20. The range in titers was five dilutions (-10 to 4+160) during 
the first week, then decreased as the mean titer declined. Seven cows 
responded to the challenge at a 1+10 or a 2+10 during Weeks 26 and 27, 
Group VC-2 (Figure 42) had four cows that failed to respond on the 
CF test. The remaining 11 cows developed a maximum mean titer of a )+20 
during Week 4, The mean titer decreased rapidly following Week 6 and 
was essentially negative by Week 14. Cow No, 106 developed the highest 
individual titer of a )+160 during Week ), Only two cows responded be-
yond Week 8. After.Week 12 only one cow (No, 106) responded (at a 2+10 
and a r+lO) until Week 24, 
Ten cows.in Group VC-J (Figure 4J) did not respond to the vaccina-
tion ·or challenge on the CF test. Only two cows (Nos. 55 and 56) re-
sponded to the vaccination with the highest titer being a 4+20 during 
Week 5, Following challenge, the only cows which responded were those 
from which:!?.· abortus strain 2)08 was isolated (Nos, 67 and 69), 
Figure 44 (Group VC-4) includes the results of 15 cows; 10 of which 
did not respond to the CF test. Four cows responded to the vaccination 
for five weeks (Weeks J-7) with a maximum titer of.a 2i40 during Week), 
After the challenge only two cows responded on the CF test, Cow No. 2) 
Figure 33, 
Figure )4, 
Results of biweekly mercaptoethanol tests for Group VC-5 
(vaccination-challenge) following vaccination with 2.3 X 107 
B. abortus strain 19 organisms and challenged with B. abortus 
strain 2308 during Week 16 (15 animals per group) -
Results of biweekly mercaptoethanol tests for the Control 
Group (nonvaccination-challenge) following challenge. with 
~. abortus strain 2308 dliring Week 16 (20 animals per group) 
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Figure 35,· 
Figure 36~ 
Resul~s of biweekly rivanol tests for Group VC~l (vacci-
nation-challenge) following vaccination with 78 X 109 
:§.. abortus strain 19 organisms and challenged with:§.. 
abortus strain 2308 during Week 16 (14 animals per group) 
Results of biweekly rivanol tests for Group VC-2 (vacci-
nation-challenge) following vaccination with 5 X 109 
:§.. abortus strain 19 organisms and challenged with:§.. 
abortus strain 2308 during Week 16 (15 animals per group) 
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Figure 37, Results of biweekly rivanol tests for Group VC-3 (vacQi-
. nation-challenge) following vaccination with 9,2 X lOtl 
~. abortus strain 19 organisms and challenged with B, 
abortus strain 2308 during Week 16 (14 animals per ~cup) 
Figure 38, Results of biweekly rivanol tests for Group VC-4 (vac§i-
nation-challenge) following vaccination with 1,4 X 10 
B. abortus strain 19 organisms and challenged with B. 
abortus strain 2308 during Week 16 (15 animals per ~cup) 
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Figure 39. 
Figure 40, 
Results of biweekly rivanol tests for Group VG-5 (vacci-
nation-challenge) following vaccination with 2.3 X lo? 
~. abortus strain 19 organisms and challenged with·B, 
abortus strain 2308 during Week 16 (15 animals per ii":roup) 
Results of biweekly rivanol tests for the Control Group 
(nonvacciriation-challenge) following challenge with ~· 
abortus strain 2308 during Week 16 (20 animals per group) 
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Figure 41. 
Figure 42. 
Results of biweekly complement fixation tests for Group VG-1 
(vaccination-challenge) following vaccination with 78 X 109 
~· abortus strain 19 organisms and challenged with ~· abortus 
strain 2308 during Week 16 (14 animals per group) 
Results of biweekly complement fixation tests for Group V~-2 
(vaccination-challenge) following vaccination with 5 X 10 
B, abortus strain 19 organisms and challenged with~· abortus 
strain 2308 during Week 16. (15 animals per group) 
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Figure 43, 
Figlire 44. 
Results of biweekly complemen:t fixation tests for Group VC-3 
(vaccination-challenge) following vaccination with 9,2 X 108 
~· abortus strain 19 organisms and challenged with B, abortus 
strain 2308.during Week 16 (14 animals per group) -
Results of biweekly complement fixation tests for Group VC-~ 
(vaccination-challenge) following vaccination with 1.4 X 10 
B, abortus strain 19 organisms and challenged with B. abortus 
strain 2308 during Week 16 (15 animals per group) ~ · 
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hl\td a 2+10 titer during Weeks 21 and 22, and Cow No. 20 developed a titer 
at Week 26 which continued to rise until Week 36. Group VC-5 (Figure 
45) did not respond on the CF test during the J6 .week study. 
Only two out of the 20 cow.s (Nos. 75 and 82) in the Control Group 
(Figure 46) developed a detectable CF titer. The first response was at 
Week 22, six weeks following challenge, and a maximum titer of a 2+1280 
was reached by Week 30 (14 weeks after challenge). Brucella abortus 
strain 2308 was isolated from both of these animals. 
Comparison of Tube and Mercaptoethanol Tests 
·Figures 47-51 are comparisons of the results of the ME and tube 
tests for each of the five groups of vaccinated cows. In Figure 47 
(Group V-1) the results of the ME and tube tests have the same general 
pattern; however, the tube test titers are significantly higher than the 
ME titers and appeared one week before the ME test. The results of the 
other four groups had similar titer patterns between the two tests; 
however, as the vaccine dosages decreased, the corresponding titers also 
decreased. 
Persistently Infected Cows. 
Isolations of ~. abortus were made from only 11 cows in this study 
(Table 7), Strain 19.was isolated from four cows and strain 2308 from 
seven cows, The cultural results for each of these eleven animals are 
presented in Figures 52-62, along with the individual antibody responses 
and clinical observations. The tube and ME test .results are presented 
Figure 45. 
Figure 46, 
Results of biweekly complement fixation tests for Group.VC-5 
(vaccination-challenge) following vaccination with 2.3 X 107 
B • abortus strain 19 organisms and challenged with B. abortus ~train 2308 during Week 16 (15 animals per group) -
Results of biweekly complement fixation tests for the Control 
Group (nonvaccination-challenge) following.challenge with 
:!?.· abortus strain 2308 during Week 16 (20 animals per group) 
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Figure 47, 
Figure 48. 
Comparison of the results of the mercaptoethanol (ME) and 
tube tests for Group V-1 following vaccination with 78 X:·l09 
!!_, abortus strain 19 organisms (8 animals per group) 
Comparison of the results of the mercaptoethanol (ME) and 
tube tests for Group V-2 following vaccination with 5 x1109 
!!_, abortus strain 19 organisms (8 animals per group) 
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Figure 49, 
Figure 50, 
-' 
Comparison of the results of the mercaptoethanol (ME) and 
tube tests for Group V-3 following vaccination with 9,2 X 108 
B. abortus strain 19 organisms (7 animals per group) 
Comparison of the results of the mercaptoethanol (ME) and 8 
tube tests for Group V-4 following vaccination with 1.4 ·X 10 
~· abortus strain 19 organisms (8 animals per group) 
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Figure 51. Comparison of the results of the mercaptoethanol (ME) and 
tube tests for Grotip V-5 following vaccination with 2.3 X 107 
B. abortus strain 19 organisms {8 anima,ls per group) 
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as line graphs for each infected cow, The card, rivanol, and CF test 
results are presented using the negative, suspect,· or positive class-., 
ification as specified in the. Brucellosis Eradication ,1 Federal Uniform 
Methods and Rules.1 
Table 7, List of the cows, by group, from which~· abortus was isolated 
and the source of the isolations 
Group 
c 
c 
c 
VC-1 
V-2 
V-3 
VC-3 
VC-3 
VC-3 
VC-4 
VC-4 
Animal 
No, 
73 
75 
82 
30 
105 
62 
67 
116 
69 
16 
20 
Isolated 
strain 
2308 
2308 
2308 
19 
19 
19 
2308 
19 
2308 
2308 
2308 
Tissues a 
+c1d 
+ 
~issues collected at slaughter. 
Source of isolation 
b Fetus 
c,e -
+ 
+ 
+c 
+ 
c 
c 
+ 
c 
+ 
Milk 
+ 
+ 
+ 
+ 
+ 
+ 
Vaginal 
mucus 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
~etus includes fetal membranes and meconium from live calves. 
cLive calf. 
d+ ,,; an isolation of ~· .abortus was made. 
e_ ~an.isolation of B, abortus was not made • 
. 1uSDA, Animal and Plant Heal th Inspection Service, 1979 ( 92) , 
:).10 
Brucella abortus strain 2308 was isolated from three cows in the 
Control Group (Nos. 73, 75, and 82). Cow No. 73 (Figure 52) did not 
develop a detectable titer on the card, ME, rivanol, or CF tests through-
out the duration of the study. Tube and plate test titers peaked at a 
+25 during Weeks 20-22 and that was the only significant antibody re-
sponse developed toward the challenge, She calved normally, and attempts 
to isolate Brucella from the milk, placenta, meconium, and vaginal mucus 
were negative. However, !l_. abortus strain 230.8 was isolated from the 
retropharyngeal lymph nodes collected at slaughter. 
Cow No. 75 (Figure 53) developed a +25 to an I50 titer on the tube 
test prior to challenge. Following challenge, the titer increased to a 
+BOO ~y Week 24. Seven weeks later (Week 23) she aborted, Isolations 
of )!_. abortus strain 2308 were made from the fetal tissues, milk, and 
vaginal mucus at the time of abortion. Three weeks following abortion, 
!!_. abortus strain 2308 was isolated from the vaginal mucus swabs only. 
The ME titer was detected one week before abortion or six weeks following 
the challenge. It then reached a +BOO but began to gradually decline 
following Week 26. The card test became positive three weeks following 
challenge and remained positive throughout the remainder of the study, 
.. 
The rivanol test reached the reactor classification ( +50) two weeks 
before the abortion (five weeks post-challenge) and remained in a reactor 
status. The CF titer was in the suspect category one week before the 
abortion. It then increased after the abortion to a reactor status for 
the remainder of the study. 
Figure 52. Serologic and-cultural results for cow No. 73 (Control Group) preceding and following 
challenge during Week 16 with 8.27 X 105 ~· abortus strain 2308 organisms 
The tube and ME test results are presented as line graphs 
The card test is read as positive (+), a weak positive (W), or negative ( ) 
A +50 or higher dilution on.the rivanol test is classified as a reactor(~); 
I50 or less is negative(-) 
The CF test dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor ( +); 50% fixation in a diluti_on of l •10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 50% fixation in a +•10 dilution is. 
negative (-) . . 
The culture resul~s are read as positive(~), negative(-), or contaminated (C) 
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Figure 53, Serologic and cultural results for cow Uc. 75 (Control Group) preceding and following 
challenge during Week 16 with 8.27 X 105 B. abortus strain 2308 organisms · · 
Th~ tube and ME test results are presented as line graphs · 
The card test is read as positive(+), a weak positive (w), or negative(.-) 
A +50 or higher dilution on the rivanol test is classified as a reactor(+); 
150 or less is negative (-) 
The CF test dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor ( +); 50% fixation in a dilution of l :10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 50% fixation in a 1:10 dilution is 
negative (-) 
The culture results are read as positive(+), negative(-), or contaminated (C) 
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Cow No, 82 (Figure 54) developed a low transient tube titer of a 
+25 between Weeks 5 and 14. Her titer was negative again at the time of 
challenge (Week 16). Following challenge, the tube test titer increased 
to a +25 for three weeks then continued to increase until Week JO when 
it was positive at a 1:1600 dilution. By Week 36 it had declined to 
i400. She aborted 11 weeks after challenge (Week 27), A reaction to 
the ME test occurred during Week 24 and was a i400 at the time of the 
abortion. Thereafter, it was identical to the tube titer, The card 
test became weakly positive six weeks following challenge (Week 22) 
then became a strong positive one week before the abortion. It remained 
positive throughout the remainder of the study, The rivanol and CF 
tests detected titers in the reactor category ten weeks after challenge 
(one week before the abortion) and remained positive for at least 12 
weeks, At the time cow No. 82 aborted, :!?_. abortus strain 2308 was iso-
lated from the fetal tissues, milk, and vaginal mucus. Strain 2308 
continued to be isolated from the vaginal mucus for three weeks fol~ 
lowing the abortion. 
Only one cow in Group VC-1 was positive on cultures for Brucella, 
Brucella abortus strain 19 was isolated from cow No •. ~O (Figure 55) 
during Weeks 29-JJ, She calved normally 13 weeks after challenge (Week 
29). The first isolation was made at the time of calving from the pla-
centa and vaginal mucus. Brucella was not isolated from the milk, The 
vaginal mucus yielded :!?_, abortus strain 19 for four weeks after the 
Figure 54. Serologic and cultural results for cow No. 82 (Control Group) preceding and following 
challenge during Week 16 with 8,27 X 105 ~· abortus strain 2J08 organisms 
The tube and ME test results are presented as line graphs 
The card test is read as positive(+), a weak positive (W), or negative(.-) 
A +50 or higher dilution on the rivanol test is classified as a reactor(+); 
150 or less is negative(-) · 
The. CF test. dilution of 1 :40 with a 25% fixation or higher is classified as a 
reactor(+); 5o% fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 5o% fixation in a 1:10 dilution is 
negative (-) 
The culture results are read as positive(t), negative(-), or-contaminated (c) 
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Figure 55, Serologic and cultural results for cow No. 30 (Group VC-1) following vaccination with 
78 X 109 ~· abortus strain 19 organisms (Week 0) and challenge during Week 16 with 
8,27 X 10 ~. abortus strain 2308 organisms 
The tube and ME test results are presented as line graphs 
The card test is-read as positive(+), a weak positive (W), or negative(.-) 
A +50 or higher .dilution on the rivanol test is classifi-ed as a reactor(+); 
I50 or less is negative(-) 
The CF test. dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor(+); 5o% fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 50% fixation in a 1:10 dilution is 
negative (-) · . 
The.culture results are read as positive(+); negative(-), or _contaminated (C) 
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abortion. Following vaccination cow No, JO developed a -!BOO tube titer, 
a +50 ME titer, and was positive on the card test. At the time of chal-
lenge, her titer had receded to a +50 on the tube test and was negative 
on the ME and card tests. The ME test titer was a +25 three weeks after 
challenge, increased to an IJ200 during Week.s 27 and JO, and declined 
to an I800 by Week 38. The tube test titer increased to a +3200 by 
Week JO (one week after calving) then declined, The rivanol and CF 
tests were positive in the reactor category following the 23rd week. 
In Groups VC-3 and V-J, four cows were positive on culture for 
Brucella. Cows No. 67 and 69 shed !!· abortus strain 2308; whereas, 
cows No, 62 and 116 shed!!· abortus strain 19. Cows No. 69 and 62 
aborted, while cows No, 67 and 116 had normal calves. 
Cow No.· 67 (Figure 56, Group VC-3) reacted on the tube test at an 
IlOO during Week 2, then her titer receded to a +25 until Week 25. 
Thereafter it increased to an I800 by Week 32 and then leveled off. The 
· card, rivanol, CF, and ME tests did not show reactions until Week 27 
(nine weeks after challenge), The ME titer increased to an Il600 from 
Week 27 to Week 32 and then began to decline, After Week 26 the card 
test remained positive. The CF test titer was in the suspect classifi-
cation during Week 27 and then increased to the reactor status during 
Weeks 28-38 as did the rivanol test. Isolations of Brucella were made, 
from the vaginal mucus, at the time of normal calving (Week 29) and for 
11 weeks thereafter. 
Figure 56. Serologic and cultural results for ·cow No. 67 (Group VC-3) following vaccination with 
9.2 X 108 !!_, abortus strain 19 organisms (Week 0) and challenge during Week 16 with 
B.27 X 105 !!_. abortus strain 2308 organisms 
The tube and ME test results are pr.esented as line graphs 
The card test is read as positive ( +) , a weak positive ( W) , or negative (-) 
A +50 or higher dilution on the rivanol test is classified as a· reactor(+); 
I50 or less is negative(~) 
The -CF test dilution.of 1:40 with a 25% fixation or higher is classified as a 
reactor(+); 5o% fixation in a dilution of 1:10 but less than 25% fixation in a 
1 :40 dilution is a suspect (S); less than 5o% fixation in a 1 :10 dilution is 
negative (-) . . . 
The culture results are read as positive(+), negative(-), or contaminated (c) 
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Cow No. 116 (Group VC-3, Figure 57) calved normally during Week 30
1 
at which time ~. abortus strain 19 was isolated only from the milk. The 
tube titer increased rapidly to a -:1400 after vaccination, then decreased 
to a +50 until Week 12 when it began to rise again and was a +200 during 
Weeks 17-23. Thereafter, the tube titer fluctuated between a +100 and a 
+200. The ME titer became positive four weeks after vaccination at a 
IlOO. During Weeks 17-24 it was a +200 1 after that it fluctuated be-
tween an IlOO and an I200. The card and ri vanol tests remained in the 
reactor status after Week 1. The CF test titer was in the suspect cat-
egory during Weeks 2, 3, and 5 and was classified as a reactor there-
after. 
Cow No. 69 (Figure 58, Group VC-3) aborted eight weeks after chal-
lenge. and~. abortus strain 2308 was isolated from the fet~s, milk,·and 
vaginal mucus; ·,Isolations of strain 2308 were made from the vaginal 
mucus for three weeks following abortion. Eleven weeks following abor-
tion strain 2308 was isolated from the· milk. The card test was positive 
during Weeks 2-5 and again on Weeks 19-38. The tube test titer peaked 
at a -:1400 and declined to a +50 at the time of challenge. It :i.ncreased 
to a +3200 during Week 23 and remained at that level throughout the 
study. There were no responses on the ME, rivanol, or CF tests until 
Week 19. After Week 19 the rivanol and CF tests remained in the reactor 
status and the ME: test increased, to a +3200 by Week 24 (time of abortion), 
By Week 36 it was still an I3200. 
Figure 57. Serologig and cultural results for cow No. 116.(Group VC-3) following vaccination with 
9.2 X 10 ~ •. abortus strain 19 organisms (Week 0) ·and challenge during Week 16 with 
s.27 x 105 ~. abortus strain 2308 organisms 
The tube and Mlj: test results are presented as line graphs . . 
The card test is read as positive(+), a weak positive (W), or negative(-) 
A +50 or higher dilution on the rivanol test is classified as.a reactor(+); 
I50 or less is negative (-) . 
The CF test dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor(+); 50% fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 50% fixation in a 1:10 dilution is 
negative (-) . 
The culture results are read as positive(+), negative(-), or contaminated (c) 
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Figure 58. Serologig and cultural results for cow No. 69 (Group.VC-J) following vaccination with 
9.2 X 10 ~· abortus strain 19 organisms (Week 0) and challenge during Week 16 with 
8,27 X 105 ~. abortus strain 2J08 organisms 
The tube and ME test results are presented as line graphs 
The card test is read as positive(+), a weak positive (W), or negative(.-) 
A +50 or higher dilution on the rivanol test is classified as a reactor(+); 
150 or less is negative (-) 
The CF test. dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor(+); 50% fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 50% fixation in a 1:10 dilution is 
negative (-) · .. 
The culture·results are read as positive(+), negative(~), or contaminated (c) 
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Cow No. 62 was originally in Group VC-3; however, the post-vacci-
nation serological response decreased until Week 12 and then began to 
incrB?-se (Figure 59). This response was indicative of strain 19 infec-
tion; therefore, she.was replaced with another cow from Group v-3, Cow 
Nq. 62 aborted on Week 21 and strain 19 was isolated from the fetus and 
vaginal mucus. Strain 19 was isolated from the vaginal mucus for two 
weeks following abortion. The tube and ME test titers were a -1800 from 
Weeks 14-28, then they began to decline. The CF titer increased to the 
suspect range during Weeks 4-6, then returned to negative until Week 12, 
Thereafter, the titer remained in the reactor category. The rivanol 
test titer was in the reactor status during Weeks 2-5 and after Week 11. 
Cow No, 62 was sacrificed during Week 30, 
Cow No, 16 (Group VC-4, Figure 60) was negative on the CF, ME, and 
rivanol tests throughout the study, She was positive on the ca.rd test 
during Weeks 2-4. A peak tube titer of an !200 during Weeks 2 and 3 
declined to a +25 at the time of challenge, Aft;er challenge, the tube 
test titer fluctuated between a +25 and a +50. Cow No. 16 calved nor-
mally during Week 29. Brucella abortus strain 2308 was only isolated 
from the milk, during that one week. Additional isolation attempts were 
negative. Based on the serologic response, this aiiimal would not have 
been classified as either a reactor or suspect. 
Cow No, 20 (Group VC-4, Figure 61) did not develop a serologic 
response to vaccination, One contributing factor may have been stress. 
Figure 59. Serologic and cultural results for cow No. 62 (Group V-3) preceding and following 
challenge during Week 16 with. 8.27 X 105 ~. abortus strain 2308 organisms 
The tube and ME test results are presented as line .graphs 
The card test is read as positive(+), a weak positive (w),. or negative(.-). 
A +50 or higher dilution on the rivanol test is classified as a reactor ( +); 
150 or less is negative ( ...:) · ·. · 
The CF test. dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor (.+); 50% fixation in a dilution of 1:10 but less than 25% fixation in a 
t:40 dilution is a suspect (S); less than 50% fixation in a 1:10 dilution is 
negative (-) . 
The culture results are read as positive(+), negative(-), or contaminated (d) 
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Figure 60. Serologi§ and cultural results for cow No, 16 (Group VC-4) following vaccination with 
1.4 X 10 ~. abortus strain 19 organisms (Week 0) and challenge during Week 16 with 
8.27 X 105 ~. abortus strain 2308 organisms · . 
The tube.and ME test results are presented as line graphs 
The card test is read as positive(+), a weak positive (W)., or negative(-) 
A +50 or higher dilution on the ri vanol test is classified as a reactor ( +) ; 
150 or less is negative (-) 
The CF test dilution of 1.:40 with a 25% fixation or higher is classified as a 
reactor(+); 5a% fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 diluti_on is a suspect (S); less than 5a% fixation :\.n a 1:10 dilution is 
negative (-) 
The culture results are read as positive ( +) , negative ( - ) , or contaminated (c) 
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She was wild, mean, and difficult to handle (as many cows were) espe-
cially in the isolation stalls. Two weeks before being vaccinated she 
tried to escape from the headgate and developed a pressure necrosis on 
both sides of her neck. During the next several weeks she was anorexic 
and became very weak, She was treated with penicillin and given special 
care until she regained strength. Following challenge she developed a 
tube test titer of a +25 during Week 20, After that, the titer inereased 
to ,an.IJ200 by Week 38. The ME test titer increased from an 125 before 
abortion to a ¥1-00 the week. following abortion, The CF test was in the 
suspect category for two weeks before the abortion. After abortion the 
card, CF, and rivanol test titers remained in the reactor category. Cow 
No, 20 aborted 13 weeks after challenge (Week 29) and~. abortus strain 
2308 was cultured from the fetus, milk, and vaginal mucus. The card 
test became positive on Week 23. 
Cow No, 105 (Group V-4, Figure 62) responded to vaccination on all 
tests. She developed a tube titer of an 1800 two weeks following vac-
cination. The titer gradually declined to an l2S by Week 16, but in-
creased again and fluctuated between lt:· +25 to an 1100 the remainder of 
the study, The card test was positive between Weeks 1 and 7, The 
. . . 
rivanol test showed agglutination titers beginning Week 2 ( +50), which 
peaked during Week 4 (1200) and returned to negative by Week 17. Cow 
No. 105 responded on the ME test during Weeks 2 to 10 with a peak titer 
of a+lOO during Week 5, There was a CF response between Weeks 3 to 10 
Figure 61, Serologic and cultural results for cow No, 20 (Group VC-4) following vaccination with 
1,4 X 108 B •. abortus strain 19 organisms (Week 0) and challenge during Week 16 with 
8.27 X lOS-~. abortus strain 2308 organisms 
The tube and ME test results are presented as line graphs 
The card test is read as positive(+), a weak.positive (W), or negative(.-) 
A +50 or higher dilution on the ri vanol test is classified as a reactor ( +) ; 
I50 or less is negative (-) 
The CF test. dilution of 1:40 with a 25% fixation or higher is classified as a 
reactor(+); 50% fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 50% fixation in a 1:10 dilution is 
negative (-) 
The culture results are read as positive(+), negative(-), or contaminated (c) . . 
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Figure 62. Serologic and cultural results for cow No, 105 (Group V-2) following vaccination 
with 5 X 109 B, ·abortus strain 19 organisms 
The tube and ME test results are presented as line graphs 
The card test is read as positive(+), a weak positive (W), or negative(.-) 
A +50 or higher dilution on the rivanol test is classified as a reactor ( +); 
I50 or less is negative (-) 
The CF test dilution of l :40 with a 25% fixation or higher is classified as a 
reactor(+); 5fJJ{, fixation in a dilution of 1:10 but less than 25% fixation in a 
1:40 dilution is a suspect (S); less than 5fJJ{, fixation in a 1:10 dilution is 
negative(-) 
The culture results are read as positive(+), negative(-), or contaminated (C) 
f' I GUl\'E E2 
CUL TUl\'E + 
CARD +++++WWT T 
RIV - + + + + - - -
Cf' - - + 5 5 5 - -
i-32DD 
.... +I EDD -' 
t.J a: 
l!:l .... 
2: 
t.J -' +BDD f-' -' a: \.,) 
-' ::c -.J a: 0:: 
:::i: CJ .... 2: i-'·lIID 
I-
+2DII 
+I DD 
+!>II 
+2S: +2!> 
-25' -25" 
8 12 IE 20 2'1 28 32 36. YD 
WEEK POST-VACCINATION 
138 
with the peak titer of a 4-140, Attempts to isolate Brucella from milk, 
vaginal mucus, placenta, and meconium were negative, However, strain 
19 was isolated from lymph nodes collected at slaughter. 
Replacement Cattle 
The cattle were vaccinated on Week· 0 (12-13-77) and developed 
titers following vaccination that began to recede after Week 2. All 
cows. were reexamined for pregnancy one week following vaccination. Cow 
No. 68 had an abnormal uterus and ovaries upon palpation. Because of 
this abnormality, she was replaced, by random selection, with cow No. 
116. 
Ten weeks post-vaccination the titer of cow No. 62 (Group VC-3) 
began to increase rather than continue to recede. This response was 
indicative of strain 19 infection. She was replaced, by random selec-
tion, with cow No. 119 of Group V-3. 
During Week 14, cow No. 18 (Group VC-4) developed a prominent 
actinomycotic lesion on her jaw. This introduced a possible variable 
in her response to the vaccination and challenge. Therefore, she was 
replaced, by random selection, with cow No. 124 (originally in Group 
V-4). Cow No, 133 (Group V-5) also developed actinomycosis and was 
sold for slaughter during Week 16. 
On 3-27-78 (Week 15), cow No. 51 (Group VC-2} aborted. Attempts 
to isolate Brucella were negative and her post-vaccination titer had 
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receded to almost negative. Since it was desirable to challenge preg-
nant cattle, she was exchanged, by random selection, with cow No. 106 
from Group V-2 before the challenge (Week 16), 
On 4-4-78 (Week 16), the five vaccine do~age groups and the non-
vaccinated group were challenged with strain 2308. Two weeks later cow 
No. 42 (Group VC-2) aborted. Attempts to isolate Brucella were nega-
tive. The serological titers remained stable; therefore, the serologic 
and cultural data indicated that she aborted from another cause. 
A summary of the clinical signs observed in the cattle challenged 
with B. abortus strain 2308 is presented in Table 8. 
Table 8 • Summary of clinical signs observed in the cattle challenged with B •. aborlus 
strain 2308 
Group 
c 
c 
c 
c 
c 
c 
c 
c 
VC-1 
vc~1 
VC-1 
VC-2 
VC-2 
VC-2 
VC-2 
VC-2 
VC-2 
VC-2 
Animal 
No, 
75 
76' 
77 
81 
82 
86 
89 
90 
27 
32 
38 
41 
42 
46 
50 
51 
52 
53 
No, of weeks a Clinical signs observed 
post challenge 
7 Aborted, gestation-213 days 
14 Calved near term, calf was weak and died at 7 days of age 
14 Calved near term, calf weak 
14 Calved near term, calf weak 
11 Aborted, gestation-252 days, 
16 Calved near term, calf weak and died at 4 days of age 
15 Calved near term, calf born dead 
14 Calved near term, calf weak 
12 
13 
14 
.14 
2 
12 
12 
-1 
14 
15 
Dystocia, live calf manually delivered 
Calved near term, calf born dead 
Dystocia, live calf manually delivered 
.Calved near·. term; calf died at 2 days of age 
Aborted,. gestation-203 days 
Dystocia, dead calf manually delivered 
Dystocia, live calf manually delivered 
Aborted before challenge date; gestation-182 days 
Calved near term, calf' born·dead 
Dystocia, dead calf manually delivered 
'' 
VC-3 61 12 Dystocia, cow.paralyzed, calf.killed later 
VC-3 62 5 Aborted, ·gestation-231 days 
VC-3 69 8 Aborted, gestation-223 days 
VC-4 17 15 Calved near term, calf died at 1 day of age 
VC-4 20 13 Aborted, gestation-264 days 
VC-4 72 12 Calved early, calf weak 
VC-4 93 15 Calved near term, calf died at J days of age 
VC-5 5 Nonpregnant 
VC-5 10 14 Calved near term, calf weak 
VC-5 11 15 Calved near term, calf died at 2 days of age 
VC-5 13 14 Dystocia, live calf manually delivered I-' 
-!'" 
I-' 
aOccurrence of clinical signs, 
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DISCUSSION 
The antibody response of adult cows to vaccination with Brucella 
abortus strain 19 was dose related with respect to both the degree and 
the duration. The group of 'cows that received the highest (standard) 
dosage developed the highest geometric mean tube test titer. (+1600); 
whereas, the reduced dosage groups developed co=espondingly lower mean 
titers (+50 in Group V-5). This same relationship was true with respect 
to the duration of mean titers for each group, The group receiving the 
highest dosage produced a detectable mean titer that persisted 18 to 20 
weeks. longer than the groups that received reduced dosages of vaccine. 
Studies by others, using various dosages of~· abortus strain 19 in 
yearling heifers (26), calves (70), and pregnant cows (75), have re-
ported similar results. In each of these studies the antibody response 
· was found to be related to the dosage of vaccine, However, Manthei et 
al. (57) did not find as great a difference between mean titers in two 
groups of yearling heifers injected with different vaccine dosages. 
However, the dosages used in that study were relatively close together 
compared to those used by other investigators, but co=esponded approx-
imately to the two highest dosages used in this study, Nevertheless, 
Manthei concluded that the antibody response is lower and declines to 
a negative status more rapidly in cattle when the dose of strain 19 is 
reduced. The results.of th~ present',study, along with the results of 
others, agree that reduced dosages of strain 19 produce co=espondingly 
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lower antibody responses which persist for shorter periods of time, 
In addition to the monitoring of the antibody responses stimulated 
by various dosages of strain 19, the cattle were challenged with viru-
lent organisms to determine whether or not reduced dosages would pro-
duce adequate immunity. A challenge dosage .of B.27 X 105 .strain 2JOB 
was used. This dose was slightly greater than that recommended in 1947 
(54) by the USDA as the challenge standard. 
Direct evidence of the existence of Brucella infection includes the 
production of clinical signs (abortion and weak or dead calves) and the 
isolation of Brucella from the secretions, excretions, or tissues. When 
these two criteria are applied to the results of challenge, the vacci-
nated animals were sigilificantly (P < 0.005)1 more resistant to the chal-
lenge than the control cattle. However, no significant difference was 
found among the vaccination groups when they were compared with each 
other; 
If the absence of clinical signs is considered separately as a 
criterion of immunity, there is also a significant difference (P < 0. 025) 
. between the vaccinates and the controls, but no significant difference 
among the vaccinates (P < 0,5), However, if the cultural results are 
used as the only basis of evaluating resistance to challenge, the resist-
ance of the vaccinates and controls are not significantly different at 
the 0.01 level, even though there was a higher percentage of recoveries 
from the ·control cattle versus the vaccinates, 
~earson chi-square was used to determine the significance level, 
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The·overall effect of the challenge was somewhat less than expected. 
Only nine out of 20 control cattle had serologic evidence of exposure 
(positive on the card test). Brucella abortus straiff 2308 was iso~ated 
from only three of the nine cattle. These expectations were based on 
results of other investigators (11, 12, 26, 49, 53) ·who reported higher 
rates of abortion and infectivity. While many of the conditions in this 
investigation were the same as those reported by others., there were sev-
eral differences which could have influenced the results. Differences 
such as number of viable organisms in the challenge dose, virulence of 
the organism, age of the cattle, pregnancy status, time interval between 
vaccination and challenge, housing, breed variation, stress, and genetic 
background, were not uniform amorig the various investigations and could 
accolint for some of the differences in results. 
A traditional method for evaluating an animal's "immunity" has been 
the measurement of the antibody response. In this study, the tube agglu-
tination response of the control cattle to challenge was significantly 
higher (P <::"0.05) than the response of the cattle in the vaccination-
challenge ( VC) groups. The tube test titers of ·12 out of the 20 control 
cows (6o%) increased from negative to a 1:50 or greater, following chal-
lenge, whereas only 16% of the vaccinated-challenged cattle had similar 
responses. Deyoe et al. (26) reported similar serological responses 
following challenge in cattle vaccinated with reduced dosages of strain 
19; however, the titer increase of the control cattle was from negative 
.to a 1:200 or greater. Manthei et al. (57) and Berman and Irwin (12). 
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however, reported increases in the mean agglutinin titer from negative 
to a 1:100 or greater following .challenge of vaccinated cattle, 
There was no s.ignificant difference, following challenge, in the 
tube test titers of the cattle in each of the VC groups when compared 
with those of the corresponding groups that were not challenged, These 
results indicate that a significant anamnestic response was not produced 
by the exposure of vaccinated cattle to strain 2308. 
In studies (9, 10,' 27) using the anamnestic response to differen-
tiate vaccinal and infection titers, it was proposed that infected cattle 
may be saturated with antigen (~. abortus) which stimulates the antibody-
producing cells to capacity and creates a "static phase." Therefore, 
an injection of strain 19 during this static phase would not elicit the 
formation of additional antibodies, If this can be expanded to include 
recentiy vaccinated animals exposed to a challenge, then perhaps the time 
interval between vaccination and challenge in this study was short enough 
to provide a "static phase," One difficulty with this theory is that 
several cows, especially those in the lower dosage groups did not develop 
an antibody response when challenged. It has recently been established 
(45, 47) that cell-mediated mechanisms are significant in providing 
immunity to Brucella. The possibility must be considered that cell-
mediated mechanisms may have eliminat·ed the challenge dose of Brucella 
' ' 
before antibody-forming cells wei;e stimulated to activity, Another fac-
tor, whi.ch might favor the rapid elimination of the challenge organisms, 
would be a reduction in virulence of the challenge strain. 
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A persistent elevated antibody response is a good indication of 
exposure and/or infection. The most pronounced and P.ersistent increase 
in antibody response in this study, following challenge, occurred in 
those cows in which the infection became established and Brucella was 
isolated. Strain 19 was isolated from four cows and strain 2308 from 
another seven. cows. Eight of the 11 cows, from which Brucella was iso-
lated, produced characteristic antibody responses on all six serological 
tests which are recognized as diagnostic evidence of an established per-
sistent infection. Five of these eight cows aborted and three had nor-
mal calves. However, three of the 11 cows, with an established Brucella 
infection (two cows with strain 2308 and one with strain 19) had low 
antibody respons.es which would not have been interpreted as reactors by 
usual serological methods. These cows also had normal calves, One cow 
shed strain 2308 in her milk for one week after calving, The other two 
cows did not shed Brucella, but had localized infections and Brucella 
was isolated from individual tissues. Whether these cows would have 
overcome the infection or succumbed and aborted during a later pregnancy 
is unknown. 
other vaccination-challenge studies have reported similar findings. 
Berman and Irwin (12) stated that "an interesting and important aspect of 
the work with the lower exposure l~vel (6 X 105 strain 2308 organisms) 
is the number of infected animals which failed to develop agglutinins of 
diagnostic significance," Deyoe et al. (26) used a higher challenge 
dosage of strain 2308 and reported the same observations. Both 
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investigators theorized that this lack of response was related to the 
severity and extent of infection in which some localization in the tis-
sues had occurred with little or no contact with antibody forming cells, 
This fact is consistent with field observations where it has been diffi-
cult to eliminate the disease from herds through the use of serological 
tests as the only means of diagnosis. 
Apparently, when cattle are naturally exposed or challeriged, the 
dosage and/or virulence may be critical in the production of antibody 
and cell-mediated responses, Therefore, cattle in infected herds that 
are exposed to low numbers of organisms may develop localized.infections 
that persist for unknown periods of time before the organismS are elim-
inated or cause abortion and/or shedding.· This points out the problem 
that·regulatory personnel and cattle·owners face if they depend entirely· 
on the serological tests to identify infected cattle. It stresses the 
importance of collecting milk, vaginal mucus, and tissue samples, if 
possible, when attempting to detect all of· the cattle which are shedding 
the organism. 
It is appropriate to look at the protection produced in other 
studies using reduced dosages of~. abortus strain 19. Nicoletti et al. 
·(75), 'ui>in% 1nfec~~,r:~in herds, reported "+.here were no apparent dif-
ferences in protection afforded by the standard vaccine dose (5.9 X 1010) 
~nd the reduced dose (2 X 109) of strain 19 administered subcutaneously,'! 
These finding are supported by trials in England (70) in which there 
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were no differences in protection between calves inoculated with 0.25 cc 
(2,4 X 109) and 5 cc (4.4 X 1010). The calves were challenged ten months 
after vaccination with strain 544, However, in the same study, a dosage 
of 3,6 X 107 (l/1000 of the normal dose) reportedly failed to provide 
"protection •. " The method of evaluating protection was by the isolation 
of Brucella from tissues and by the serological response which was "slow 
to develop, reached a low peak, and had virtually disappeared two months 
after vaccination •. " Since the calves were not pregnant, any effect the 
challenge may have had upon reproduction was not evaluated, 
Manthei et al. (57) stated in 1952 that the minimum dose of viable 
strain 19 organisms that will produce a serviceable resistance to bru-
cellosis in cattle was unknown at that time. Yet, based on their study, 
they found that the subcutaneous inoculation of 2.4 X 109 viable strain 
19 provided an immunity equal to that produced by the subcutaneous in-
oculation of 6 X 1010 viable organisms~ Deyoe et al. (26) stated in 
1979 that a vaccine dosage as low as l X 107 colony forming units (or 
1/5000, of the current minimum recommended dose) given subcutaneously 
was fully as protective as a standard dose. These studies provide evi-
dence that a dosage greater than 3,6 X 107 should provide adequate. 
immunity, 
One problem occasionally encountered in cattle vaccinated with 
strain 19 is the establishment of persistent infections which stimulate 
diagnostically significant serological titers. Strain 19 was isolated 
from four of the 115 cattle (3,5% infection rate) vaccinated in this 
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study. Three of the four cows were classified as reactors on the basis 
of their serological titers. One of the.three aborted and strain 19 was 
isolated from the fetus, Other studies "(25, 35, 52, 60, 68, 93) have 
~lso reported abortions and persistent infections in cows vaccinated 
during pregnancy. Apparently strain l~ aoes not cause as many persist-
ent infections when given to nonpregnant cattle (53, 68). 
Strain 19 was not isolated from cows in the two groups receiving 
the lowest dosages (2.3 X 107 and 1.4 X 108 organisms). Perhaps the 
number of organisms at these dosage levels was insufficient to produce 
persistent infections. However, the next highest dosage ( 9. 2 X 108 
organisms) produced strain 19 infection in two cows; one cow aborted 
and one had a normal cal:f. Whether or not this dosage level will rou-
tinely produce more persistent strain ·19 infections or clinical problems 
than other dosages is difficult to evaluate without further testing, 
Each of the groups that received the. two highest vaccine dosages, 
contained one strain 19 infected animal. One of these had a persistent 
·.antibody titer and the other had no serological evidence of persistent 
strain 19 infection eight weeks after vaccination·. Both cows calved 
normally. An explanation for the failure of the one cow to produce an 
antibody response was undetermined, 
Six serological tests were included in this study to monitor the 
antibody responses due to vaccination with varied dosages and to observe 
their usefulness in distinguishing infection due to virulent strain 
2308 versus vaccination with strain 19. The CF, rivanol, and ME tests 
1.50 
gave similar results in correctly identifying cattle (72%) from which 
Brucella was isolated, However, in those cattle that had transient 
infections, the CF test titer· returned to a negative status earlier than 
the other five tests. This reduced time interval between vaccination 
and the return to a negative status is the main advantage of using re-
duced dosages of strain 19. When the supplemental tests were used with 
cattle given a standard dosage of strain 19, most vaccinated cows from 
which Brucella was not isolated.could be differentiated from those in 
which Brucella was isolated, 16 weeks following vaccination, However, 
by using reduced dosages, this time interval was reduced to ten weeks. 
Therefore, under the conditions of this study, it was possible to iden-
tify and remove infected cattle ten weeks after vaccination. If similar 
results were obtained under field conditions, this practice would aid 
in reducing the exposure potential, 
The tube and plate tests were the most sensitive test procedures 
for the detection of antibody responses to both vaccination and chal-
lenge earlier and longer than the other four tests, The card test was 
the next most sensitive test for detecting antibodies produced from 
either vaccination or infection. However, the test was not as selective 
in differentiating between vaccination and infection as were the CF, 
rivanol, or ME tests, but was more selective than the plate and tube 
tests in revealing infected animals, 
151. 
SUMMARY 
The purpose of this study was to evaluate the effect of varied 
dosages of :!!· abortus strain 19 in· adult pregnant cattle, One hundred 
thirty-five beef cows were purchased and bred for this study, Forty 
cows were used in the vaccination-control phase and 95 were used in the· 
challenge phase. The 95 cows were randomly divided into six groups. 
One group of 20 cows was used as nonvaccinated-challenged controls. The 
remaining 75 cows were divided ·into five groups of 15 animals and each 
group was ... given a different dose of vaccine. 
Four months following vaccination the 95 cows ~ere challenged with 
.:!!_, abortus strain 2308, administered into the conjuncti val sacs. Blood 
samples were collected and evaluated using six tests. Vaginal swabs 
were.taken at weekly intervals following challenge. Milk samples were 
collected following abortion or calving. All cows were slaughtered at 
the end of the study and tissues were cultured for Brucella. 
The antibody titers produced against the strain 19 organisms varied 
in proportion to the dose given. The vaccinated animals were. found to 
be significantly more resistant to challenge than the control cattle 
(P < 0.005), as determined by the combination of clinical signs and cul-
tural recovery. However, isolations of B. abortus strain 2308 were made 
f;r.om only three of 20 control cattle. (15%). Sixty percent of the control 
cattle developed a two dilution tube test titer increase following chal-
. lenge. Generally, Brucella was not usually isolated from vaccinated-
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challenged animals which did not have persistent elevated antibody 
responses.· 
Brucella was isolated from milk, vaginal swabs, fetal tissues, 
and/or tissues collected at slaughter from 11 cows. Three of these cows 
had low antibody titers and were not suspected as carriers by serologi-
cal procedures. Brucella abortus strain 19 was isolated from four cows 
within the three highest dosage groups, and was responsible for an abor-
tion in one. Persistently high antibody titers were observed in three 
of the four cows from which strain 19 was isolated·. 
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CONCLUSIONS 
1, The maximal antibody response to ~. abortus strain 19 vaccine was 
proportional to each dosage given. 
z. The duration of the antibody response corresponded directly to the 
dosage of vaccine given, 
3, A high persistent titer is an indication of an active Brucella 
infection. 
4. The CF, rivanol, and ME tests were better predictors of an active 
established Brucella infection than the card, tube, and plate tests, 
5, The CF titer returned to a negative status more rapidly than the 
other tests in vaccinated cattle from which Brucella was not iso-
lated. 
6, The tube and plate tests were. the most sensitive and detected the 
antibody responses to both vaccination and challenge earlier and 
for a longer period than the other four .tests. 
' . 
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BRUCELLOS l S SEROLOGY FOR Control Group 
ANIMAL VIEEK \ISL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
73 0 -25 -25 -25 -25 -10 
I -25 -25 -25 -25 -10 
2 -25 -25 -25 -25 -10 
3 -25 -25 -25 -25 -10 
4 -25 -25 -25 -25 -10 
5 -25 -25 -25 -25 -10 
6 -25 -25 -25 -25 -10 
7 -25 -25 -25 -25 -10 
8 -25 -25 -25 -25 -10 
10 -25 -25 -25 -25 -10 
12 -25 -25 -25 -25 -10 
14 -25 -25 -25 -25 -10 
16 -25 ~25 -25 -25 -10 
1.7 -25 -25 -25 -25 -10 
18 -25 -25 -25 -25 -10 
19 -·25 -25 -25 125 -10 
20 -25 +25 -25 +25 -10 
21 -25 +25 -25 +25 -10 
22 -25 -25 -25 +25 -10 
23 -25 -25 -25 -25 -10 
24 -25 -25 -25 -25 -10 
25 -25 -25 -25 -25 -10 
26 -25 -25 -25 -25 -10 
2·7 -25 -25 -25 -25 -10 
28 -25 -25 c-25 125 -10 
30 -25 -25 -25 -25 -10 
32 -25 125 -,-25 125 -10 
34 -25 125 -25 -25 -10 
36 -25 -25 -25 -25 -10 
38 -25 125 -25 -25 -10 
40 
74 0 -25 -25 -25 -25 -10 
1 -25 125 -25 -25 -10 
2 -25 -25 -25 -25 -10 
3 -25 -c25 -25 -25 -10 
4 -25 -25 -25 -25 -10 
5 -25 ~25 -25 -25 -10 
6 -25 -25 -25 -25 -10 
7 -25 -25 -25 -25 -10 
8 -25 -25 -25 -25 -10 
10 -25 -25 -25 -25 -10 
12 -25 125 -25 -25 -10 
14 -25 -25 -25 -25 -10 
16 -25 -25 -25 -25 -10 
17 -25 -25 -25 -25 -10 
18 -25 -25 -25 -25 -10 
19 -25 -25 -25 -25 -10 
20 -25 -25 -25 -25 -10 
21 -25 +25 -25 I 50 -10 
22 -25 125 -25 +25 -10 
23 -25 125 -25 125 -10 
24 -25 -25 -25 -25 -10 
25 -25 -25 -25 -25 -10 
26 -25 -25 -25 125 -10 
27 ·-25 -25 -25 -25 -10 
28 -25 I 25 -25 -25 -10 
30 -25 -25 -25 -25 -10 
32 -25 -25 -25 -25 -10 
34 -25 -25 -25 -25 -10 
36 -25 -25 -25 -25 -10 
38 -25 -25 -25 -25 -10 
40 
165 
BRUCELLOSIS SEROLOGY FOR Control Group 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
7S 0 - -2s -2S -2s I25 -10 1 - -25 -2S -2S -2S -10 
2 - -2S -25 -2S -25 -10 
3 ·- -2S -25 -2S ·-25 -10 
4 - -25 -2S -25 -2s -10 
s - -2s I 2S -2S -25 -10 
6 - -25 -2S -2S +25 -10 
7 - -25 I 25 -2S I2S -10 
B -· -2s -2S -2S +25 -10 
10 - -2S I2S -2S 150 -10 
.12 - -2S 125 -25 ISO -10 
14 - -25 I2S -25 +25 -io 
16 - -2S I 2S -2S +25 -10 
17 - ·-2S l 2S -2S ISO -10 
18 - -25 +2S -2S +SO -10 
19 w -2S I l 00 -25 1200 -10 
20 w -2S 1l00 -2S +100 -10 
21 w -2S 1100 1100 +200 -10 
22 w 125 +100 +SO +200 2+10 
23 + IlOO 1200 +100 +200 3+20 
24 + +800 I400 +400 IBOO 4+80 
2S + I 800 +400 +400 +800 2+320 
26 + +800 1400 +400 +800 1 +640 
27 + +400 1400 +400 +800 3+640 
2B + 1800 +400 +400 +800 1 +640 
30 + 1400 +400 +4()0 +8()0 3+320 
32 + +400 1400 +400 1800 4+160 
34 + +400 I400 1400 +400 1 +160 
36 + +200 I 200 !400 +400 3+80 
38 + +200 1200 1200 1400 1+80 
40 + l 200 +-100 +100 +200 1 +BO 
76 0 - -25 -25 -25 -2S -10 
1 - -2S 125 -2S -2s -10 
2 - -25 -25 -2S -25 -10 
3 - -2S. -25 -25 ~2s -10 
4 - -25 -25 -25 -25 -10 
s - -25 -25 -2s -25 -10 
6 - -25 -25 -25 -25 -10 
7 - -25 -25 -25 -25 -10 
8 - -2s -25 -25 -25 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 125 -25 -25 -10 
14 - -2S -2S -2S 125 -10 
16 - -25 125 -2S 125 -10 
17 - -25 I25 -25 125 -10 
18 - -25 125 -25 125 -10 
19 - -25 I25 -25 12S -10 
20 - -25 +25 -25 +50 -10 
21 - -25 l 50 -2S 1100 -10 
22 - -25 150 -25 +50 -10 
23 - -'-2S I SO -2S +so -10 
24 - -25 I 50 -25 150 -10 
25 - -2S 150 !25 +25 -io 
26 - -25 I2S -25 +25 -10 
27 - -2S +25 -2S +25. -10 
28 - -2S I 2S -2S 12S -10 
30· - -2S l SO -2S +2S -10 
32 - -2S +SO -2S. I2S -10 
34 - .. -25 ISO -25 +2S -10 
36 - -2S +25 -25 I2S -10. 
38 - -25 ;1-25 -2S !2S -10 
40 
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BRUCELLOSIS SEROLOGY FDR Control Group 
ANIMAL lllEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
77 0 - -25 -2s -2S -2S -10 
1 - -25 -25 -2S -25 -10 
2 - -2S -2s -2S -25 -10 
3 - -25 -25 -25 -25 -10 
4 - -25 -2S -25 -2S -10 
5 -. -2S l 25 -2S -25 -10 
6 - -2S -2s -2s +2S -10 
7 - -2s 12S -25 125 -10 
B - -25 l 2S -2S -2S -10 
10 - -2S I25 -2S 125 -10 
12 - -2S -25 -25 -2S -10 
14 - -2s 125 -2S +2S -10 
16 - -2S l2S -2S +25 -10 
17 - -2S +25 -2S +25 -10 
18 - -25 +25 -25 +25 -10 
19 - -2S +25 -2S 150 -10 
20 - -25 +2S -2S +50 -10 
21 -· -2S +2S -25 +SO -10 
22 - -25 +2S -ZS +25 -10 
23 - -2s I 25 -2S +2S -10 
24 - -2S l SO -2S ISO -10 
2S - -2S +2S -2S .+2S -10 
26 - -2s l 2S -2S +SO -10· 
27 - -2S +2.s -2S ISO -10 
28 - -2s +2S -2S +SO -10 
30 - -2S +25 -2S ISO -10 
32 - -25 +2S -25 12S -10 
34 - -2S ISO -2S -2S -10 
36 - -2S +2S -2S lSO -10 
38 - -25 +2S -25 150 -10 
40 
78 0 - -25 -25 -2S 125 -10 
1 ·- -2s -2S -2S -2S -IO 
2 - -25 -25 -25 -2S -10 
3 - -2S -25 -2S -25 -10 
4 - -25 -2S -2S -2S -10 
s - -2s -2S -2S -25 -10 
6 - -25 -25 -2S -2S -10 
7 - -2S 12S -2S -2S -10 
8 - -2S -25 -2s -2s -10 
10 - -25 -25 -25 -25 -10 
12 - -2S -25 -25 -25 -10 
14 - :-25 -25 .-2S . I 25 -10 
16 - -2S 125 -25 +25 -10 
17 - -2S -25 -2S 125 -10 
18 - -25 125 -25 125 -10 
19 - -2S l2S -2S +2S -10 
20 - -25 +25 -2s +2S -10 
21 - -25 +25 -2s +SO -10 
22 - -25 +25 -25 +50 -10 
23 - -25 +25 -2S +2S -10 
24 - -2S 150 -25 +25 -10 
25 - -2s +25 -2S +2S -10 
. 26 - -2S J 2S -2S +2S ~lo 
27 - -2S +2S -2s +25 -10 
28 - -25 I2S -25 I25 -10 
30 - -25 I 25 -25 +25 -10 
32 - . ~25 125 -2S 125 -10 
34 - -25 +.2s ~2s -2S -10 
36 - ~25 125 -2s 125 -10 
38 - -25 I 2S -25 l2S -10 
40 - -2S ISO -2S I25 -10 
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BRUCELLOS I 5 SEROLOGY FOR Control Group 
·AN! MAL WEEK' VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
79 0 - -25 -25 -25 -25 -10 
' l - -25 -25 -25 -25 -10 
2 - -25 -25 -25 -25 -10 
3 - -25 ·-25 -25 -25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 -25 -25 -10 
7 - -25 -25 -25 -25 -1.0 
8 - -25 -25 -25 -25 -10 
I 0 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -2s -10 
16 - -2S -25 -25 -25 -10 
17 - -2S -25 -25 -25 -10 
IS - -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -2S -25 -2S -25 -10 
21 -· -25 -25 -25 -25 -10 
22 - -25 -25 -25 -25 -.10 
23 - -25 -25 -25 -25 .:.10 
24 - -25 -25 -25 ·-25 -10 
'25 - -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 -25 -25 -2s -10 
28 - -25 -25 -2S -2S -10 
30 - -25 -2S -2S -2S -10 
32 - -25 -25 -25 -25 -10 
34 - -2S -25 -25 -2S -10 
36 ·- -25 -25 -25 -25' -10 
38 - ·-25 -25 -25 -25 -10 
40 
80 0 - -25 +50 -2S +2S -10 
l - -2S I SO -2S +25 -10 
2 - -2S I SO -2S 125 -10 
3 - -2S ISO -2S +2S -10 
4 - -2S ISO -2s 125 -10 
s - -2s I SO -2S +25 -10 
6 - -2S +so -2S ISO -10 
7 - -2S +50 -25 150 -10 
8 - -25 I SO -2S l2S ~10 
10 - -2S +2S -25 +2S -10 
12 - -25 l 50 -2S 12S -10 
14' - -25 +25 -25 +25 -10 
16 - -25 +25 -25 +25 -10 
17 - -25 +25 -25 •25 -10 
18 - -25 150 -25 125 -1·0 
19 - -25 +25 -25 +25 -io 
20 - -25 12S -2S 12S --10 
21 - -2S +25 -25 I 2S -10 
22 - -25 125 -25 +25 -10 
.23 - -25 I 25 -'2S 12S -10 
24 - -25 I 2S .:.2s -2S -io 
2S - -2S I 25 -25 -2S -10 
26 - -25 I2S -2S I2S -10 
'27 - -25 -2S -25 +2S -10 
28 - -25 -2S -25 125 -10 
30 ·- -25 +25 -25 +25 -10 
32 - -25 +25 -25 .+25 -10 
34 - -25 +25 -25 +25 -10 
36 - -25 +25 -25 +25 -10 
38 - -2S 125 -2S +25 -10 
40 
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BRUGELLOS [ s SEROLOGY FOR Control Group 
ANlMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
81 0 - ·-25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - -.25 -25 -25 -25 -10 
3 - -25 -25 -25 ~25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 -25 -25 -10 
7. - -25 -25 -25 -25 -10 
8 - -25 -25 -25 -25 -10 
10 - -25 -25 -25 -2.5 -10 
l.2 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 125 -25 +25 -10 
17 - -25 -25 ...:25 -25 -10 
1·8 - -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -1·0 
21 - -25 -25 -25 [25 -10 
22 - -25 -25 -25 I 25 -10 
23 - -25 [ 25 -25 +25 -10 
24 - -25 125 -25 +25 -10 
25· -25 [25 -25 +25 -10 
26 - -25 [ 25 -25 -25 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 ·- ·-25 -25 -25 125 -10 
32 - -25 -25 -25 -25 -10 
34 - ...:25 -25 -25 -25 -10 
36. - -25 -25 -25 -25 ·-10 
38 - -25 125 -25 -25 -10 
40 
82 0 - -25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - -25 -25 -25 -25 -10 
3 - -25 125 -25 -25 -10 4· - -25 -25 -25 '--25 -10 
5 - -25 -25 -25 +25 -10 
6 - -25 -25 -25 +25 -10 
7 - -25 125 -25 +25 -10 
8 - -25 -25 -25 [25 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 125 -25 I 25 -10 
14 - -25 125 -25 .+25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 +25 -25 +25 -10 
18 - -25 125 -25 +25 -10 
19 - -25 125 -25 +25 -10 
20 - -25 I 50 -25 150 -10 
21 - -25 I 100 -25 +100 -10 
22 w -25 [100 -25 +100 -10 
23 w -25 1100 [50 1200 -10 
24 w 125 1100 .[ 25 +100 1+10 
25 w I 25 [100 150 +200 3+20 
26 .. +200 I 200 [200 1400 1 +160' 
27 + +400 [400 +400 +400 3+320 
28 + +BOO +400 +400 +800 3+640 
30 + + 160 0 +400 +400 +1600 2+1.280 
32 + +800 +400 +400 +800 2+640 
34 + .+800 +400 +400 +800 4+320 
36 + +400 +200 +400 +400 2+320 
38 + +400 +200 1400 +40.0 4+160 
40 + 1400 1100 I 200· +400 2+160 
169. 
BRUCELLOSIS SEROLOGY FOR Control Group 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
83 0 - -25·· I 25 -25 -25 -10 
1 - -25 +25 -25 -25 -10 
2 - -25 -25 -.25 125 -10 
3 - -25 -25 -25 -2S -10 
4 - -25 -25 -25 125 -10 
s - -25 -2S -25 -25 -10 
6 - -2S -25 -25 I2S -10 
7 - -2S -2S -25 125 -10 
8 - -2S -2S -2S -2S -10 
10 - . -2S I 25 -25 -2S -10 
12 - -25 -25 -.25 -2S -10 
14 - -25 -25 -25 -25 -10 
16 - -25 125 -25 125 -10 
17 - -25 I 25 -25 125 -10 
18 - -25 I25 -25. +25 -10 
19 - -25 +25 -25 +50 -10 
.20 ·- -25 125 -25 ··+so -10 
21 - -25 +25 -25 +50 -10 
22 - -25 +25 -25 +50 -10 
23 - -25 +25 -25 +25 -10 
24 - -25 +25 -25 150 -10 
25 - -25 125 -25 ·+25 -10 
26 - -25 125 -25 !25 -10 
27 - -25 +25 -25 125 -10 
28 - -25 -25 -25 ISO -10 
30 - -2S -2S :-2S I 25 -10 
32 - -2S +25 -25 +2S -10 
34 - -25 I2S -2S -25 -10 
36 - -25 +25 -25 +25 -10 
38 - -2S +25 -2S +2S 2+10 
40 
84 0 - -2S -2s -25 !25 -10 
1 - -2S -2S -25 -2S -10 
2 - -25 -2S -2S !25 -10 
3 - -25 12S -25 -25 -10 
4 - -2S -25 -25 -25 -10 
5 - -25 125 -25 125 -10 
0 - -25 -25 -2S 12S -·10 
7 - -25 12S ~25 125 -10 
8 - -2S 125 -2s +2S -10 
10 - -2S 12S -2S 125 -10 
12 - -2S 12S -2S +25 -10 
14 - -2S I 2S -2S ISO -1.0 
16 -- -25 12S -25 +25' -10 
17 - -25 +25 -25 150 
18 - -<:'S +25 -2s +so -10 
19 w -25 I SO -2S 1100 -10 
20 w -2s ISO -2s +100 -10 
21 w -25 +so -25 +100 -10 
22 w -2S +50 -25 +50 -10 
23 w --25 I 50 -2S +so -10 
24 w -2S 150 -2S +50 -10 
25 w -25 150 -2S +so -10 
26 w -25 150 ·-25 +50 -10 
.27 - -25 150 -25 +25 -10 
28 - --'2S +25 -25 +50 -10 
30 - -25 +2S .-2S +so - fo 
32 - -25 .I 50 -2s +25 -10 
34 - -25 I 50 -2S +50 -10 
36 - -25 +25 -25 +25 -10 
38 - -25 +2S. -'25 150 -10 
40 
. ,; 
c 
··~{ , 
.-.,-·· . ·" 
170 
BRUCE LL OS I 5 SEROLOGY FOR Control Group 
ANIMAL WEEK VSL VSL .VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
85 0 - -25 -25 -25 -25 -10 
l - -25 -25 -25 -25 -10 
2 - -25 -25 -25 -25 -10 
3 - -25 -25 -2·5 -25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 ~25 -25 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 -25 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 .:25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 125 -25 +25 -10 
22 ~ -25 I 25 -25 I 25 -10 
23 - -25 125 -25 125 -10 
24 T -25 -25 -25 -25 -10 
25 - -25 I 25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 +25 -25 -25 -10 
28 - -25 I 25 -25 -25 -10 
30 - -25 -25 -25 -25 -10 
32 - -25 -25 -25 -25 -10 . 
34 - -25 125 -25 -25 -10 
36 - -25 I 25 -.25 .,-25 -10 
38 - -25 -25 -25 -25 -10 
40 - -25 -25 -25 -25 -10 
86 0 - -25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - -25 -25 -25 -25 -10 
3 - -25 -25 -25 -25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 -25 ·-25 -10 
.7. - -25 -25 -25 -25 -10 
8 ·- -25 -25 -25 -25 -10 
10 - -25 ..:.25 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 125 -25 -25 -10 
18 - -2s· -25 -25 -25 -10 
19 - -25 I 25 -25 +50 -10 
20 w -25 I 50 -25 +100 -10 
21 w -25 +50 -25 +100 -10 
22 w -25 f-50 -25 +50 -10 
23 w -25 +50 -25 +25 -10 
24 T -25 150 -25 125 -10 
25 - -25 +25 -25 150 -10 
26 - -25 +50 -25 +25 -10 
27 - -25 +25 -25 125 -10 
28 - -25 +25 -25 125 -10 
30 - -25 -25 -25 +25 -1 o_ 
32 - -25 +25 -25 -25 -10 
34 - -25. -:-25 -25 +25 -10· 
36 - -25 125 -25 -25 -10 
38 - -25 I 25 -25 -25 -10 
40 - -25 I 25 -25 -25 -10 
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BRUCELLOSIS SEROLOGY FOR Control Group 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
B7 0 . -25 -25 -2S -2S -10 
1 -2S. -2S -2s -2s -10 
2 -25 -2S -'2S -2S -10 
3. -2S -25 -2S -25 -10 
4 -2S -25 -2S -25 -10 
5 -25 ·-25 ~2s -25 -10 
6 -25 -25 -25 -2S -10 
7 -25 -2s -25 -25 -10. 
B -25 -25 -25 -25 -10 
·1 b -25 -25 -25 -2S -10 
1.2 -2S -2S -25 -25 -10 
14 -25 -25 -25 -2S -10 
16 -25 -25 -25 I25 -10 
17 -25 -25 -25 I25 -10 
t.B -25 -25 -25 +25 -10 
19 -2S +25 -'-25 ISO -10 
20 w -25 150 -25 +50 -10 
21 w -25 +50 -25 IlOO -10 
22 w -25 +50 -25 +50 -10 
23 w -2S I 50 -25 +50 -10 
24 w -25 I 50 -25 +so -10 
2S T . -2S 150 -2s ISO -10 
26 -2S ISO -2S +2S -10 
27 -2S +25 -25 +2S -10 
2B -2S +25 -2S ISO -10 
. 30 -2S +25 -25 +2S -10 
32 -2S +25 -2S +2S -10 
34 -2S I SQ -25 +SO -10 
36 -25 +25 -25 ISO -10 
3B -'2S +25 -25 150 -10 
40 -25 +25 -2S ISO -10 
BB 0 -2S -2S -2S -25 -10 
1 -25 -2S -25 -25 -10 
2 -2s -25 -25 -25 -10 
3 -25 -25 -25 -25 -10 
4 -25 -25 -2S -25 -10 
s -25 -25 -2S -25 -10 
6 -25 ·-2S -25 -25 -10 
7 -25 -25 -2S -2S -10 
B -2S ~25 ~25 -2s -10 
10 -25. -25 -2S -25 -10 
12 -25 -25 -25 -25 -10 
14 -25 -25 -:25 -25 -10 
16 -25 -25 -2S -25 -10 
17 -25 -25 -25 -25 -10 
lB -25 -25 -25 -25 -10 
19 -25 -2S -25 -25 -10 
20 -25 -25 -25 -25 -10 
21 -25 -25 -25 -25 -10 
22 -25 -25 -25 . I 2!:i -10 
. 23 ~25 +25 -.25 125 -10 
24 w -25 lSO +25 +50 -10 
25 w -25 +50 I25 +50 -10 
26 w -25 I SO -25 -25 -10 
27 -25 +25 -25 +25 -10 
2B -25 -25 -25 125 -10 
30 -25 -25 -25 -25 -10 
32 -25 -25 -25 -25 -10 
34 -25 -25 -25 -2S -10 
36 -25 -25 -2S -25 -10 
3B -25 I25 -25 125 -10 
40 
172 
BRIJCELLOSIS SEROLLJGY FOR Control Group 
AN! MAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
89 0 - -25 -25 -25 -25 -10 
l - -25 -25 -25 -25 -10 
2 - -25 -25 -25 -25 -10 
3 - -25 -25 -25 -25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -'25' -25 -25 -10 
6 - -25 -25 -25 -25 -1.0 
7 - -25 -25 -25 -25 -10 
8 ·- -25 -25 -25 -25 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 -25 -25 ·-25 -10 
18 - -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 125 -25 +25 -10 
21 - -25 125 -25 ·+25 -10 
22 - -25 -25 -25 125 -10 
23 - -25 -25 -25 125 -10 
24 - -25 -25. -25 125 -10 
25 - -25 125 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 -25 -25 -25 ~10 
28 - -25 -25 -25 125 -10 
30 - -25 -25 -25 125 -10 
32 - -25 125 -25 -25 -10 
34 - -25 -25 -25 .125 -10 
36 - -25 125 -25 125 -10 
38 - -25 I 25 -25 125 -10 
40 
90 o - -25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - -25 -25 -25 -25 -10 
3 - -25 -25 -25 I 25 -10 
4 - -25 -25 -25 ~25 -10 
5 - -25 I 25 -25 125 -10 
6 - :-25 -25 -25 +25 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 125 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 +25 -10 
16 - -25 -25 -25 +25 -10 
17 - -25 -25 -25 125 -10 
18 - -25 -25 -25 +25 -10 
19 - -25 -25. -25 125 -10 
20 ·- -25 +25 ·-25 125 -10 
21 - -25 125 -25 150 -10 
22 - -25 I 25 -25 +25 -10 
23 - -25 125 -25 125 -10 
24 - -25 125 -25 +25 -10 
25 - -25 I 25 -25 +25 -10 
26 - ~25 -25 -25 125 -10 
27 w -25 150 -25 125 -10 
28 - -25 +25 -25 +50 -10 
30 - -25 +25 ·-25 150 -10 
32 - -25. -25 -25 -25 -10 
34 - -25 125 -25. +25 -10 
36 - -25 -25 -25 125 -10 
38 - -25 +25 -25 125 -10 
40 
173 
BRUCELLOSIS SEROLOGY FOR Control Group 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
91 0 - ·-25 -25 -25 ~25 -10 
1 - ~25 125 -25 -25 -10 
. 2 ·- -25 -25 .-25 -25 -10 
3 - -25 -25 -25 -25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 -25 +25 -10 
7 - -25 125 .-25 I 25 -10 
8 - . -25 .l 25 -25 125 -10 
10 - -25 +25 -25 +25 -10 
12 - -25 +25 -25 +25 -10 
14 - -25 I 25 -25 +25 -10 
16 - -25 125 -25 +25 -10 
17 - -25 l 25 -25 +25 -10 
18 - -25 125 -25 +25 -10 
19 w -25 I 100 -25 +200 -10 
20 w -25 I 100 -25 +100 -10 
21 w 125 I 100 125 1200 -10 
22 w I 25 +100 +25 1200 -10 
23 w -25 +50 -25 +100 -10 
24 w -25 150 -25 IlOO -10 
25 w -25 I 50 -25 +50 -10· 
26 w -25 I50 -25 +50 -10 
27. - -25 +25 -25 +25 -10 
26 -· -25 +25 -25 +50 -10 
30 w -25 1100 -25 +100 -10 
32 - -25 .150 -25 +50 -10 . 
34 - -25 +25 -25 +50 -10 
36 - -25 l 25 -25 +25 -10 
38 - -25 +25 -25 +50 -10 
40 
92 0 - -25 -25 -25 .-25· -10 
1 - -25 -25 -25 -25 -10 
2 ·- -25 -25 -25 -25 -10 
3 - -25 -25 -25 -25 -10 
4 - -25 -25 -25 -25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 -25 -25 -10 
7 - -25 -25 -25 -25 -10 
.8 - -25 -25 -25 -25 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 ·-25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -'25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 I 50 -25 -25 -10 
21 - -25 +25 -25 +25 -10 
22 - -25 +25 -25 +25 -10 
23 - -25 125 -25 +25 -10 
24 - -25 l 25 -25 +25 -10 
25 - -25 -25 -25 . 125 . -10 
26 w -25· 125 -25 125 -10 
27 - -25 -25 -25 -25 -10 
28 - -:25 -25 -25 -25 -10 
30 - -25 -25 -25 -25 -10· 
32 - -25 125 -25 -25 -10 
34 - -25 I 25 -25 . 125 -10 
36 - '--25 -25 -.25 -25 -10 
38 - -25 -25 -25 I25 -10 
40 - -25 125 -25 125 -10 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
25 0 - ~25 -25 -25 -25 -1·0 
l + -25 +400 +100 +800 4+160 
2 + +3200 +400 +200 1640 0 l +320 
3 + +400 +400 1400 +320•) 3+160 
4 + +400 +400 +400 +3200 3+160 
5 + +200· +400 1200 11600 2+160 
6 + +200 +400 1200 +800 2+80 
7 + +100 !'400 1200 +800 1+40 
8 + +50 +200 l 100 +400 3+20 
10 + +50 1200 150 +400 1+20 
12 w +50 +200 +50 +400 1 +10 
14 w -25 +200 -25 I 800 1+10 
16 w 125 +200 -25 +400 l·+l 0 
17 + 125 1400 +25 +400 1+10 
18 Ill -~5 +200 125 .+400 1+10 
19 w -25 +200 125 +400 1+10 
20 w -25 1200 -25 +400 1+10 
21 w -25 +200 -25 +400 -10 
22 w -25 I 200 -25 +400 -10 
23 w -25 1200 125 +400 -10 
24 w -25 1200 125 1800 -10 
25 w -25 1200 1100 +400 -10 
26 + -25 1200 150 +400 2+10 
27 w -25 1400 1200 +400 1+10 
28 + -25 +·200 +50 +400 -10 
30 Ill I 50 1400 +400 1800 -10 
32 w 150 +200 I I 00 +400 -10 
34 w +25 +200 125 1800 -10 
36 w -25 +200 +50 +400 -10 
38 w -25 +100 -25 +400 -10 
40 
26 0 - -25 -25 -25 125 -10 
I + -25 +400 -25 +800 1·+4.0 
2 + +200 +400 +200 +3200 2+80 
3 + +200 +400 1400 13200 l+loO 
4 + +400 +400 +400 +3200 3+160 
5 + +400 +400 1400 +1600 1+160 
6 + +400 1400 1400 +BOO 1+160 
7 + +200 1400 1400 +800 2+80 
8 + +200 +400 +200 +800 2•80 
. 10 + 1100 +200 1200 +400 2+40 
12 + +100 l 400 1200 +400 3+20 
14 + +100. +200 1200 1800 2+2.0 
16 + +50 1400 1200 +400 3+10 
17 + +25 1400 +100 +400 2+10· 
18 w +50 1400 1200 +400 1+10 
19 + ·125 +200 1200 .+400 2+10 
20 + 125 +200 +100 +400 1+10 
21 + +25 1400 +200 +400 -10 
22 w -25 1400 +25 +400 -10 
23 + -25 +200 1100 +400 -10 
24 + 125 1200 1100 1800 
25 + -25 +200 1200 +400 -10 
26 + 125 i 200 +100 +400 2+10 
27 + -25 +200 1200 +400 1+10 
28 + -25 +200 I l 00 +400 -10 
30. w +25 1400 1200 +800 -10 
32 + +50 +400 +50 +400 -to 
34 + · I 50 +200 125 1800 -10 
36 w -25 1400 125 1800 -10 
38 w -25 1200 -25 +400 -10 
40 
175 
BRUCELLOSIS SEROLOGY FDR GROUP VC-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
27 0 - -25 -25 -25 -25 -10 
I + -25 I 400 1100 +800 1+40 
2 + 1100 I 400 +200 I1600 l+BO 
3 + +100 l 400 1100 11600 1+40 
4 + +50 +400 +100 +1600 3+40A 
5 + 150 +200 +100 +400 2+40 
6 + +50 I200 1100 +400 4+20 
7 + +50 +100 l 10 0 l 200 1+10 
B + +50 +100 150 1200 -10 
10 + 125 +50 150 +100 -10 
12 w +25 +50 I25 +100 -10 
14 w -25 1100 -25 +50 -10 
16 w -25 IlOO I25 +100 -10· 
17 w -25 ·I I 00 -25 IIOO -10 
lB w -25 +50 125 +100 -10 
19 "' -25 +50 -25 +50 -10 20 w -25 : .l 50 -25 1100 -10 
21 w -25 +50 -25 l 100. -10 
22 w -25 l 50 -25 +100 -10 
23 Ill -25 l 50 -25 +25 -10 
24 w -25 I 50 -25 +50 -10 
25 w -25 1100 -25 1100 -10 
26 w -25 150 -25 +100 -10 
27 w -25 1100 -25 1100 -10 
2B w -25 +50 -25 +100 -10 
30 w -25 I 100 -25 +50 -10 
32 w -25 +50 -25 +100 -10 
34 w -25 150 -25 +100 -10 
36 - -25 +50 -25 IlOO -10 
3B 
40 
2B 0 - -25 -25 -25 -25 -10 
I + -25 +400 +100 +3200 1+40 
2 + +1600 +400 +-200 I6400 2+BO 
3 + 1400 +400 1400 I.3200 2+160 
4 + +400 +400 +400 +3200 3+80 
5 + +200 +400 I200 ""1600 2+40 
6 + I 100 +400 I200 +BOO 4+40 
7 + +100 +-400 1200 +BOO 2+20 
B + +100 +400 1200 +.400 .3+10 
10 .. +50 +-200 I 100 +-400 1+-l0 
12 w I 25 1200 1200 1400 -10 
14 w 125 1200 150 1400 -10 
16 w +25 +200 1100 +400 -10 
17 + +25 I 400 1100 +400 1+10 
IB w 125 +200" 1100 +400 -10 
19 w +25 +200 1100 +400 1+10 
20 w +25 +200 +100 +400 -10 
21 W· ,f-25 I 400 I 100 +400 -10 
22 w +-25 1200 150 +400 -10 
23 w ·-25 +200 I -100 I BOO -10 
24 .. -25 +200 +so +400 -1.0 
25 + -25 +200 ISO +400 -10 
26 + 125 1400 I50 . IBOO 1+10 
27 + 125 I 400 +50 +400 -10 
2B + 125 +400 I 50 +400 -10 
30 w , l 25 +400 1100 +BOO -10 
-32 + +50 +400 I"lOO +1600 -10 
34 + +25 +200 150 +BOO -10 
36 w •25 1400 I I JO +400 -10 
3B w 125 
40 
I 400 150 +400 -10 
176 
BRUCELLOSIS SEROLOGY FOR GROUP VC-1 
ANiMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
29 0 - -25 -25' ·-25 -25 -10 
1 + -25 1400 125 11600 -10 
2 + +50 +400 +200 l 1600 1+80 
3 + +200 +400 1400 l 3200 2+160 
4 + +400 +400 +400 +800 4+160 
5 + +200 +400 1400 +400 1+160 
6 + +200 1400 1400 +200 1+160 
7 + +200 +200 1400 +200 3+80 
8 + +200 +200 +200 +200 2+80 
10 + +100 l 200 1200 +100 3+40 
12 + +100 1200 llOO +100 2+20 
14 w +25 +100 1100 +100 2+20 
16 w +·25 1200 150 l 100 1+10 
17 w +25 l 200 +25 +50 2+10 
18 w I 25 l 200 !25 l l 00 2+10 
19 w +2S +100 +25 1100 2+10 
20 w +25 l 100 +25 +50 -10 
21 w +25 I 100 150 +SO -10 
22 w I 2.5 +50 -25 +50 -10 
23 w -25 I 100 125 +50 -10 
24 w 125 1100 125 +25 -10 
25 w -25 I I 00 150 +50 -10 
26 ltl 125 +50 125 +50 1+10 
27 w. -25 1100 -25 1100 -10 
28 w -25 I l 00 -25 ISO -10 
30· w 125 I 200 125 +50 -10 
32 w 125 +100 -25 +100 -10 
34 w -25 +100 -25 +100 -10 
36 w -25 l 100 125 1100 -10 
38 w -25 l I 00 -25 !100 -10 
40 
30 0 - -25 -25 -25 125 -10 
1 + -25 +200 -25 +800 -!O 
2 + -25 +200 150 +800 -10 
3 + +25 +200 150 ·+500 -10 
4 + -25 +200 150 1800 -10 
5. + +50 1200 +25 1400 1+10 
6 + +25 +!00 150 +200 3+10 
7 + +25 +100 125 1200 -10 
8 w 125 +50 -25 1100 -10 
10 w -25 +50 -25 +50 -!O 
12 w -25 +50 -25 I l 00 -10 
14 T -25 150 -25 +50 -!O 
16 r -25 +25 -25 +50 -10 
17 w -25 +50 -25 ISO -10 
18 w -25 150 -25 +50 -10 
19 Ill I 25 +100 -25 +50 2+10 
20 w +25 150 -25 +50 -IO 
21 w I 25 I 50 -25 +50 -10 
22 w. 125 +25 -25 +50 -10 
23 w +l 00 1100 1100 +100 2+40 
24 + +200 I 200 +200 +100 4+80 
25 + I 800 +200 1400 1800 1 +320 
.26 + +800 +400 +400 +800 2+640 
27 + 13200 +400 +400 11600 1+1280 
28 + + 1600 +400 +400 13200 3+1280 
30 + 13200 +400 +400 +3200 4+1280 
32 + + 1600 +400 +400 +1600 2+1280 
34 + +800 +400 +40 () I 1600 4+320 
36 + 1800 1400 +400 +800 3+320 
38 + 1800 I 200 +200 1800 1+320 
40 + I 800 +!00 1100 1800 4+160 
177 
BRUCELLOSIS SEROLOGY FOR GROUP VC-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARO ME PLATE RIV TUBE CF 
31 0 - -25 -25 -25 -25 -10 
I + ,-,25 +20.0 -25 +400 -10 
2 + +50 +200 IIOO +800 2+20 
3 + +100 +200• 1200 16400 1+80 
4 + +200 +400 +400 +800 2+80 
5 + +100 ·l 400 +400 +400 4+40 
6 + 1200 +200 I 400 +400 AC 
7 + +100 1400 +200 +400 AC 
8 + +100 1200 1400 1400 AC 
10 + +50 I 200 I 200 +200 AC 
12 +· +50 +100 +100 +200 3+10 
14 + ISO +100 l 10 0 +200 -10 
16 + +50 +!00 +100 +200 -I 0 
17 + +5.0 +100 I I 00 1200 3+10 
18 w l25 +!00 +100 +100 -10 
19 w +25 ·+100 1100 1200 3+10 
20 l>I +25 +!00 1100 +100 -10 
21 It/ +25 +100 +100 I200 -10 
22 w l 25 I 100 IIOO 1200 -10 
23 w -25 +100 IIOO +100 - I() 
24 w 125 1100 I 10 0 · +100 -10 
25 w 125 [100 I 100 +100 -10 
.26 "' 125 I 100 +25 +100 -10 27 w -25 I !00 125 1100 -10 
28 w -25 +50 I 25 +100 -10 
30 w I 25 I I 00 1100 +100 -10 
32 Ill I 25 l 100 +50 +100 -10 . 
34 w -25 1100 150 +too ~10 
36 w -25 1100 ISO 1200 -10 
38 w l25 +100 +25 1200. -10 
40 
32 0 - -25 -25 -25 -25 -ro 
l + -25 1200 -25 +400 -lo 
2 + +1600 +400 +200 +3200 2+80 
3 + +200 +400 .. 400 .13200 1+!60 
4 + +400 +400 .. 400· +1600 3+80 
5 .. 1100 1400 +400 +800 3+40 
6 + 1200 1400 +200 +800 4+40 
7 + I I 00 1400 1400 +800 l +20A 
8 + +100 +200 1400 +40.0 · 1 +I 0 
10 + +50 I 400 1200 +400 1+10 
12 + 150 +200 + 100 +400 -10 
14 .. -25 1200 [100 +.400 -10 
16 111 -25 1200 +100 1400 -10 
··1 7 w -25 1200 +25 1400 -10 
is w -25 I200 I I 00 +200 -10 
19 w ~25 1200 IlOO +200 -10 
20 w -25 I 200 1100 +200 -10 
21 w -25 l200 +100 +200 -1.0 
22 w -25 1200 125 1400 -10 
23 w -25 +100 -25. +200 -10 
24 w -25 I 200 -25 +100 -10 
25 w -25 +100· -25 +200 -10 
26 w -25 +100 125 +200 - lo 
27 w -25 +100 150 1400 -10 
28 It/ -25 1200 -25 +200 -10. 
30 w l 25 [400 +100 +400 -10 
32 + +25 1400 +100 I 1600 -10 
34 + +50 I 400 . 110 0 +800 -1 ci 
36 ·+ I 50 1400 I I 00 I800 -10 
38 + l 50 +200 1100 !800 -10 
40 + +25 1400 +50 1800 -10 
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BRUCELLOSIS SERGLUG Y FOR GROUP VC-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
3.3 0 -25 -25 -25 -25 -ID 
I + -25 +200 -25 +800 - 1 ci 
2 + 125 I 400 I200 I 1600 -10 
3 + +50 1400 1200 I800 -10 
4 + I 400 +400 +-100 +800 2+40 
5 + 1100 1200 IlOO 1400 .3+10 
6 VI +50 +100 !100 +200 4+20 
7 w I50 +100 I 10 0 1400 J+!O 
8 Ill +25 I I 00 1100 +200 2+10 
10 w +25 I I 00 +25 1200 -10 
12 'd +25 1100 125 +100 -10 
14 Ill -25 +50 -25 1100 -10 
16 w -25 1100 -25 +50 -10 
17 w -25 1100 -25 +100 -10 
18 w -25 +-50 -25 +100 -10 
19 w -25 +!00 -25 I100 -10 
20 w -25 I I 00 -25 •100 -10 
21 w -25 1100 -25 +100 -10 
22 T -25 +50 -25 +100 -10 
23 T -25 +50 -25 +100 -10 
24 w -25 l l 00 -25 I I 00 -10 
25 T -25 1100 -25 +100 -10 
26 -25 1100 -25 +50 -10 
27 -25 +50 -25 I I Ou -10 
28 •1 -25 +100 -25 +400 -10· 
30 w -25 +100 -25 +200 -10 
32 Ill -25 1200 -25 1400 -10 
34 w -25 I 200 -25 +200 -10 
36 -25 1100 -25 I200 -10 
38 T -25 +50 -25 +100 -10 
40 
34 0 -25 -25 -25 125 -10 
I + -25 I 400 l 100 +1600 1 +-40 
2 + +1600 +400 +200 13200 2+80 
3 + +400 +400 1400 +1600 3+160 
4 + +400 +400 +400 + 1600 3+160 
5 + + 100 +400 +400 +800 4+80 
6 .. r 100 1400 1400 +800 2+160 
7 + +100 I400 1400 +400 3+40 
8 + +100 1400 1400 +-400 2+40 
10 + +100 +-200 1200 1400 2+10 
12 + +50 +200 l 10 0 +400 1+20 
14 + +50 I400 1100 +200 2+10 
16 Ill +25 I 200 +100 1400 3+10 
17 .. +25 +200 I 100 1400 l +! 0 
18 + •50 1400 1200 1400 -10 
19 + +-25 +200 1200 1400 2+10 
20 + -25 1200 1200 1400 -10 
21 w +25 1400 +100 f-400 -10 
22 w +25 I 200 +50 +400 -10 
23 + -25 +200 + 100 1400 -10 
24 .. f-25 +200 1200 1400 -10 
25 \II -25 +200 1200 1400 -10 
26 w +25 +200 +25 +400 2+10 
27 w I25 +200 +50 +400 -10 
28 Ill .I50 +200 I200 +400 -10 
JO w 125 I 2PO I 200 +400 -10 
32 w +50 1400 +50 +400 -10 
34 w 125 +200 I25 +200 -10 
36 w +25 1200 +50 +400 -10 
38 w +25 1200 150 +400 -10 
40 
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BRUCELLOSIS SEROLOGY FOR. GROUP VC-1-
AN.I MAL WEEK VSL VSL VSL VSL \ISL VSL 
CARD ME PLATE RIV TUBE CF 
·35 0 - -25 -25 -25 -25 -10 
l + ~25 1400 +25 +1600 l +40 
2 + 13200 ·+400 1200 13200 . l +40 
3 + +50 140 0 1200 +1600 1+40 
4 • +100 +400 1400 + 1·600 2+80 5 • 1100 1400 1200 +800 3+40A 
6 + +100 +200 1200 1800 3+40 
7 + +100 1400 1200 +400 2+20A 
8 + +50 +200 +200 1400 2+10 
10 + +50 1200· 1200 +200 l +10 
12 + +50 1200 +100 +100 -10 
14 + . +25 I.200 llOO + i.oo -10 ' 
16 + -25 +100 110 0 +100 -10 
17 + 125 1200 +50 +100 -10 
18 + ~25 1100 1100 1200 -10 
19 Iii -25 1100 150 +100 -10 
20 w -25 1100 150 +100 -10 
21 w -25 1100 150 110 0 -10 
22 w -25 I 100 +50 +100 -10 
23 w -25 JIOO ·150 1100 -10 
24 + -25 I I 00 125 +50 -10 
25 w -25 I 100 125 +50 -10 
26 w -25 1100 +25 1100 -10 
27 w -,,.25 I 100 125 +100 -10 
28 w -25 +50 -25 !100 -10 
.30 w -25 1100 -25 1100 -10 
32 w -25 +50 -25 +100 -10 
34 w -25 l 100 -25 +100 -10 
36 w -25 +50 -25 1100 -10 
38 w -25 +50 -25 1100 -10 
40 - -25 l 50 125 +50 -10 
36 0 - -25 -25 -25 125 -10 
l + -25 1200 -25 18.0\l -10 
2 + 16400 +400 +200 +6400 l +320 
3 +· I 4.00 +400 1400 +3200 1+,l60 
4 + .+400 +400 +400 +6400 2+1.60 
5 + +200 +400 l 400 +l600 3+4·0 
6 + +200 +400 1400 11600 3+80 
7 + 1200 l 400 +20.0 +800 2+40 
8 + +100 1400 1400 +400 3+20 
10 + +50 +2.00 1100 +400 3+10 
12 + +50 +200 I I 00 1400 1+10 
14 + 150 1200 1100 +400 2+10 
16 + +25 +200 :+-50 +400 -10 
17 + +25• +200 150 +400 2+10 
18 + +25 1400 l 100 +200 1+10 
19 + +25 I 400 1100 +400 1 +10 
20 + +25 +200 +50 1400 -10 
21 .. +25 +200 125. 140.0 -10 
22 + 125 I 200 +25 +400 -10 
23 + 125 1200 125 1400 - . .10 
24 + +25 +200 125 +400 -10 
25 + -25 1200 -25 I 400 -10 
'26 + -25 I 200 125 1400 lHO 
27 + ·+25 +200 125 +400 -10 
.28 + -25 +200 -25 +400 -10 
30 + -25 1400 -25 +400 -10 
32 +. -25 +200 -25 1400 -10 
34 + -25 I 200 -25 +400 -10 
36 w -25 1200 -25 1400 -10· 
'39 + -25 1200 -25 1400 -10 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
37 0 - -25 -25 -25 -25 -10 
1 + .-25 I 200 125 +800 -10 
2 + l I 00 +400 +20,0 +3200 1+80 
3 + +200 1400 1400 I 320 0 2+80 
4 + +400 +400 +400 +1600 2+160 
5 + +200 +400 I 400 11600 4+80 
6 + I I 0 0 1400 1400 +800 3+160 
7 + +100 1400 +200 1800 3+40 
8 + +50 +200 1400 1800 3+20 
10 + +50 +200 I200 +400 2+26 
12 + +so 1200 1100 +400 2+10 
14 + +50 I 200 1100 +400 2+10 
16 + +2S 1200 +100 +200 3+10 
17 + l2S 1400 +SO 1400 2+10 
18 + +25 1400 +so +400 2+10 
19 + +2S +200 +so 1400 2+10 
20 + <-2S 1200 ISO +200 -10 
21 + +2S l 200 l 100 I 400 -10 
22 w 12S !200 ·J 100 +400 -10 
23 + I 25 +200 +50 +400 -10 
24 + 12S +200 +SO +400 -10 
2S w -25 1400 ISO 1400 -10 
26 + 125 +200 +100 1400 1+10 
27 + 125 +200 +100 +400 -10 
28 .. -2S +200 +50 +400 -10 
30 w -25 1200 I 100 +400 -10 
32 w +25 +200 150 I 400 -10 
34 w 125 I 200 +25 +200 -10 
36 w -25 +200 +25 +200 - l'O 
38 w -25 +100 150 1400 -10 
40 + ~25 +100 12S +200 -10· 
38 0 - -2S -25 -25 -25 -10 
1 + -25 1200 -2S +800 -10 
2 + 13200 +400 +200 16400 2+80 
3 + +200 +400 1200 +1600 1+40 
4 + 1400 +400 1400 +3200 2+80A 
5 + +200 +400 +200 + 1600 4+40 
6 + +100 J 400 +200 +BOO 2+80 
7 + '+100 1400 1200 1800 1 +40A. 
8 + +100 l 400 1200 +400 2+20A 
10 + +SO I 400 +!00 +400 1+10 
12 + +SO 1400 +50 +400 -10 
14 + -2S 1200 l.50 1400 -10 
16 + -2s 1200 150 I 400 -10 
17 + -25 +200 lSO +200 -10 
18 + I 25 +200 110 O 1400 - l'O 
19 + +25 +200 1200 +400 -10 
20 + +2S +200 +2.S 1400 -10 
21 + +2S +200 +2S +400 -Hi 
22 + +2S +200 +2S +400 -10 
23 + J 2S 1200 1100 +400 -10 
24 + +2S +200 1100 1400 -10 
2S + 125 +200 1200 +400 -10 
26 + +25 +200 1200 +400 -10 
27 + <-2S +200 1100 +400 -10 
28 + -2S +200 +25 +400 -10 
30 + -2S +400 +200 +400 -10 
32 + +50 +400 +100 +800 -10 
34 + +·so 1400 .I I 00 !800 -10 
36 + !2S 1400 +100 1800 -10 
38 + 1 SO l 400 +!00 1800 -10 
40 + 150 +200 -25 +400 -10 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
39 0 - -25 -25 -25 125 -10 
l + -25 +200 125 1800 -10 
2 + +50 I 400 +200 1800 1 +40 
3 + +50 +200 1200 1400 1 +20 
4 +· +100 +200 +100 +400 3+20 
5 + +100 I 200 1100 1400 4+10 
6 w ! SO +100 I 10 o. +100 3+20 
1 w +25 +l·0-0 +SO +100 4+io 
8 w -25 1100 ISO +100 -10 
10 w -25 I 100 +2S 1100 -10 
12 w I 2S I 100 125 +SO -10 
14 w -25 +100 -25 +so -10 
16 T -25 +SO 125 1100 -10 
17 T -25 l 100 -25 +so -10 
18 T -25 1100 -25 +SO -10 
19 T -25 +100 125 +so -10 
20 T -25 +50 -25 +SO -10 
21 T -25 +50 -25 +so -10 
.22 - -2S ISO -25 +50 -10 
23 - -2S +50 -2S +50 -10 
24 - -2S +5.0 -25 1100 -1 () 
2s - -2S 150 -2S +50 -10 
26 - -25 ISO -25 +SO -10 
27 :- -25 I 50 -2S +SO -10 
28 ·- -25 ISO -2S ISO -10 
30 ·- -25 +50 -25 +50 -10 
32 - -2S I I 00 -25 1100 -10 
34 - -2S 1100 -25 +100 -10 
36 - -2S +50 -25 1100 -10 
38 - -2S I 100 -25 +50 -10 
40 
182 
BRUCELLOS [ S SEROLOGY FOR GROUP V-1 
ANIMAL WEEK \ISL VSL II SL VSL VSL \ISL 
CARD ME PLATE .. RIV TUBE CF 
96 0 - -2S -2S -2S -2S -10 
1 + -2S +400 lSO +800 1+20 
2 + +800 +400 +200 +1600 2+80 
3 + +400 +400 +400 +3200 4+80 
4 + 1400 +400 +400 +800 3+40 
5 + +100 +200 1400 +-400 4+40 
6 + JIOO +200 I 400 +200 4+40 
7 + +SO I200 I400 +200 2+40 
8 ... t-SO 1200 1200 +100 1+40· 
10 .. +so +100 +100 t-100 2+20 
12 w +2S +100 +50 +100 3+20 
14 w J2S [ 100 +25 +100 2+10 
16 w +25 1100 I25 +50 -10 
·I 7 
18 w -2S Jioo 125 +100 -10 
19 
20 w -2S I 100 -2S +SO -10 
21 NT 
22 w -2S 
23 
.. 1 0.0 -2S +50 -10 
2.4 w 12S l I 00 12S +100 -10 
2S 
26 w -25 ·+100 -2S +100 1+10 
27 
28 w -25 +100 -2S +100 -10 
.JO 
32 w -2S 
34 
1200 125 +100 -10 
36 - -25 +100 -2S IlOO -10 
38 
40 - -2S +so -25 +so -10 
97 0 - -2S -2S -25 -25 -10 
I + -25 +200 1100 11600 1+80 
2 + +160 0 +400 I200 I1600 1+80 
3 + +400 +400 1200 11600 3+80 
4 + +200 1400 +200 +800 1 +160 
s + IlOO +200 +200 +400 4+40 
6 + +50 +200 +100 1200 4+40 
7 + +50 +100 1200 +100 2+40 
8 + +25 +100 I 10 0 +100 .3+20 
10 .. 1 SO I 100 I I 0 0 +100 1+20 
12 w f-25 +100 125 +100 2+20A 
14 w J 2S +-SO I2S +10.0 -10 
16 w !2S +so -25 ·+so -10 
17 
18 w -2s +so -2S I I 00 -10 
19 
20 - -2S 
21 
+so -2S +SO -10 
22 w -2S I 100 -'25 1100 -10 
23 
24 - -2s 
25 
+SO -25 +100 -10 
26 - -25 
27 
l 100 -2S +100 -10 
28 - -2S 
30 
ISO -2S .1100 -10 
32 - -2s 
34 
I I 00 -2S ·+100 -10 
36 T -2S 1100 
38 
-2S +100 -1 () 
40 
183 
BRUCELLOS l S SEROLOGY FOR GROUP V-1 
ANIMAL WEEK VSL \ISL VSL VSL VSL VSL 
.CARD ME PLATE RIV TUBE CF 
98 0 - -25 -25 -25 -25 -10 
i ·+ 125 +200 +100 +1600 1 +80. 
2 + 13200 +400 +200 +1600 1 +80 
3 + +800 +400 +.400 I 16.0 0 3+160 
4 + +200 +400 +400 +1600 3+-160 
5 + +200 +400 1400 ·+400 4+80 
6 + +200 1400 1400 1400 4+80 
7 + I 200 +200 1400 +200 4+80 
8 + +200 +200 +200 +200 4+40 
10 + I l 0 O 1200 1200 +100 4+20 
12 + 1100 +.100 + 100 1100 2+20 
14 + +50 +100 1100 +50 3+10 
16 w +25 1100 150 +50. I +l 0 
1,7 
18 w -25 1100 IlOO +50 -10 
19 
20 w J 25 +50 I 50 150 -10 
21 
22 Ill 125 I l 00 +25 +50 -10 
23 
24 T -25 I I 00 I 50 +50 -10 
25 
26 - -25 I I 00 -25 +50 -10 
27 
28 - -25 +50 -25· +50 -10 
30 
32 - -25 1100 125 1100 -10 
34 
36 - -25 +50 -25 . +50 -10 
38 
40 
99 0 - -25 -25 ·-25 -25 -10 
1 + -25 +200 +LOO +1600 1+40 
2 .. I 1600 +400 +200 +1600 1 +80 
3 + +800 +400 +400 +1600 1+320 
4 + 1400 +400 +400 +800 4+160 
5 + +200 +400 +400 +800 4+80 
6 + +200 +400 +400 +800 1+160 
7 .. +200 1400 +400 +40.0 3+80 
8 + +200 1400 +400 +400 1 +80 
10 + +100 +200 1400 +200 4+40 
12 + +100 +200 1400 +200 1 +40 
14 + +100 I 200 1200 I 200 3+20 
16 + +100 I 200 .1200 .+100 2+20 
17 
18 + +50 +100 1200 +100 2+10 
19 
20 Ill +25 +100 1100 +100 2+10 
21 
22 Ill I 50 +100 1100 +100 I +l 0 
23 
24 + 125 .. I 00 1100 +100 2+10 
25· 
26 w +25 +100 I 10 0 +100 3+10 
27 
28 w I 25 I 100 150 +100 1 +10 
30 
32 w -25 +100 1100 1200 -10 
34 
36 w -25 
-:38 
I 100 -25 +100 -10 
40 + .,-25 1100 -25 +100 -10 
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BRUCELLOSIS SEROLOG.Y FOR GROUP V-1 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
100 0 -25 -25 -25 -25 -10 
I + -25 +200 -25 +800 -10 
2 ... +50 +400 1200 11600 l •40 
3 .. 1800 i-400 1400 +800 4+80 
4 .. +200 1400 I400 +1600 2+.160 
5 + f-200 +400 +200 11600 3+80 
6 + f-100 +200 +200 +400 4+80· 
7 .. +100 1400 +200 +400 1 +80 
8 + +100 +200 1200 +200 3+40 
10 + 1100 1200 1100 +200 4+40 
12 + +50 .. 1.00 +50 t-200 3t-10 
14 t- f-50 f-100 +25 t-200 2t-l 0 
16 + t-25 +100 150 t-200 1+10 
17 
18 .. •25 1200 +25 i-400 1 t-1 0 
19 
20 Ill 125 +100 +25 +200 -10 
21 
22 ill t-25 I 200 150 1400 -to 
23 
24 + -25 +100 f-50 +200 1+10 
25 
26 w I 25 +100 +25 +200 2+10 
27 
28 w -25 +100 125 +200 l +l 0 
30 
32 w -25 +100 +25 +200 -10 
34 
36 w· -25 1200 -25 +200 -10 
38 
40 T -25 +100 -25 f-100 -10 
I 0 1 0 -25 -25 -25 -25 -10 
1 + -25 +200 I I 0 0 +1600 -10 
2 + f-50 +200 1200 11600 -10 
3 + +400 f-400 1·200 +800 3+80 
4 +. +200 1400 1400 +800 3+80 
5 .. +100 1400 I 200 f-400 2+80 
6 + +100 1400 I 400 +400 3+80 
7 + +100 +200 1200 +200 2+80 
8 + +100 +200 +100 ·+200 4+40 
10 + I I 00 f-100 I 200 +100 l f-80 
12 t- I 100 +100 +100 +100 3+40 
14 .. •100 +100 I I 0 0 +100 3+40 
16 + +50 1200 1100 +100 1+40 
17 
18 w I 50 I 100 +50 1100 3+10 
19 
·20 w +50 +50 1100 .+50 1+20 
21 
22 w l 50 +50 1100 t-50 3•10 
23 
24 w l 25 1100 150 +50 1 +20 
25 
26 w +25 1100 150 I I 00 2+20 
27 
28 w 125 +50 -25 1100 4+10 
30 
32 w -25 •50 -25 f-50 -10 
34 
36 T -25 I 100 -25 1100 -10 
38 -10 
40 -25 150 -'-25 +50 -10 
18.5 
BRUCELLOSIS SEROLOGY FOR GROUP V-1 
AN I MAL WEEK VSL VSL VSL VSL VSL VSL 
CARD "'E PLATE RIV TUBE CF 
102 0 - -2S -25 -25 12S -10 
1 + -25 +200 -25 l 800 -10 
2 + 1100 +400 +200 +3200 1 +160 
3 + +400 +400 1400 +3200 1 +160 
4 .. 1400 +400 +400 +1600 3+160 
s + 1400 +400 +400 11600 3+.320 
6· .. +400 +400 +400 +1600 3+640 
7 + +400 +400 +400 11600 4+640 
8 + +400 +400 +400 .+1600 4+320 
10 + +400 +400 +400 +800 3+320 
12 + +400' 1400 1400 +800 .3+160 
14 + +200 1400 1400 +400 1+160 
16 .. +400 +200 1400 +400 4+80 
17 
-18 + +200 +200 l 400 +200 3+40 
19 
20 + +100 1400 1400 +200 2+40 
21 
22 .. - +100 +200 1200 +400 2+40 
23 
24 + 1100 +200 +200 +400 1+40 
25 
26 + I I 00 +100 +200 +200 2+40 
27 
28 + 1100 1200 f-100 -+200 1+40 
30 
32 .. +50 +100 +50 +200 2+10 
. 34 
36 w -2S l 100 125 1200 -10 
38 
40 + +25 I 100 12S 1200 -10 
103 0 - -2S ·-25 -2S -2s -10 
1 + -2S I 400 1 SO +1600 1+40 
2 + +800 1400 1200 11600 2+40 
3 + +400 +400 1400 +800 2+160 
4 + 1400 +400 +400 11600 2+160 
5 + +200 1400 1400 f-800 4+80 
6 + +200 +200 1200 +200 4+80 
7 .. +100 1200 l 200 +200 2+80 
8 + 1100 +100 + 100 +200 3+40 
10 .. I SO 1100 I 100 +100 2+20 
12 w I SO +50 150 IlOO l +l 0 
14 w +25 +so 12S +so -10, 
16 w +25 1100 I2S IIOO -10 
17 
18 w +2S +SO -25 1100 '-10 
19 
20 w 12s 
21 
11,00 -25 'I l 00 -10 
22 w 12S +so -25 150 -10 
23 
24 w -2S 
25 
+50 -25 +100 -10 
26 w -25 +50 
27 
125 I 100 -10 
28 w -2S 
30 
+so -25 1100 -10 
32 w -2S 
34 
+SO -25 +so -10 
36 - -2S +50 
38 
-25 +100 -10 
40 
186 
BRUCELLOSIS SEROLO.:iY FOR .:iROUP VG-2 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
40 0 - -2S +25. -25 +2S -10 
1 + -25 I 400 -25 1400 -10 
2 + -25. I 200 150 IBOO -10 
3 + I 25 1200 150 +400 -10 
4 + -25 I.200 +50 +400 l +20 
5 + +25 +100 150 +400 3+10 
6 w 125 +100 150 1200 2+20 
7 Ill +25 +100 150 +100 -10 
8 w 150 1 100 -25 +100 -10 
10 w +25 IlOO -25 +100 -10 
12 w -25 +50 -25 +100 -10 
14 T -25 +50 -25 +100 - !Ci 
16 T -25 +50 -25 1100 -10 
17 T -25 +50 -25 1100 -10 
18 T -25 +50 -25 1100 -10 
19 w -25 I I 0 0 -25 1100 -10 
20 - -25 1100 -25 +100 -10 
21 T -25 +50 -25 1100 -10 
22 T -25 +50 -25 1100 -10 
23 w -2S +SO -25 IlOO -10 
24 w -2S l 100 -25 ISO -10 
25 w -25 +SO -2S +50 -10 
26 T -25 +50 -25 1100 -10 
27 T -2S +50 -25 +100 -10 
2B w -2S +50 -25 1200 -10 
30 w -25 +50 -25 1100 -1.0 
32 Ill -2S + l·OO 125 +200 -10 
34 w -2S +100 -2s 1200 -10 
36 T -25 +SO -2S 1200 -10 
38 - -2S r 1 oo -2S 1200 -10 
40 - -2S +SO -25 150 -10 
41 0 - -25 -25 -2S -25 -10 
1 + -25 1200 -2S 1400 -10 
2 w -2s 1200 ISO +400 -10 
·3 + -25 I 200. +25 +400 2+20 
4 + -25 +100 1l00 +400 2+20 
5 + I 50 +100 ISO 1400 3+20 
6 w +50 1100 +2S +100 4+20. 
7 w +so +100 +25 +100 1+20 
8 vi .. 50 l 100 125 +so 3HO 
10 vi +2S ISO -25 +25 -10 
12 - -25 +SO -25 +2S -10 
14 - -2S +25 -2S +25 -:-10 
16 - -25 +25 -25 +50 -10 
17 - -25 150 -2S r 25 -10 
18 - -25 +25 -25 125 -10 
19 - -2S .. 2S -25 +25 -10 
20 - -2S +2S -2S +50 -10 
21 - -25 +25 -25 .. 25 -10 
22 - -25 I 50 -25 125 -10 
23 - -2S +25 -2S 125 -10 
24 - -25 +2S -'2S +SO -10 
2S - -25 +25 -25 .. 25 -10 
26 - -25 +2S -25 +50 -10 
27 - -25 .. 25 -2S +2S -10 
28 - -2S I 50 -25 .. 2S -10 
30 - -25 +25 -2S +25 -10 
32 - -2s 125 -25 125 -10 
34 - -2S 150 -25 +25 -10 
36 - -25 +25 -25 +25 -10 
38 - -25 .. 25 -25 .. 25 -10 
40 
187 
BRUCELLOSIS SEROLOGY FOR GROUP W-2 
·ANIMAL . WEEK. VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
42 0 - -2s -2S -2S -2s -10 
I T -2s +200 -25 +100 -ID 
2 w -25 120D +50 1400 -10. 
3 + -25 +lOD ISO +200 2+20 
4 w -25 I I 00 I 1·00 +100 1 +I 0 
s w -25 1100 150 +100 1+10 
6 w -25 +50 -2S 150 l.+I 0 
-; T -25 +2S -25 +50 -10 
B T -25 150 -25 +SO -10 
10 - -25 +25 -25 +50 -10 
12 - -25 150 -25 +25 -10 
14 - -25 125 -2S ISO ~10 
16 - -2S I 2S -2S +2S -10 
17 - -25 +2S -2S ISO -10 
18 - -2S +25 -2S ISO -10 
19 - ~2s I 25 -2S +2S -10 
20 - -2S +25 -2S +SO -10 
21 - -2S +2S -2S ISO -10 
22 - -2S +2S -2S :+2S -10 
23 - -2s I2S -25 ISO -10 
24 - -2S I SO -25 ISO -10 
25 - -25 I 50 -25 +25 -10 
26 - -25 I 50 -2S +25 -10 
27 - '-2S +25 -2s lSO -10 
28 - -2S l 50 -2S +SO -10 
30 - -2S: ISO -25 ISO -10 
.32 - -25 12S -2S 125 -10 
34 • - -2s +2S -25 -2S -10 36 - -2S +2S -2S 125 -10 
38 
40 
43 0 - -2S -2S -2s -25 -10 
1 w -2S +100 -2S 1400 -ID 
2 + 125 1400 1.200 11600 1+40 
3 + +SO I 40D +100 +800 2+4() 
4 + +100 I 4DO 1200 +800 1 +8D 
s + +SO .120D 120D +400 2+40 
6 + +so 120D 1100 +20D 2+40 
7 + +SD 1200 l 100 1400 2+2D 
8 + 12S 1200 1100 +200 3+10 
10 w l 2S +100 lSO +2DO -10 
12 w I 25 +100 l2S +!OD -10 
14 w -2S I I OD 12S IIDO -10 
16 w -2S l I 00 +2S I20D -10 
17 w -2S +!DO +25 l2DO -10 
18 w -25 IIOO -2S +20D ~10 
19 w -2S +100 ISO +200 -10 
20 w -25 +100 I2S +200 -10 
21 w -25 +LOO 12S +2DD -10 
22 w -2s +100 -2S +200 -10 
·23 w ~2s IlDD +2S +2DO -10 
24 w -25 l 200 I25 +2DD -10 
2S w -2S 1200 lSO +20D -10 
26 w -2S +100 ISO +200 -10 
27 w -25. 1200 -25 +2DO -10 
28 w -2S 12DO I50 +.40D -10 
3D YI -2S I 200 -25 +40D - i-o 
32 w -2s +100 +2·5 +200 -10 
34 w -2S 1200 -25 +200 -.10 
36 w -2S ·+100 I2S +200. -10 
38 w -25 1100 -2S +200 -10 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-2 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RlV TUBE CF 
44 0 - -2s -2S -2S -2s -10 
1 + -2s 1200 -2S I 400 ~10 
2 + I2S +200 llOO +BOO l +20 
3 + ISO +200 1100 +400 3+20 
4 + +SO 1400 +100 +400 3+20 
s + +SO +IQO +100 +400 2+20 
6 Ill I SO +100 1100 +100 3+20 
7 "' +so +100 +so 1100 2+10 8 w +so I I 00 +so +100 1+10 
10 w +2S +100 ISO +100 -10 
12 w +25 +100 +25 +100 -10 
14 w -2S I 100 125 +50 -10 
16 w -25 +so +25 +SO -10 
17 w -25 1100. 12S +SO -10 
18 w -2S +so -2S +LOO -10 
19 w -25 +SO 125 llOO -10 
20 w -25 +50 I2S IlOO -10 
21 w ~2S +SO +25 IIOO -10 
22 w -25 l l 00 I2S +50 -10 
23 T -2S +50 !25 +50 -10 
24 - -25 IIOO -2S 1100 -10 
25 w -2S I 200 -2S 1100 -10 
26 w -25 +100 +25 1100 -10 
27 - -25 +100 I2S +100 -10 
28 w -2s I 100 125 +100 -10 
30 w -2s +so -25 +SO -10 
32 w -2s +SO -2S +50 -10 
34 T -2S +-SO -25 +SO -10 
36 - -2s I 100 -25 1100 -10 
38 
40 
4S 0 - -2S -2s· -25 -2s -10 
1 w -2s l 100 -25 IlOO -10 
2 T -25 1100 -25 +50 -10 
3 r -2S +50. -25 +100 -10 
4 w -2S +SO :-25 +100 -10 
s T I2S 150 -25 +SO -10 
6 - -2S +25 -2S 125 ~10 
7 T -2s 150 -2S 12S -10 
8 - -25 +25 -25 +25 -10 
10 - -25 +-25. -.25 +25 -10 
12 - -25 +25 12S +2S -10 
14 - -2S I 2S -25 +2S -10 
16 - -2S l 2S -25 +25 -10 
. 17 - -2S +2S -2S +2S -10 
18 - ·-25 I SO -2S +2S -10 
19 - -2s I 2S -25 +2S -10 
20 - -25 125 -2S +25 -10 
21 - -'-2S +-2S -2S +2S -10 
22 - -2s l 2S -2S +2S -10 
23 - -2S f2s -25 +25 -10 
24 - -2S -2S -2S +2S -10 
2S - -2S 125 -2S +25 -10 
26 - -2S I 25 -25 +25 -10 
27 - -2s -2S .:.25 +2S -10 
28 - -25 125 -25 125 ~10 
30 - -25 +-25 -25 +25 -10 
32 - -25 +2S -25 +25 -10 
34 - -2s 12S -2s +25 -IO 
36 - -2S -25 -2S 12S -10 
38 - -2s 125 -25 +2S -10 
40 
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BR UC ELL: OS l S SEROLOGY FOR GROUP VC-2 
ANIMAL WEEK VSL VSL VSL VSL \/SL VSL -
·CARO ME PLATE . RI \,I TUBE CF . 
46 0 - -25 -25 -25 -25 -10 
l + -25 I400 i 50 +400 -10 
2 + -25 I400 ISO I800 -10 
3 + +50 +200 I 50 +400 4+20 
4 + +50 1200 +50 +200 2+20 
5 w +25 +50 I25 +100 2+10 
6 T -25 +SO -25 +50 4+10 
7 T -25 ISO -25 +25 -1.0 
8 - -25 +25 -25 ISO -10 
10 - -25 +25 -25 150 -10 
12 - -25 +25 -25 150 -lO· 
14 - -25 +25 -25 150 -10 
16 - -25 125 -25 +25 -10 
17 - -25 150 -25 150 -10 
l8 - -25 I 50 -25 ISO -10 
19 - -25 125 -25 150 -10 
20 - -25 125 -25 +25 -10 
21 - -25 125 . -25 150 -IO 
22 - -2S I 25 -25 . +25 -10 
23 - -25 I 25 -25 +25 -10 
24 - -25 .l 2S -25 +25 -10 
25 - -2S +25 -25 +SO -10 
26 - -25 125 -25 lSO -10 
27 - -25 +2S -25 +25 -10 
28 - -25 +25 '-25 +SO -'-10 
30 - -25 I 50 -25 +25 -10 
32 - -25 +50 -25 150 -10 
34 - -25 I50 -25 +25 -10 
36 - -2S 150 -25 +25 -lO 
38 
40 
47 0 - -25 -2S -2s -25 -10 
1 + -2S 1200 -25 +200 -10 
2 + -25 1200 150 +400 -10 
3 + +50 +l 0.0 +50 +400 -10 
4 + +100 1200 1100 +200 4+20 
5 + +50 +100 llOO +200 3+20 
6 + +50 +100 +50 +100 4+20 
7 w +50 +100 I I 0 0 ll 00 J+ l.O 
8 w +50 1100 150 +5.0 2.+l 0 
10 Ill 125 1100 +25 +50 -10 
12 w 125 +50 ~25 +50 -10 
14 T -25 150 -25 +2S -10 
16 - -25 lSO -2S +25 -10 
17 - -2S +25 -2S 150 -10 
18 - -25 150 -25 +25 -10 
I9 - . -25 150 -2S lSO -10 
20 - -25 +25 -25 +25 -10 
21 - -25 +25 -25 150 -10 
22 - -25 +25 -25 +25 -10 
23 - -25 +25 -25 150 -10 
24 - -25 +25 -25 +25 -10 
25 - -25 +25 -'-25 +25 -10 
26 - -25 +25 -25 +25 -10 
27 -· -25 +25 -25 +25 -IO 
28 - -25 +25 -25 150 -10 
30 - -,25 150 -25 +25 -10 
32 - -25 150 ~25 +25 -10 
34 - -25 150 -25 150 -IO 
36 - -25 +25 -25 +50 
38 - -25 +25 -25 150 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-2 
ANIMAL WEEK V.:iL VSL VSL VSL \ISL VSL 
CARD ME PLATE RIV TUBE CF 
48 0 - -25 125 -25 IZ5 -10 
I + -25 +100 -Z5 +100 -.10 
z + -Z5 1 200 IZ5 +ZOO -10 
3 + -Z5 +100 -Z5 +ZOO -10 
4 + +25 +100 IZ5 +100 -10 
5 w -Z5 +50 -25 +100 -10 
6 w -Z5 +50 -25 +50 -10 
7 T -25 +50 -25 150 -10 
8 T -ZS +50 -ZS +50 -10 
10 - -25 +50 -Z5 150 -10 
lZ - -25 150 -Z5 +50 -10 
14 - -Z5 150 -25 +50 -10 
16 ~ -25 150 -Z5 +50 -10 
17 - -25 I 50 -Z5 +100 -10 
18 - -Z5 +50 -Z5 . 1100 -10 
19 - -Z5 150 -Z5 +50 -10 
zo - -ZS 150 -Z5 +50 -10 
21 - -Z5 150 -Z5 +50 -10 
2Z - -ZS 150 -Z5 +50 -10 
23 - -25 ISO -Z5 +50 -10 
Z4 - -ZS 150 -Z5 +50 -10 
Z5 - -25 150 -Z5 +50 -·10 
Z6 - -25 I 50 -25 +50 -10 
Z7 - .,.z5 150 -ZS +50 -10 
Z8 Ill -ZS +50 -Z5 1100 -10 
30 Ill -Z5 I 50 -Z5 +100 -10 
3Z Ill -ZS I l 00 -25 IlOO -10 
34 w -Z5 I 1 0 O -25 +100 -10 
36 w -Z5 I 100 -ZS +100 -10 
38 T -25 +50 -Z5 IlOO -10 
40 - -Z5 150 -25 +50 -10 
49 0 - -25 .,-25 -Z5 -Z5 -10 
I + -25 +400 -ZS +800 1+20 
z +. + 1600 1400 +ZOO +3200 I +ZO 
3 + I 400 +400 +400 I 3ZOO Z+SOA 
4 + 1400 +400 +400 +3200 2+80A 
5 + +too +400 +400 11600 1+80A 
6 + 1100 +400 1400 +800 3+40 
7 + +50 .1400 +zoo +400 2+ZOA 
8 + +50 +200 +zoo +400 l+ZOA 
lO + 1100 +ZOO 1200 1400 1+10 
12 + +50 +200 +100 +200· -10 
14 Ill -25 I 200 +100 +ZOO -10 
16 w 125 +100 l 100 1200 -10 
17 w +25 I 200 +100 +100 -10 
18 w 125 IZOO IZOO +200 -10 
19 w +Z5 +100 I I 00 +200 -10 
20 Ill +Z5 1200 1100 +200 -10 
ZI "' 125 +100 +1,00 +200 -10 2Z w -25 I ZOO 150 1400 -10 
23 w -25 1100 I i'o 0 +200 -10 
Z4 w I25 I 200 1100 +400 -10 
25 w -25 +100 + 100 +zoo -10 
26 w 1Z5 1200 +100 +ZOO -10 
Z7 w -25 I 200 · +50 +200 -10 
Z8 w -Z5 I200 +50 +400 -10 
30 w 1Z5 +200 1 l Q 0 +400 -10 
32 VI +Z5 1200 1100 1400 -10 
34 IN 125 I 200 I 50 +zoo -10 
36 Ill -25 1200 150 1400 -10 
38 w -25 I 200 +25 +200 -10 
40 
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BRUCELLOSI'S SEROLUGY FOR GROUP VC-2 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
50 0 - -25 -25 -25 -25 -10 
1 + -25 1400 -25 I400 -10 
2 + +50 I400 +200 +1600 1+40 
3 + +200 +400 +200 +1600 2+40 
4 + I 400 +400 1400 11600 2+80 
5 + +100 I400 +200 I800 3+40 
6 + I 1 00 1400 1200 +400 3+40 
7 + +50 I 400 1200 +400 3+20 
8 + +50 +200 1200 +400 l +20A 
10 + +50 +200 +100 1400, 1+20A 
12 + +50 +-200 +50 1400 l +-1 0 
14 w +50 1200 +50 +200 -10 
16 w +25 I 200 I 10 0 +200 -10 
17 + 150 +- 100 1100 +200 -10 
18 + 125 1200 +-100 1400 -10 
19 + +25 I200 +50 +200 -10 
20 +. 125 1200 +-50 +400 - 1 Cl 
21 w +25 I200 ISO 1400 -10 
22 w -25 I 200 +25 1400 ~10 
23 w -25 +too +50 1400 -10 
24 w -25 I 200 I 200 +400 -10 
25 w I25 1200 + 100 I400 -10 
26 w +25 .1200 l l,00 +-20 0 -10 
27 w I 25 I 20 0 I 200 1400 -10 
28 w I 25 1200 150 1400 -10 
30 w +25 I200 +100 +4.00 -10 
,32 w +-25 +200 I 100 +400 -10 
34 w +25 I200 I25 +200 -10 
36 Ill -25 I 200 125 I400 -10 
38 w -25 I 200 ISO I400 -10 
40 +- -25 I200 125 I4.00 -10 
106 0 - -25 -25 -25 -25 -10 
1 + -25 +400 ISO +1600 I +80 
2 + ISO +400 +200 +3200 1+160 
3 + +400 +400 +400 +3200 3+16() 
I 
4 +- +200 +400 +400 I3200 2+160 
5 + +200 +400 I 400 +800 3+40 
6 + +-200 I400 1400 +800 l +80 
7 + I 200 I 40 0 1400 I 800 1 +40 
8 + 1200 +200 1400 +400 2+20A 
10 + +-100 +200 1400 I400 2+20A 
12 + +-50 +-200 +200 1400 2+20A 
14 + +-50 1200 1200 l 400 1 +-1 0 
16 + +50 +200' +200 +400 2+10 
17 + +50 I200 1100 +400 2+10 
18 + +25 +200 1200 +400 1+l0 
19 + +25 +200 +200 '+400 1 +l 0 
20 +- +25 1200 1200 +400 1+l0 
21 +- 150 I 200 1200 +400 -10 
22 + 125 I 200 I 200 +400 -10 
23 + -25 +100 +100 I400 1+10 
24 + -25 +200 +25 +400 lf-10 
25 + -25 +200 1100 1400 -10 
26 + -25 1200 1200 +400 -10 
27 + -25 +100. +100 +400 -10 
28 + '-25 +200 +50 +400 -10 
30 w -25 I 400 +50 +400 -10 
32 + -25 +200 ISO +400 -10 
34 + -25 I200 125 +400 -10 
36 + -25 I 200 +25 +400 -10 
38 w -25 +100 I25 +200 
_40 + -25 +100 +25 I400 -10 
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BRUCELLOSIS SEROLOGY FDR GROUP VC-2 
ANIMAL WEEK V·SL . VSL VSL VSL VSL VSL 
CAR<:> ME PLATE RIV TUBE CF 
S2 0 - -2S 125 -25 125 -10 
l + -25 +400 ~2s 1400 -10 
2 + +.25 l 200 150 +400 -10 
3 + +50 +100 ISO +200 1 +20 
4 + +SO +100 +100 +200 2+20 
5 w +50 +100 ISO +200 3+10 
6 w +25 l 100 150 +100 3+.I 0 
7 w -25 +50 +25 I 100 -to 
8 W, -25 I I 00 125 +100 -10 
10 - -2S +SO -25 +50 -10 
12 - -25 l 50 -25 1100 -10 
14 - -25 150 -25 +51) -10 
10 - -25 +2S -25 +50 -10 
17 - -25 I 50 -25 150 -10 
18 - -25 150 -25 +so -10 
19 - -25 125 -25 150 -10 
20 - -25 +50 -25 150 -10 
21 - ,-25 +25 -25 +50 -10 
22 - -25 125 -25 ISO -10 
23 - -25 +25 -25 +50 -10 
24 - -25 +25 -25 +so -10 
25 - -25 +25 -25 +2S -10 
26 - -25 +25 -25 +50 -10 
27 - -25 +25 -25 +50 -10 
28 - -25 l 50 -25 150 -10 
30 - -25 150 -25 +50 -10 
32 - -25 150 -25 +25 -10 
34 - -25 +50 -25 +50 -10 
36 - -25 l 50 -25 !100 -10 
38 - -25 I 50 -25 1100 -10 
40 
53 0 - -25 -25 -2S -25 -10 
I - -25 +50 -25 I 2S -10 
2 + -25 .+ 100 +25 +100 -10 
3 + 125 l 100 125 +100 -10 
4 w -25 +50 +25 +50 -10 
5 T -25 +50 -25 +so -10 
6 T -25 150 -25 150 -10 
7 - -25 150 -25 +25 -10 
8 - -25 l 50 -25 +25 -10 
10 - -25 +25 -25 +25 -10 
12 - -25 I 50 -25 150 -10 
14 - -25 I 50 -25 +25 -10 
16 - -25 +25 -25 +25 -10 
17 - -25 150 -25 +25 -10 
18 - -25 +25 -25 +25 -10 
19 - -25 +50 -25 150 -10 
20 - -25 l 25 -25 +25 -10 
21 - -25 +25 -25 +25 -10 
22 - -25 +25 -25 125 -10 
23 - -25 +25 -25. +25 -10 
24 - -25 +25 -25 +25 -10 
25 - -25 +25 -25 +25 -10 
26 - -25 +25 -25 +25 -10 
27 - -25 +25 -25 +50 -10 
28 - -25 +25 -25 +25 -10 
30 - -25 150 -2S +25 -10 
32 
34 
36 
38 
40 
193 
BRUCELLOSIS SEROLOGY FOR GROUP VG-2 
ANIMAL WEEK VSL VSL VSL V.':iL VSL VSL. 
CARD. ME PLATE RIV TUBE CF 
54 0 - -25 -25 -25 -25 -10 
1 w -25 +200 -25 +4.00 -10 
2 + -25 +100 125 1400 -10 
3 w 125 .. +50 125 +200 -10 
4 w +25 . 1100 150 1200 -10 
5 w -25 +50 125 IIOO -10 
6 w 125 150 -25 IIOO -10 
7 T -25 +50 -25 +50 ...: l 0 
8 - -25 +50 -25 +50 -10 
10 - -25 +25 -25 +25 -10 
12 - -25 +25 -25 · 150 -10 
14 - -25 . +25 -25 +25 -10 
16 w -25 +25 -25 . 150 -10 
17 - -025 +25 -25 +25 -.10 
18 - -25 125 -25 +25 -10 
19 - -25 +25 -25 150 -10 
20 - -25 +25 -25 +25 -10 
21 - -25 +25 -25 150 -10 
22 - -25 125 -25 +25 -10 
23 - -25 +.25 -25 150 -10 
.24 - -25 +25 -25 +25 -10 
25 - .-25 125 -25 +25 -10. 
26 - -25 I 25 · -25 +25 -10 
27 - -25 125 -25 +25 -10 
28 - .,-25 I 25 -25 +25 -10 
30 - -25 125 -25 150 -10 
32 - -25 +25 -25 +25 -10 
34 - -25 +25 -25 +50. -10 36. - -25 I 50 -25 +50 -10 
38 - -25 +25 -25 +50 -10 
40 - -25 +25 -25 150 -10 
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BRUCELLOSIS SEROLOGY FOR GROUP V-2 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
104 0 - -25 -'25 -,,25 -25 -10 
l .. -25 'f-200 -2~ f-400 -10 
2 + t25 1400 1200 I 1600 -1.0 
3 .. +200 I 400 1200 +800 1 +80 
4 + +20.0 I 400 1200 +800 3+40 
5 .. +100 l 200. 1200 1400 1+40 
6 .. f-100 +100 +100 f-200 2f-40 
7 .. +50 1 l o'o 1200 1200 3+20 
8 + ISO +100 l 10 0 +100 4+10 
10 IN +25 l l 00 1100 I 100 3f-10 
12 w -25 I 100 150 +50 -10 
14 w -25 +50 125 +50 ·-10 
16 w 125 I I 00 125 +50 -10 
17 
18 w -25 +50 125 +100 -10 
19 
20 W· -25 +50 125 I l 0 0 -10 
21 
22 w -25 +50 -25 +50 -10 
23 
24 w -25 I I 00 -25 1100 -10 
25 
26 T -25 I l 00 -25 +100 -10 
27 
28 T -25 I l 0 O -25 +100 -10 
30 
32 w -25 1100 -25 +100 -10 
34 
36 - -25 + 50 -25 1100 -10 
38 
40 - -25 +50 -25 +100 -10 
105 0 - -25 -25 -25 -25 -10 
l + -25 +200 -25 +400 -10 
2 + f-25 +200 1200 1800 -10 
3 + +50 +100 1100 +400 3'+-40' 
4 + +50 1200 IlOO +200 3+20 
5 + I 50 +100 f-50 +100 4+20 
6 w 150 l l 00 150 +100 l +20 
7 w 125 +50 +25 +100 l.+10 
8 T -25 +50 -25 +50 -10 
10 T -25 I 50 -25 +50 -10 
12 - -25 l 50 -25 +50 -10 
14 - -25 +50 -25 +25 -10 
16 - -25 150 -25 125 -10 
17 
18 - '-25 150 -25 150 -10 
19 
20 - -25 +25 -25 1100 ~ l'G 
21 
22 - -25 +50 -25 +50 -10 
23 
24 - -25 150 ~25 1100 -10 
25 
26 - -25 150 -25 +50 -10 
27 
28 ·- -25 150 -25 +50 -LO 
3.0 
32 - -25 +50 -25 +25 -10 
34 
36 - -25 150 -25 +50 -10 
38 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP V-2 
ANIMAL WEEK VSL 'VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
51 0 - -25 -2,5 -25 -25 -10 
1 + . -25 +200 -25 1200 -10 
2 + 125 1200 +50 1200 -lO 
3 + +25 1200 +50 +200 3+40 
4 + 1100 +100 1200 +200 1+80 
5 + +100 +100 1100 +100 4+40 
6 + +50 1100 1100 +100 3+4ll 
7 w 125 l 100 110 0 ISO 3+20 
8 w +.25 1100 150 1100 . 1 +20 
10 w +25 +50 +25 +50 3+10 
12 T -25 150 125 1100 -10 
14 - -25 150 125 150 -10 
16 - -25 125 I 2:5 +25 -10 
17 - -25 +25 -25 125 -10 
18 - -25 I 25 -25 +25 -10 
19 
20 - -25 -25 -.25 +25 -10 
21 
22 - -25 125 -25 +25 
23 
24 - -25 +25 -25 I 25 -10 
25 
26 - +25 -25 +25 -10 
27 
26 - -25 +25 -25 +25 -10 
30 
32 - -25 I 50 -25 125 -10 
34 
36 - -25 +25 -25 125 -10 
38 -10 
40 
107 0 - -25 -25 -25 -25 -10 
1 + -25 +200 -25 1400 -1.0 
2 + l 50 +200 1100 +400 2+20 
3 + +50 .+ 100 150 1400 1 +40 
4 + 150 '+ 100 150 +200 1 +40 
5 + ·+so +100 150 +50 3+20 
6 w 125 +50 125 +50 2+20 
7 " +25 +50 125 1100 4+10 8 w +25 +50 125 +50 2+10 
10 w 125 +25 -25 150 -10 
12 - -25 +25 -25 +50 -10 
14 ~ -25 +25 -25 +25 -10 
16 - -.25 +25 -25 +.25 -10 
17 
lB - -25 +25 -25 +25 -10 
19 
20 - -25 +25 -25 +25 -10 
21 
22 - -25 +25 -25 . I 25 -10 
23 
24 - "'.'25 +25 -25 I 50 -to 
25 
26 - -25 125 -25 +25 -10 
27 
28 - -25 [,25 -,-25 125 -10 
30 
32 - -25 +25 -25 150 -10 
34 
36 - -25 +25 -25 +25 -10 
38 
4.0 
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BRUCELLOSIS SEROLOGY FOR GROUP V-2 
ANIMAL WEEK \ISL \ISL VSL VSL \ISL YSL 
CARD ME PLATE RIV TUBE CF 
106 0 -25 -2S -25 -'-2S -10 
1 + ·,,-25 +200 -2S [800 -10 
2 + +SO 1400 +200 11600 -10 
3 + +400 '"400 +400 +1600 2+80 
4 + 1200 .. 400 1400 +800 1 +80 
5 + +100 +200 +200 +400 1 +40 
b + .. 100 .. 200 I200 1400 3+40 
7 + .. so 1200 1200 .. 200 3+20 .a .. .. 50 +100 1200 .. 100 2 .. 10 
10 w 125 1100 1100 1100 ~lo 
12 w -25 IlOO 150 +so -10 
14 w -2s .. so +2S +so -10 
16 11' -2S +SO 125 .. so -10 
17 
18 w -2S .. so 12S +so -10 
19 
20 r -2S I I 00 125 1100 -1.0 
21 
22 ltt -25 l I 00 -2S +so -10 
23 
24 w -25 [ 100 -2S +100 -10 
2S 
26 w -.2S I SO ·I 2S +100 -IO 
27 
28 w . -25 +so -2s 1100 -10 
30 
32 w -2S 1100 -2S +100 -10 
34 
36 -2S I SO -2S +SO ~10 
38 
40 -2S +50 -25 r5o -10 
109 0 -2S -2S -25 -2S -10 
1 w -2S I I 00 -2s 1200 -1.0 
2 .. +so 1200 J 200 +200 1+20 
3 + .. 100 +!OD I l 00 +200 l +20· 
4 + 12S .. 100 IlOO 1200 2+10 
s Ill +2S 1100 +SO +so -10 
6 w .. 25 +so +SO ISO .-10 
7 Ill -2S +SO 150 I SO -10 
8 T -2S +so +2S +so -10 
10 -2S I SO -2S ISO -io 
·12 -2S +2S -2S +2S · -: I 0 
14 -2S +2S -2S +2S -10 
16 -2s I SO -2S +25 -10 
17 
18 T -2S +25 -2s +so -10 
19 
20 -2S +2S -2s +so -10 
21 
22 -2S ISO -2S I SO -10 
23 
24 -2S I SO -2S +so -10 
25 
26. -2S I SO -2s ISO -10 
27 
28 -2s +25 -2.S ISO -10 
30 
32 -2S ISO -2S ·ISO -10 
34 
36 -2S I 2S -25 +2S -1 cl 
38 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP V-2 
ANIMAL INEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE .RIV TUBE CF 
1 I 0 0 - -2S -2S -25 -2S -10 
I w -25 +100 .-25 1400 -10 
2 f- f-25 +100 ISO +200 2+10 
3 + -2S +100 +so +!00 3t-2o 
4 + +2S 1100 150 +100 2+40 
s w -2S +so l2S ISO 3+10 
6 VI -.2S I 50 -25 +50 -10 
7 - 125 l 50 -25 150 -10 
8 T -25 +2S -25 +50 -10 
10 - -25 +25 -25 12S -10 
12 - -25 +25 -25 +2S -10 
14 ~ -25 +2S -25 +25 -10 
16 - -2S +25 -25 [25 -10 
17 
18 - -25 +2S -25 150 -10 
19 
20 - -25 ·lSO -25 +50 -10 
21 
22 - -25 +25 -2S 125 -10 
23 
24 - -25 150 -25 +50 -10 
25 
26 - -25 I 50 -25 150 -10 
27 
28 - -25 +25 -25 150 -10 
30 
32 - -25 I 50 -25 +SO -10 
34 
36 - -25 125 -25 +25 -10 
38 
40 
I I I 0 - -25 -25 -25 -25 -10 
1 + -25 +200 -25 1800 -10 
2 + I 50 +200 +200 +800 1+20 
3 + +200 +400 1400 +800 2+80 
4 + f-100 1400 +400 I 200. 3+40 
5 + +100 1200 1200 1200 2+40 
6 + +50 +100 'f-10 0 +100 2+40 
7 w +50 1100 +100 1100 2+20 
8 w +SO I I 00 +50 +100 2+10 
ID w +25 I 100 +50 +50 1+l0 
12 T -25 +50 125 1100 -10 
14 - -25 I 50 125 +50 -10 
16 T -25 +50 125 +50 -10 
17 
18 - ·-25 +25 -25 llOO -10 
19 
20 T -25 
21 
+25 -25 IlOO -10 
22 T -25 150 -25 +50 -10 
23 
24 w -25 . I 50 
25 
-25 1100 -10 
26 w -25 I 50 -25 +50 -10 
27 
28 w -25 150 -25 +so· -10 
30 
32 ·- -25 
34 
I 50 -25 »+50 ·-10 
36 - -25 
38 
I 50 -25 [ 50 -10 
40 
198 
BRUCELLOSIS SEROLOGY FOR. GROUP VC-3 
ANIMAL WEEK VSL VSL VSL VSL .VSL VSL 
CARD ME PLATE RIV TUBE CF 
55 0 - -25 -2S -25 12S -10 
1 Ill -25 +so -25 +100 -10 
2 + -25 +100 12S !200 -10 
3 + 12S +·50 -25 +SO -10 
4 w -25 +5.0 I25 +50 2+10 
5 w I 2S +SO -25 HOO -10 
6 w -2S I SO -2S 1100 -10 
7 T -25 +so -25 +SO -10 
8 T -2S +so -2S 12S -10 
1.0 - -2S +2S -2S +2S .-10 
12 - -25 12S -25 +2S -10 
14 - -25 I 2S -25 +2S -10 
16 - c-2S I 2S -25 +25 -10 
17 - -25 I SO -25 +25 -to 
18 - =2S 125 '-25 +2S -.1·0 
19 - -2S .I 2S -25 +25 -10 
20 - -25 -25 -25 +25 -10 
21 - -2S 12S -25 +25 -10 
22 - -25 I 25 -2S +2S -10 
23 - -2S I 2S -2s +2S -10· 
24 - -25 l2S -2S +2S -10 
25 - -25 I 25 -2S +25 -10 
26 - -2S I 2S -2S ISO ~10 
27 - -2S +25 '-25 +25 -10 
28 - -25 I 2S -2S 125 -10 
30 - -2S l2S -25 +25 -10 
32 - -2S +2S -25 +2S -10· 
34 - -25 I 25 -25 -2s -1·0 
36 - -25 -25 -25 125 -10 
38 - -2·s 125 -2S 12S -10 
40 
56 .o - -25 -2S -25 -2s -10 
l - -25 +100 -25 +SO -10 
2 T -25 +100 -2S +200 -1,0 
3 w -2s I 100 -25 +200 ~10 
4 w -2s IlOO I25 1100 -10 
s w -25 +50 -25 ·.+so -10 
6 T -2S +50 -2S +2S -10 
7 T -25 +so -25 +2S -10 
8 T -25 ISO -25 150 -10 
10 - -25 +25 -25 +50 -10 
12 - -2S +2S -25 +25 -10 
14 - -2S 125 -2S +50 -10 
16 - ~2s 12S -25 +SO -10 
17 - -2S ISO -25 +50 -10 
18 T -25 +25 -25 +50 -10 
19 - -25 ISO -25 150 -10 
20 - -25 I 2S -25 +50 -10 
. 21 - -25 +25 -25 I 50 -10 
22 - -25 I 2S -25 I 25 -10 
23 - -25 +2S -2S +50 -10 
24 - -25 +25 -2S +so -10 
25 - -25 +25 -25 150 -10 
26 - -25 125 -25 +2S -10 
27 - -25 +25 -2S +50 -10 
:28 - -25 I 2S -25 ·+so - l.0 
30 w -'-2S 150 -25 +50 -16 
32 - -25 150 -25 +25 -10· 
34 - -25 I 50 -25 +50 -10 
36 - -25. 150 -2S +5.0 -10 
38 - -25 ·150 -25 150 -10' 
40 
,, 
199 
BR UCELLOS 1 S SEROLOGY FOR GROUP VC-3 
AN I.MAL WEEK vsi.. VSL VSL VSL VSL VSL 
CARD ME PLATE R[V TUBE CF 
57 0 -25 -25 -25 -25 -10 
I Ill -25 +100 -25 +100 -10 
2 .. -25 1 100 125 t-100 -10 
3 Ill -25 +50 -25 +50 -10 
4 w -25 +50 -25 +50 -10 
5 -25 [ 50 -25 +25 -10 
6 -25 t-25 -25 +25 - i (j 
7 -25 150 -25 +25 -10 
8 -25 t-25 -25 +25 -10 
10 -25 [25 -25 +25 -10 
12 -25 [25 -25 125 -10 
14 -25 125 -25 -25 -10 
16 -25 -25 -25 +25 -10 
17 -25 +25 -25 [25 -10 
18 -25 [ 25 -25 +25 -10 
19 -25 125 -25 +25 -1 (j 
20 -25 -25 -25 125 -10 
21 -25 125 -25 125 -10 
22 -25 l 25 -25 +25 -10 
23 ~ -25 125 -25 125 -10 
24 -25 +25 -25 +25 -10 
25 -25 125 -25 +25 -10 
26 -25 -25 -25 -25 -10 
27 -25 125 -25 -25 -10 
28 -25 125 -25 125 -10 
30 -25 150 -25 +25 -10 
32 -25 .. 25 -25 +25 -Ul 
34 -25 -25 -25 +25 -10 
36 -25 [25 -25 -25 -19 
38 
40 
58 0 -25 -25 -25 125 -10 
1 + -25 +400 t-50 11600 -10 
2 + ·-25 1400 +100 11600 -10 
3 + -25 1400 +25 +800 -10 
4 + 125 +200 150 +400 -10 
5 + +50 +100 I 25 +200 -10 
6 Ill 125 +50 -25 +100 -10 
7 w -25 I 100 -25 IlOO -10 
8 w -25 +50 -25 +50 -10 
10 T -25 +50 -25 +50 -10 
·12 -25 +50 ~25 +100 -10 
14 -25 l 50 -25 +50 -10 
16 -25 +50 -25 1100 -10 
17 -25 +50 -25 +50 -10 
18 -25 150 -25 +50 -10 
19 -.25 +50 -25 +50 -10 
20 T -25 .. 50 -25 +100 -10 
21 -25 +25 -25 1100 -10 
22 ~ -25 +50 -25 1100 -10 
23 -25 .. 25 -25 +50 -10 
24 -25 150 -25 +50. -10 
25 ~25 l 50 -25· +100 -10 
26 -25 150 -25 +100 -10 
. 27 -25 +50 -25 . +50 -10 
28 . W· -25 +50 -25 +100 -10 
30 w -25 1100 -25 1200 -10 
32 \'I -25 +100 -25 1200 -10 
34 Ill -25 I I 0 0 -25· +100 -10 
36" w -25 150 -25 [100 -10 
38 -25 r50 -25 +100 -10 
40 -25 150 -25 1100 -10 
200 
BRUCELLOSIS SEROLOGY FOR GROUP VC-3 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARO ME PLATE RIV TUBE . CF 
59 0 - -25 -25 -25 -25 -10 
1 T -25 I 100 -25 +200 -10 
2 - -25 +50 -25 1100 -10 
3 w -25 +50 -25 +50 -10 
4 w -2$ +50 -2s +50 -10 
5 w -25 +SO -25 +SO -10 
6 w -25 +50 -:2S +50 -10 
7 w -2S +50 -25 150 ~10 
8 - -25 +50 -25 150 -10 
lo - -25 +25 -25 +25 -1 O' 
12 - -25 +25 -25 +25 -10 
14 - -25 +25 -25 +25 -10 
16 - ~25 +25 -25 +25 -10 
17 - -25 I50 -25 I50 -10 
18. T -25 I 50 -25 I 50 -1.0 
19 - -25 +50 -25 I50 -10 
20 - -25 +25 -25 . 150 -10 
21 - -25 ISO -25 ISO -10 
22 - -2S I 25 -25 !50 -10 
23 - . -25 !25 -25 +25 -1.0 
24 - -25 +25 -25 +5·o -10 
25 - -'-25 I 25 -25 +25 -10 
26 - -25 I 25 -25 .-2s -10 
27 - -25 125 -25 +25 -10 
28 - -25 +25 -25 +50 --;10 
30 w -25 +SO -25 +SO -10 
32 - -25 150 -25 I50 -10 
34 - -25 +25. -25 +so -10 
.36 - -25 +2S -25 +50 -10 
38 - -25 ISO -25 !50 -10 
40 
60 0 - -2S +2S -25 -2S -10 
1 +. -25 +SO -25 1100 -10 
2 + -25 +50 -2S I200 -10 
3 + 125 !100 -25 +100 -10 
4 + 125 +50 f-25 I 200 -10· 
s + l2S I l 00 125 +100 -10 
6 w !2S +SO -25 1100 -10 
7 w -25 +so -25 +SO -10 
8 Ill -25 +SO -2S +SO -10 
10 - -2S +25 -2S ISO -10 
12 - -25 +2S -25 ISO -10 
14 - -2S +2S -2S 150 -10 
16 - -2S +2S -25 +25 -10 
17 - -2S ISO -2S +2S -10 
18 - -2S +25 -2s +so -10 
19 ·- -2S I SO -2S ISO -10 
20 - -2S +2S -25 +SO -10 
21 - -25 I 50 -25 +2S -ro 
22 - -25 +25 -25 +SO -10 
23 - -25 +2S -2S. +25 -10 
24 - -25 .+2S -2S I 50 -1·0 
is - ·-2s +25 ~2s +2S -10 
26 - -2S +25 -2s I50 -t'o 
27 - -·2s I SO -2S ISO -10 
28 - -2s I SO -2s I25 -10 
30 Ill .-2S IlOO -25 +SO -10 
32 - -25 +so -2s +50 -10 
34 - -25 150 -2S +50 -10 
36 - -2S +2S -2s +so -10 
38 - -2S I 50 -25 +so -10 
40 - -2$ +25 -2s ISO -IO 
201 
BRUCELLOSIS 5E.ROLOGY FOR GROUP VC-3 
ANIMAL WEEK VSL VSL VSL VSL VSL v·sL 
CARD ME PLATE RIV TUBE CF 
61 0 - -'-25 -25 -25 l25 -10 
l - . -25 I 200 -25 140() -10 
2 + -25 +iOO I25 1400 -10 
3 w -25 1100 -25 +100 -10 
4 w ·-25 +50 125 !200 -10 
5 T -25 l 50 -25 +50 -10 
6 - -25 +50 -25 +50 -10 
7 - -25 +50 -25 +50 -10 
B - -25 125 -25 +50 -10 
10 - -25 125 -25 150 -10 
12 - -25 I 25 -25 150 -10 
14 - -25 125 -25 '+25 -10 
16 - -25 125 -25 +25 -10 
17 - :..25 ~as -25 +25 -10 
18 - -25 -25 -25 +50 -10 
19 - -25 -25 -25 +50 -10 
20 - -25 -25 -25 +25 -10 
21 - -25 ras .,-25 +25 -10 
22 - -25 -25 -2s +25 -10 
23 - -25 -25 -25 +25 -10 
a4 - -25· I 25 -25 +25 -10 
as - -25 la5 -as +25 -10 
26 - -25 125 -25 +25 -10 
27 - -25 -25 -25· +25 -io · 
28 - . -25 -25 -25 +25 -10 
30 - -25 +25 -25 150 -10 
32 - -25 ISO -25 150 -10 
34 - -25 +50 -25 150 -10 
36 - -25 I 25 -25 150 -10 
38 
40 
119 0 - -25 -25 -25 +25 -10 
l + -25 +100 -25 1400 -10 
2 + -25 +100 +50 +40 .. 0 -10 
3 + 150 +100 +25 +200 -10 
4 w I 25 +50 125 +100 ~10 
5 - 125 +50 -25 +50 - l () 
6 T -25 150 -25 125 -10 
7 - -25 +25 -.25 +50 -10 
8 - -25 +25 -as +25 -10 
10 - -25 +as -25 -a5 -10 
12 - -25 I 25 -25 ~25 -10 
14 - -as -25 -25 -25 -10 
16 - -25 -25 -as -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 l 25 -25 +25 -1 () 
19 - -25 I 25 -25 l 25 -10 
20 - -25 125 -25 +25 -10 
21 - -25 I 25 -25 +25 -10 
22 - -25 125. -25 +25 -10 
23 - -25 -25 -25 -25 -10 
24 - -25 I 25 -25 la5 -10 
25 ·- -25 -as -25. -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 I 25 -25 -25 -10 
a8 - -25 -25 -25 125 -10 
30 - ~as I 25 -25 +25 -10 
32 - -25 125 -25 +25. -10 
34 - -25 125 -25. +25 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 -25 -25 125 -10 
40 - -25 +25 -25 125 -10 
202 
SRUCELLOS lS SEROLOGY FOR GROUP VC-J 
ANlMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RlV TUBE. CF 
63 0 - -25 -25 -25 [25 -10 
l - -25 +200 -25 +100 -10 
2 + -25 1100 .-25 +200 -10 
3 w -25 I 100 -2.5 1200 -10 
4 w -25 I l 0 o -25 +200 -10 
5 Ill -25 +50 -25 +200 -10 
6 T -25 [ 10 0 -25 +100 -10 
7 T -25 1100 -25 +100 -10 
8 - -25 I l 00 -25 1100 -to 
10 - -25 1100 -25 +100 -10 
1.2 - -25 150 -25 1100 -10 .. 
14 - -25 +50 -25 +50 -10 
16 - -25 i5o -25 +50 -10 
17 - -25 +50 -25 1100 -10 
18 - -25 150 -.25 +50 -10 
19 - -25 +50 -25 1100 -10 
20 - -25 150 -25 1100 -10 
21 - -25 150 -25 +100 -10 
22 - -25 +50 -25 +50 -10 
23 - -25 150 -25 1100 -10 
24 - -25 150 -25 1100 -JO 
25 - -25 +50 -25 +50 -10 
26 - -25 150 -25 .+50 -10 
27 - -25 +50 -25 +100 -10 
28 - -25 I l 0 0 -25 +100 -10 
30 - ·-25 1100 -25 +100 -JO 
32 - ..:25 I l 0 0 -25 +100 -10 
34 - -25 +100 -25 +100 -10 
36 - -25 1100 -25. 1200 -10 
38 - -25 l 100 -25 +100 -10 
40 - -25 +50 -25 1100 -10 
64 0 ~ -25 -25 -25 -25 -10 
1 T . -25 +100 -25 +100 -10 
2 + I 25 +100 +25 +200 -10 
3 w 125 l 100 125 +100 -IO 
4 w 150 JlOO +25. +100 -10 
5 IN 125 +50 -25 +100 -10 
6 T -25 I 50 -25 +50 -10 
7 t -25 +50 -25 !100 ~.10 
8 T -25 +50 -25 !100 -'-10 
10 - -25 150 -25 150 -10 
12 - -25 150 -25 +50 -10 
14 - -25 150. -25 +50 -10 
16 - -25 +25 -25 1100 -10 
17 - -25 150 -25 1100 -10 
18 - -25 I 50 -25 +50 -10 
19 - -'-25 +25 -25 +50 -10 
20 - -25 +25 -25 +50 -10 
21 - -25 +25 -25 +50 -10 
22 - -25 I 50 -25 +50 -10 
23 - -25 +25. -25 +50 -10 
24 - -25 +25 -25 150 -10 
25 - -25 +25 .-25 +Sci -10 
26 - -25 +2.5 -25 +50 -10 
27 -· 125 +25 -25 +50 -10 
28 - -25 l 50 -25 I l 00 -10 
30 I~ -:25 150 -25 !JOO -JO 
32 - -25 150 -25 +56 -10 
3.4 - -25 +25 -25 150 -10 
36 - -'25 +25 -25 +50 -10 
38 - -25 I 25 -25 150 -10 
.40 
203 
BRUCELLOSIS SEl<OLOGY FOR GROUP VC-J 
ANIMAL \I/EEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
6S 0 - -2s -2S -2S -25 -10 
1 + -2S +400 '150 +400 -10 
2 + -25 1200 1200 +400 2+20· 
3 + I SO I200 I 100 +200 2+20 
4. + ISO 1200 +100 ·+200 3+21) 
s + +2S I 100 ISO +200 4+20 
6 w -2S +SO 150 +100 2+20 
7 w I25 +SO 125 +50 1+l0 
8 w +2S +50 I25 +50 -10 
10 T -25 I SO -2S +50 -10 
12 - -2S I SO -2S +25 -10 
14 - -2S I SO -2S +2S -10 
16 - -25 +2S -25 l 2S -10 
17 - -2S +25 -2S .+25 -10 
18 - -2S ISO -2S +2S -10 
19 - -25 +25 -25 ·+25 -10 
20 - -2S +2S -2S ISO -10 
21 - -2S +25 -25 ·+so -10 
22 - -25 +2S -2S +25 -10 
23 - -2S +2S -2S lSO -10 
24 - -2S +25 -25 125 -10 
2S - -2S +2S -25 +25 -10 
26 - -2S +25 -2S +2S -10 
27 - -25 +25 _;25 ·150 -10 
28 w -25 +50 12S 1100 -10 
30 w -2S IlOO -25 1100 -10 
32 -. -2S +SO -2S 1100 -10 
34 - -2S I SO -25 I SO -10 
36 - -25 +so -2S +50 -10 
38 - -2S I SO -2s 1100 -10 
40' 
66 0 - -2S -2S ..,-2S -2S -10 
1 - -2S 1400 -2s 1400 -10 
2 T -25 I 100 125 +100 -10 
3 w -2S +SO 12S +100 -10 
4 w -2S I 100 ISO +50 -10 
s T -2S I SO -2S I SO -10 
6 - -2S +25 -2S +25 -10 
7 - -2S +2S -2S I2S -10 
8 - -25 125 -25 l2S -10 
10 - -2S +2S -2S I 2S -10 
12 - -2S +25 -2S -2S -10 
14 - -2S -2S -2S -2S -10 
16 - -25 -25 -2s 125 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 12S -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -2S 125 -25 12S -10 
21 - -2S I 2S -2S I2S -10 
22 - -2s -25 -25 I 2S -10 
23 - -25 -2S ·-2s i2s -10 
24 - -25 -25 -25 -2s -to 
25 - -2S '-2S -25 I25 -10 
26 - -25 -2S -25 -25 -10 
27 - -25 -25 -25 -2S -10 
28 - -25 -2S ·-25 -25 -10 
30 - -25 125 -2S +2S -10 
32 - -25 I 2S -2S 12S -10 
34 - -2S 125 -25 I2S -10 
36 - :-2S -2S -2S I2S -10 
38 - -25 I 2S -2S I2S -10 
40 
,. 
204 
BRUCELLOSIS SEROLOGY FOR GROUP VC-3 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
67 0 - -25 -25 -25 -25 -10 
I - -25 +100 -25 +25 -10 
2 T -25 1100 -25 1100 -10 
3 T -25 +50 -25 +50 -10 
4 - -25 ISO 125 +50 -10 
5 - -25 125 -25 +25 -10 
6 - -25 125 -25 +25 -io 
7 - -25 15.0 -25 I25 -10 
8 - -25 125 -25 I 25 -10 
10 - -25 +25 -25 +25 -10 
12 - -2S +25 -2S +2S -10 
14 - -2S +2S -2S +25 -10 
16 - -25 +25 -25 +25 -10. 
17 - -25 +25 -25 +2S -10 
18 - -2S 12S -25 +25 -10 
19 - -25 +2S. -25 +2S -10 
20 T -25 125 -25 +25 -10 
21 - -25 +25 -25 +25 . -10 
22 - -25 125 -25 +25 -10 
23 - -:-2S I 25 -2S +25 -10 
24 - -25 +25 -25 +25 -10 
25 - -25· I 25 -25 +25 -10 
26 - -25 I 25 -25 +2S -10 
27 + +25 +25 -25 ·+SO 3+10 
28 w I 200 I 100 +50 I 200 4+40 
30 + +400 +200 1400 +400 4i-160 
32 + I l 600 1400 I 40 o I 800 3+640 
34 + +800 +200 1400 +400 1 +640 
36 + I 800 +200· 1400 1800 2+320 
38 + 1800 1200 +200 1800 1+320 
.40 + 1800 +100 1100 1800 4+160 
116 0 - -25 -25 -25 -25 -10 
1 T -25 +100 -25 1400 -10 
2 + -25 1200 I 10 0 +400 1+20 
3 + -25 +100 +50 1400 1 +40 
4 + 1100 +100 I 100 I400 2+40 
5 w +50 +so 150 +50 1+20A 
6 w +50 +SO +50 1 SO 4+40 
7 + +50 I l 00 1100 +100 3+40 
8 w +so +50 1100 +100 1 +80 
10 w +50 I 100 I 10 0 ISO 3+4.0 
12 w 1100 +50 150 i-100 4+20 
14 + +100 I l 00 ISO +100 3+40 
16 + 1200 +100 1200 +200 1+160 
17 + +200 +100 .I 200 1400 1+160 
18 + +200 +100 +100 +200 2+160 
19 +. f-200 1100 1200 +200 1+160 
20 + +200 I 200 I 200 +200 1 +160 
21 + 1200 l 100 1200 +200 3+80 
22 + . +.200 +100 1200 +200 3+80 
23 w +200 I 100 + 100 +200 4+80 
24 + +200 1100 1200 1.200 4+80 
25 + +100 I l 00 +100 +200 3+80 
26 + +100 I 100 +50 +100 3+80 
27 + +100 +SO lSO +200 3+80 
28 w· 1100 I l 00 150 +100 4+40 
30 w +100 I 50 12S +100 2+40 
32 + i-100 +50 IlOO +200 3+80 
34 + IlOO IlOO +so i-100 3+80 
36 i- +100 i-SO +100 1200 4 i-8.0 
38 i- 1200 ISO +50 1200 3+80 
40 + 1200 I 100 +50 1200 2+160 
205 
BRUCELLOSIS SEROLOGY FOR GROUP VC"'-3 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARO ME PLATE RIV TUBE CF 
69 0 - -25 -25 -25 -25 -10 
1 - -25 +100 -25 +400 -10 
2 + -25 I 200 -25 1400 -10 
3 w -25 +100 -25 +400 -10 
4 w -25 +100 -25 +200 -10 
5 w -25 +100 -25 1200 -10 
6 T -25 I 100 -25 + l 00 -10 
7 T -25 1100 -25 +100 -10 
8 T -25 I 100 -25 + 1 00 -10 
10 - -25 +50 -25 + 10 0 -10 
12 - -25 I 50 -25 IlOO -10 
14 - -25 150 -25 IlOO -10 
16 - -25 150 -25 +50 -10 
17 - -25 +50 -25 1100 -10 
18 T -25 I I 0 0 -25 +100 -10 
19 w 150 1200 1100 +400 3+20 
20 + +200 +200 +200 +400 1+160 
21 + +400 +400 +400 +800 3+320 
22 + +400 +400 +-400 +1600 3+-640 
23 + +1600 ·+400 +400 +3200 2+1280 
24 .. +3200 +400 f-400 +3200 2+2560 
25 + 16400 +400 +400 +3200 2+5120 
26 .. +12800 +400 +400 112800 +20480 
27 + +6400 +400 +400 +12300 +20480 
28 + I 1280 0 +400 +400 I 12800 +20480 
30 .. +12800 +.400 1400 16400 +20480 
32 + +1600 +·400 1200 +3200 +10240 
.34 .. I 1600 +400 i'.400 +3200 4+5120 
•36 .. !3200 +400 i'.400 16400 3+5120 
38 .+ 13200 +400 +400 +3200 2+-5120 
40 + +3200 +400 +400 !3200 4+5120 
206 
BRUCELLOSIS SEROLOGY FOR .GROUP Y.-3 
ANlMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
1 12 0 - -25 ...:25 -25 -25 -10 
1 T -25 +50 -25 +100 -10 
2 T -25 +50 -25 +100 -10 
3 w -25 +50 125 +50 -10 
4 w -25 +50 125 +50 -1.0 
5 T -25 +25 -25 +25 -10 
6 T -25 150 -25 +25 -10 
7 - -25 +25 -25 +25 -10 
8 - -25 150 -25 150 -10 
10 - -25 I 50 -25 +25 -10 
12 - -25 I 25 -25 +25 -10 
14 - -25 125 -25 +25 -10 
16 - -25 125 -25 +25 -10 
17 
18 - -25 :-25 -25 +25 -10 
19 
20 - -25 125 -25 ·+25 -10 
21 
22 - -25 +25 -25 I 25 -10 
23 
24 - -25 125 ~25 +25 -10 
25 
26 ·- _;25 125 -2s 125 ~10 
27 
28 - -2S +25 -25 +25 -10 
30 
32 - -25 150 -25 I 25 ~10 
34 
36 - -25 +2S -25 150 -10 
38 
40 - -2S 12S -25 ISO -10 
1 1.3 0 - -25 -25 -25 -25 -10 
1 + -25 1 100 -2S +200 -10 
2 + -25 +100 125 +200 -10 
3 + -25 +100 +25 +200 1+10 
4 + +2S 1200 +25 I 200 3+10 
5 w +25 150 12S +25 -10 
6 w 125 +25 -25 125 -·10 
7 - -25 +25 -25 +2S -10 
8 - -25 +2S -2S +2S -10 
10 - -2S 125 -25 -25 -10 
1.2 - -2S I 25 -2s -2S -10 
14 - -2s I 25 -2S -2S -10 
16 - -2S I 25 ISO +2S -10 
17 
18 - -25 -2S -25 +2S -10 
19 
20 - -25 -2S -2S +2S -10 
21 
22 - -25 I 25 -2S +2S -10 
23 
24 - -2S +2S -25 ISO -10 
25 
26 ~ -25 125 -2S I2S -10 
27 
·2e - -25 
30 
+2S -2S +25 -JO 
32 - -25 
34 
+2S -25 +25 -10 
36 - -.25 125 -25 -25 -10 
38 
40 
207 
BRUCELLOSIS SEROLOGY FOR GROUP V,-3 
ANIMAL II/EEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUtlE CF· 
ll4 0 - -25 -25 -25 -25 -10 
l + -25 I 400 +1,00 +1600 1+40 
2 + +25 +400 +200 +1600 l +80A 
3 + +200 +400 1200 I 1600 2+80A 
4 + +100 +400 I 400 +800 3+40 
5 + ISO 1400 I 200 +400 4+20 
6 + +50 +200 t-100 +200 2•40 
7 + +50 I200 •100 1200 l+20A 
8 + +50 +100 IlOO ,1400 2+10 
10 .. HOO +100 +50 +100 2•10 
12 w -25 +100 t-25 t-100 -10 
14 w -25 1 1.00 I25 +50 -10 
16 w ·-25 I LOO -25 +50 -10 
17 
18 w -25 • L 00 150 +100 -10 
19 
20 w -25 I 1 o o 125 +100 -10 
21 
22 w -25 I 100 -25 +100 -10 
23 
24 w -25 +100 -25 +100 -10 
25 
26 w -25 +100 -25 I200 -10 
27 
28 w -25 +100 -25 1200 -10 
30 
32 w -25 +100 -25 1200 -10 
34 
36 w -25 .. l 00 -25 1200 -10 
38 
40 
115 0 - -25 -25 -25 -25 -10 
1 + -25 +100 -25 +400 -10 
2 + 125 1400 l LOO +400 1 +20 
3 .. 1400 +200 •100 I400 2+40 
4 + +50 1200 1200 1400 2+20A 
5 + 150 +100 1100 HOO 3+20' 
6 + -25 +50 +50 +50 4+20. 
7 w -25 +50 150 ISO 3+10 
8 w -25 +50 +25 +25 1+10 
10 w -25 +50 +25 +25 -1,0' 
12 T -25 I 50 -25 +25 -10 
14 - -25 +25 -25 +25 -10 
16 T -25 I 50 -25 +25 -10 
17 
18 - -25 +25 -25 +50 -10 
19 
20 - -25 125 -25 +25 -10 
21 
22 T -25 
23 
+25 -25 +50 -10 
24 - -25 •25 -25 +50 -10 
25 
26 - -25 •25 -25 I50 '-·10 
27 
28 - -25 +25 
30 
-25 150 -10 
32 - -25 ·+25 -25 -25 -10 
34 
36 - -25 f-25· -25 .150 -10 
38 
40 
208 
BRUCELLOSIS SEROLOGY FDR GROUP V-J 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
cARD ME PLATE RI·V TUBE CF 
68 0 - -25 -25 -25 125 -10 
1 w -25 1400 -25 +100 -to 
2 .. -25 1200 150 +200 -10 
3 + -25 . I 100 I 25 +50 -10 
4 w 125 .1 t 00 150 +50 1+10 
5 w +100 +50 125 +50 -to 
6 T I 25 +50 -25 +50 -to 
7 T +25 +50 -25 I 50 -10 
8 - ·-25 150 -25 150 -10 
to - -25 +25 -25 +25 -10 
t2 - -25 ISO -25 +25 -10 
14 - -25 +25 -25 125 -10 
16 - -25 +25 -25 +25 -10 
17 
18 - -25 125 -25 125 -to 
19 - -25 +25 -10 
20 -25 125 -25 -25 -10 
21 
22 - -25 J 25 -25 125 
23 
24 - -25 +25 -25 125 -10 
25 -
26 - -25 -25 -25 125 -ro 
27 -
28 - -25 125 -25 -25 -10 
30 
32 - -25 125 -25 -25 -to 
34 
36 - -25 +25 -25 -25 -to 
38 
40 
1 17 0 - -25 -25 -25 -25 -10 
1 w -25 +!00 -25 1400 -fo 
2 .. 125 1200 1100 1800 -10 
3 .. -25 +100 +50 +400 -10 
4 .. +25 +!00 J l 0 0 1400 -10 
5 w -25 ' + l 00 I 50 +200 -10 
6 w I 25 +50 +50 +100 -10 
7 w I 25 +50 +25 +50 -10 
8 w -25 +50 125 +50 -10 
10 w -25 I 50 !25 +50 -10 
12 - -25 I 5.0 -25 +50 -10 
14 - -25 +25 -25 150 -10 
16 - -25 +25 -25 +50 -10 
17 
18 - -25 
19 
+25 -25 +50 -10 
20 - -25 
21 
I 25 -25 +25 -10 
22 - -25 
23 
+25 -25 +50 -10 
24 - ~25 I 50 -25 +50 -10 
25 
26 - -25 150 
27 
-25 I 100 -10 
28 - ·-25 150 -25 150 -10 
30 
32 ~ -25 
34 
[ 50 ·-25 +50 -l.0 
36 - -·25 150 
38 
-25 I 50 -'"10 
40 
209 
\ BRUCELLOS[S SEROLOGY FOR GROUP V-3 
__/ ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RlV TUBE CF 
1 18 0 - ~25 -25 -25 -25 -10 
1 + -25 [ 400 [200 +400 1+40 
2 + .150 1400 +200 +800 1+40 
3 + +50 +100 +50 1800 1+40 
4 + 150 +100 l 50 +400 1+20A 
5 + -25 +100 150 +100 -10 
6 w. -25 l 10 0 150 +100 -10 
7 w 1·25 +50 +25 ·+100 -10 
B w -25 +50 -25 +50 -10 
10 w -25 I 50 125 +50 -10 
12 - -25 +25 ~25 150 -10 
14 - -25 +25 -25 [50 -10 
16 - -25 +25 -25 150 -10 
17 
18 - -25 150 -25 +25 -10 
19 
20 - -25 +25 -25 +50 -10 
21 
22 - -25 +25 -25 +25 -10 
23 
24 T -25 l 50 -25 +so -'! 0 
2.5 
26 - -25 ISO -25 IIOO ~10 
27 
28 - -25 +50 -25 1100 -10 
30 
0 32 w -25 I 100 -'25 +50 -10 v 34. 
I .36 - -25 I 100 -25 +50 -10 
38 
40 - -25 150 -25 +50 -10 
62 0 - -25 -25 -25 -25 -10 
l T -25 +100 -25 +100 -10 
2 + -25 I 200 +50 1400 -10 
3 + -25 I 200 I 100 1400 -10 
4 + +50 1200 +100 +400 2+20A 
5 + +25 1100 +50 +200 2+20A 
6 w 125 I 100 150 1100 2+10 
7 w 125 1100 150 +100 -1·0 
8 w +25 1100 150 1100 -10 
10 w 125 IIOO 125 +50 -10 
12 + +400 1400 1400 +400 l+.320 
14 + +800 +400 +400 +800 2+040 
16 + +800 +400 +400 +800 1+1280 
17 + +800 1400 +400 +800 <l-+640 
18 + l 800 1400 +400 +800 2+1280 
19 + 1800 +400 +4·00 +800 4+1280 
20 + +800 +400 +400 11600 3+1280 
21 + ·11600 +400 +400 +800 4+1280 
22 + +800 +400 l 40.0 +800 4+1280 
23 + +BOO +400 +400 11600 3+1280 
24 + +1600 +400 +400 +1600 4+.1290 
25 ·+ +800 l 400 +400 +800 4+640 
26 + +800 I 400 +400 +800 2+1280 
27 + +800 +200 +400 +800 2+1280 
28 + +800 +200 +400 +800 1+1280 
30 .. +400 +200 +400 1800 4+640 
32 
34 
36 
38 
40 
210 
.BRUCELLOSIS· SEROLOGY FOR GROUP VC-4 
ANlMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
16 0 - '-25 -25 -25 +2S -10 
1 - -25 [100 -25 +50 -10 
2 w -25 +IOO -25 [200 -10 
3 w -25 [ 100 -25 [200 -10 
4 w -25 [ l 00 -25 [100 -10 
5 T -25 +50 -25 +so -10 
6 T -25 +50 -25 +50 -10 
7 - -25 I 50 -25 +25 -10 
8 - -25 +25 -25 +50 -10 
10 - -25 +-25 '-25 +25 -10 
12 - -25 +25 -25 +-25 -10 
14 - -25 [ 2S -25 [25 -10 
16 - -25 I 25 -25 +25 -10 
17 - -25 -25 -25 +25 -io 
18 - -25 -25 -25 +25 -10 
19 - -25 +25 -25 +2S -10 
20 - -25 I2S -25 +25 -10 
21 - -2S I 2S -2s +so -10 
22 - -2s [25 -25 I 5() -10 
23 - -25 [25 -2S +2S -10 
24 - -25 +25 -25 ISO ~lo 
25 - --'25 +2S -25 +25 -10 
26 - -25 I25 -25 I 50 -10 
27 - -25 I2S -25 +25 -IO 
28 - -25 +25 -25 ISO -10 
30 - -2S [ 50 -25 +so -10 
32 - -2S I2S -25 +2S -10 
34 - -2S +2S -2S . +25 -10 
36 - -2S +2S -2S +2S -10 
38 - -25 +25 -25 +2S -10 
40 - -2S -2S -2S +25 -10 
17 0 - -2S -2s -2S -2S -10 
1 ·- -2S -2S -25 -2S -10 
2 - -2S 12S -25. -25 -10 
3 - -25 -2S -25 -2S -10 
4 - -2S I 25 -2·5 -25 -10 
s - -2S -2S -25 -2S -IO 
6 - -2S -25 -25 -2S ~10 
7 - ~2s -2S -25 -2S -IO 
8 - -25 -2S -25 -25 -10 
10 - -·2s _: 25 -25 -25 -10 
12 - -2S -25 -2S -2S -10 
14 - -2S -2S -2S -2S -10 
16 - -25 -2S -25 -2S -10 
17 - -2S -2S -2S -2S -10 
18 -· -25 -25 -2s -2S -10 
19 - -2S -25 -'2S ·-2S -10 
.20 - -25 -25 -25 -25 -10 
21 - -25 -25 -2S -25 -10 
22 - -25 -25 -25 -25 -to 
23 - -25 -25 -25 -25 -10 
24 - -25 -25 -2S -25 -10 
25 - -25 -25 ·-25 -25 -10 
26 - -25 -25 -2s -25 -IO 
27 - -"25 ~25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 - -25 -25 -2S -25 -10 
.32 - -2S -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 -25 -25 -25 -10 
40 - -25 -25 -25 -25 -' l 0 
211 
BRUCELLOSIS SEROLOGY FOR GROUP VC-4 
ANIMAL II/EEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV ·TUBE CF 
124 0 - -25 -25 -25 -25 -10 
l - -25 125 -25 -25 -10 
2 - -25. I 50 -25 +50 -10 
3 - ~25 150 -25 +25 -10 
4 - -25 +25 -25 +25 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 .-25 -25 -25 -io 
7 - -25 -25 -25 -25 -10 
8 - -25 -,.25 '-25 -25 -lb 
I 0 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 .-25 -10 
l '• - -25 -25 -25 -25 -10 16 - -25. -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 
20 - -25 -25 -25 -25 -10 
21 - -25 -25 -25 -25 -to 
22 - -25 -25 ~25 -25 -10 
23 ·- -25 -25 -25 -25 -10 
24 - -25 -25 -25 -25 -10 
25 - -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
.27 - '-25 -25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
.30 -25 -25 -25 -25 -10 
32 - -25 -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 I 25 -25 -25 -10 
38 -25 -25 -25 -25 -10 
40 
19 0 - -25 -25 -25 -25 -10 
l - -25 -25 -25 -25 -10 
2 - -25 150 -25 +50 -10· 3 - -25 +25 -25 +25 -10 
4 - -25 +25 -25 +25 -to 
5 - -25 +25 -25 +25 -10 
6 - -25 150 -25 +25 -10 
7 - -25 125 -25 125 -10 
8 - -25 -25 -25 -25 -10 
10 - -25 -25 -25 -'25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 ~ -25 -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - ·-25 -25 -25 -25 -10 
19 - -25 -25 ~25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 -25 -25· -25 -10 
22 - -25 -25 -25 -25 -10 
23 - -25 -25 -25 -25 -10 
24 - -25 -25 -25 -25 -10 
25 - -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 -25 -25 -25 -to 
28 - -25 -25 -25 -25 -1.0 
30 - -25 125 -25 +25 -10 
32 - -25 -25 -25 125 -10 
34 - -25 -25 -25 125 -10 
36 - -25 -25 -25 -25 -to 
38 - -25 -25 -25 -25 -10 
40 
212 
BRUCELLOSIS SEROLOGY FOR GROUP VC-4 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
20 0 - -25 -25 -25 -25 -10 
1 - -25 I25 -25 -25 -10 
2 - -25 I 25 .. -25 ~25 -10 
3 - -25 125 -25 -25 -10. 
4 - -25 I 25 -25 -25 -10 
5 ·- -25 125 -25 -25 -10 
6 - -25 +25 -25 -25 -10 
7 - -25 ISO -25 -25 -10 
8 - -25 +2S -25 -25 '-10 
10 - -25 125 -25 -2S -10 
12 - -25 125 -25 -2S -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 .':' ~ -25 12S -25 -25. -10 
18 - -25 +·2S -25 -2S -10 
19 - -2S +25 -25 -25 -10 
20 - -25 +2S -2S +2S -10 
21 - -25 +25 -25 -2S -10 
22 - -2S +2S -25 +SO -10 
23 " -25 I 50 -2S 1100 -10 24 + 125 +50 -25 +200 -IO 
2S w -25 +.I 00. I2S +200 -10 
26 '+ -25 +100 -25 +100 3+10 
27 + 125 I 100 -25 +100 l+IO 
28 + 125 I 100 -25 1100 3+10 
30 + +400 +400 +4.00 +400 .3+160 
32 + +1600 +400. +400 +1600 3+640 
34' .. +1600 +400 +400 l 1600 4+320 
36 + +1600 +400 +400 +1600 4+1280 
38 + 13200 .. 400 +4oo I 3200 3+1280 
40 .. +3200 .. 4:00 +40.0 I 3200 2+640 
21 0 - -25 -25 -2S l2S -10 
1 - -25 I 50 -25 I 50 -10 
2 - -25 150 -2S +50 -10 
3 - -25 +25 -25 +25 -10 
4 - -25 I 50 -25 .. 25 -10 
5 - -25 -25 -25 'I25 -10 
6 - -25 -25 -25 -25 -10 
7 - -25 I 25 -25 -25 -10 
8 - -25 125 -25 +2S -1.0 
10 - -25 -25 -2S 150 -10. 
12 - -25 -25 -25 12S -10 
14 - -25 125 -25 +2S -10 
16 - -25 I 25 -25 +25' -10 
17 - -25 :i 25 -25 125 -10 
18 - -25 -25 -25 +25 -16 
19 - -25 +25 -2S. ISO -10 
20 - -25 -25 -25 I 50 -10 
21 - -25 .125 -25 .. 50 -10 
22 - ~25 125 -25 +25 -10 
23 - -25 -25 -25.' +25 -10 
24 - -25 -25 .-25 +2S -10 
2S - -25 I 25 -25 +25 '-1 0 
26 - -25 -25 -25 +25 -10 
27 - -25 -25 -25 +25 -10 
28 - -25 .. 25 -25 ISO -10 
30 - -25 ISO -25 +SO -10 
32 - -25. 12S -25 +25 -10 
34 - -25 ... 25 -25 +50 -.10 
36 - -2S +25 -25 I50 -10 
38 
40 
213 
BRUCELLOS l S SEROLOGY FOR GROUP VC-4 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARO ME PLATE RIV TUBE CF 
22 0 - -2S -25 -2S -25 -10 
1 - -2S +50 -25 IlOO -10 
2 - -25 ·+100 -25 +100 -10 
3 w -2S [ 100 12S +SO -10 
4 w -2S 1100 I2S +100 1+10 
s T -2S +SO -2S +so 3+10 
6 - -2S +SO -2S +50 -10 
7 - -2S +so -25 +2S -lei 
8 - -2S +2S -2s +2S -10 
10 - -2S -2S -2s I2S -10 
12 - -2S -2S -2S -2S -10 
14 - -25 -25 -25 -25 -10 
16 - ·-2S -2S -2S -25 -10 
17 - -2S -2S -25 -2S -10 
18 - -25 -2S -2s -25 -10 
19 - -2S 1 SO -25 . +25 -10 
20 - -2S 125 -2s I2S -10 
21 - -2S I 2S -2S ISO -10 
22 - -25 -25 -25 125 -1 (' 
23 - -25 -25 -2S 125 -10 
24 - -25 -25 -25 125 -10 
25 - -2S -25 -25 -2s -10 
26 - -2S I 2S -2S -25 -10 
27 - -2S -2S -25 -2s -10 
28 - -2S 1 2S -25 -25 -10 
30 - -2S 12S -2S 12S -10 
32 - -2S -25 -25 -2S -10 
34 - -25 .l 25 -25 -25 -10 
36 - -25 125 -2S -25 -10 
38 - -25 125 -25 -25 -10 
40 
23 0 - -2S -2S -25 125 -10 
1 T -25 +50 -25 +50 -10 
2 + -25 +100 12S +100 -10 
3 ·+ -25 +100 ISO IlOO 2+10 
4 + -2S 1100 +SO +100 1+10 
5 + lSO l 100 150 I 100 1+20 
6 + ISO +50 150 +SO 3+10 
7 w 12S +SO 125 +so -10 
8 w +2S 150 -25 +so - 1.0 
1 0 w -25 +25 -2S lSO -10 
1.2 w -2S +25 -2S +2S -10 
14 - -2s +25 -2S +2S -10 
16 ·- -25 +25 -:2S ISO -10 
17 - -2S +2S -25 +25 -10 
18 - -25 +2S ~25 +50 -10 
19 - -2S l 50 -2S ISO -10 
20 T -2S +2S -2S +SO -10 
21 - -25 +25 -2S +2S 2+10 
22 - -25 +.25 -25 ISO 2+i'o 
23 - -25 12S -25 +50 -10 
24 - -2S ISO -2S +2S -10 
25 - -25 +2S -2S ISO -10 
26 - -2S +2S -2s +50 ~10. 
27 ·- -25 +2S -2s +so -10 
28 - -25 I SO -25 +SO -10 
30 w -25 +50 -2S +so - l.O 
32 w -2S +50 -2S +SO -10 
34 - ~2s +25 -25 .+so ~ 10· 
36 - ·-2s ISO -2S ISO -10 
38 - -2s +2S -2S ISO -10 
40 
214 
BRUCELLOSIS SEROLDG V FOR GROUP VC-4 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL-
CARO ME PLATE RIV TUBE CF 
24 0 - ·-25 -25 -25 -25 -.10 
1 - ~2s 125 -25 125 -10 
2 ~ -25 150 -25 +50 -10 
3 T -25 ISO -25 150 -10 
4 r -25 150 -25 150 -10 
5 - -25 +25 -25 +25 -10 
6 ·- -25 -25 -25 125 -10 
7 - -·25 125 -25 -25 -10 
B - -25 125 -25 +25 -10 
10 - -25 ·-'25 -25 125 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
1 7 . - -25 -25 -25 -25 -10 
18 - -25 -25 -25 -25 -10 
19 - -25 125 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 -25 -25 125 -to 
22 - -25 -25 -25 -25 -10 
23 - -25 ~25 -25 -25 -10 
24 - -25 -25 -25 -25 -10 
25 - -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 - -25 -25 -25 -25 -10 
32 - -25 -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 125 -25 -25 -10 
36 ·- -25 125 -25 -25 -10 
40 
70 0 - -25 -25 -25 -25 -10. 
l T -25 1200 -25 +200 -10 
2 + -25 +100 -25 +200 -10 
3 + l 25 +100 125 1400 -10 
4 w -25 +50 150 +100 -1.0 
5 w -25 150 125 + t"oo -10 
6 T -25 +50 -25 +50 -10 
7 T -25 +50 -25 +25 -io 
8 -· -25 +25 -25 150 -10 
10 - -25 +25 -25 +25 -10 
12 - -25 +25 -25 +25 -10 
l4 - -25 125 -25 125 -io 
16 - -25 +25 -25 +50 -10 
17 - -25 +25 ·-25 +50 -10 
18 - -25 +25 -25 150 -10 
19 - -25 +25 -25 +50 -10 
2.0 - -25 +25 -25 150 -lb 
21 - -25 150 -25 150 -10 
22 - -25 +25 -25 ISO -10 
23 - -25 125 -25 150 -10 
24 - -25 +25 -25 +.50 -10 
25 - -25 +25 -25 150 - l'O 
26 - -25 I 50 -25 +50 -10 
27 - -25 +25 -25 1100 -10 
26 - -25 +25 -25 1100 -10 
30 - . -25 +25 -25 +50 -10 
32 - -25 150 -25 +50 -10 
34 - -25 150 -25 +50 -1.0 
36 ·- -25 +25 -25 1100 -10 
.38- - -25 I 50 -25 +so -10 
40 - -25 +50 -25 150 -10 
215 
BR UCELLOS [ S SEROLOGY FOR GROUP VC-4 
AN! MAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
71 0 - -25 -25 -25 -25 -10 
l + -25 1400 -25 1400 -10 
2 w -25 .+ 100 150 1400 -10 
3 + -25 +100 125 +200 -10 
4 Ill -25 1100 +25 +100 -10 
5 w -25 +50 125 1100 -10 
6 w -25 +50 125 +50 -10 
7 T -25 1100 -25 150 -10 
B - -25 1100 -25 +50 -10 
10 - -25 150 -25 150 -10 
12 - -25 150 -25 +50 -10 
14 - -25 +25 --25 +50 -10 
16 - -2S +25 -2S 150 -10 
17 - -25 150 -2S l SO -10 
18 - -2S 1 SO -25 +SO -10 
19 - -2S I 50 -25 +50 -10 
20 - -2S +2S -25 +so -10 
21 - -2S +2S -2S 150 -10 
22 - -25 +25 -25 . +25 -10 
23 - -2S +2s -25 +SO -10 
24 - -2S +2S -2s 150 -10 
25 - -25 +25 -25 ISO -10 
26 - -25 +2S -25 +SO -10 
27 - -25 +25 -25 +50 -10 
28 - -25 150 -25 +50 -10 
30 - -25 ISO -25 +50 -10 
32 - -2S I 50 -25 +50 -10 
34 - -25 150 -25 +100 -10 
36 - -25 ISO -25 IIOO -10 
38 - -25 +25 -25 +50 -10 
40 
72 0 - -2S -25 -25 -25 -10 
I + -25 1400 -25 +200 -10 
2 w -25 +100 ISO +200 -10 
3 + -2s IlOO I2S 1200 -10 
4 w -2S I 100 -2S +100 -10 
s T -2S I I 0 0 -2S +SO -10 
6 - -25 +SO -2S +SO -10 
7 ·- -2S 150 -25 +2S -10 
8 - -25 ISO -2S +25 -10 
10 - -25 +2S -2S 125 -10 
12 - -2s +25 -25 +2S -10 
14 ~ ·-25 I 2S -2S I2S -10 
16 - -2s 125 -2S 125 ·-10 
17 ..., -25 -25 -25 125 -10 
18 - -25 -25 -25 -25 -10 
19 - -25 -25 -25 125 -10 
20 - . -25 -25 -2S +2S -10 
21 - -25 -25 -25 125. -10 
22 - -25 -25 -25 I 25 -10 
23 - -25 -25 -25 125 -10 
24 - -25 -25 -25 +25 -10 
25 - .-25 -25 -25 -25 -10 
26 - -25 -25 -25 125 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 1.25 -10 
30 - ·-25 I 2S -25 I 2S -10 
32 - -25 125 .c.25 125 -10 
34 - -2S I 25 -25 +25 -10 
36 - -25 125 -25 +25 -10 
38 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-J+ 
ANIMAL. WEEK VSL VSL VSL VSL VSL VSL 
CARO ME PLATE RIV TUBE CF 
93 0 - -25 -25 -25 -25 -10 
1 w -25 +400 -25 +200 -10 
2 + !25 +100 I 100 +200 -10 
3 + +200 1200 r2oo +200 2+40 
4 + ! 50· 1 200 +100 +200 3+20 
5 w 1l00 +100 +100 1400 2+20A 
6 w 150 ! l 0 0 +50 +100 2+10 
7 w +25 +so 150 1100 l+lO 
8 T I2S +-SO +2s +SO -io 
1 0 - -2S I SO +2S +50 -10 
12 - -2s +50 -25 +50 -10 
14 - -25 I2S -25 +SO -10 
16 - -2S +25 -25 I2S -10 
17 ·- -2s I SO -25. I SO -10 
·19 - -2S I 50 · -2S +so -10 
19 - -2S +2S -2S +SO -10 
20 - -25 +2S -25 .+SO -10 
21 T -2S +2S -25 +50 -10 
22 - -25 I SO -2S +SO -10 
23 - -2S I SO -25 llOO -10 
24 - -25 I SO -25 +SO -10 
2S - -25 J 50 -2S +-SO -10 
26 - -25 +SO -25 +SO -10 
27 - -2S +2S -2S ISO -10 
28 - -25 +25 -25 +so -10 
30 - -2S +50 -25 +2S -10 
32 - -25· J 50 -2s +25 -10 
34 - -25 +50 -2S +so -10 
36 - -25 +50 -25 +50 -10 
38 - -25 +50 -2s 1100 -10 
40 
94 0 - -25 I 2S -25 -25 -10 
1 T -25 +50 -2s +50 -10 
.2 + -25 +JOO -25 +400 -10 
3 + -25 I mo -2S 1200 -10 
4 w -25 I 100 -25 I200 -10 
5 w -25 +50 -2S +100 -10 
6 w 125 +50 -25 +100 -10 
7 w I25 +50 -25 1100 -10 
8 T -2S I 50 -25 +50 -10 
10 T --25 I50 -25 +so -10 
12 - -25 150 -25 +50 -10 
14 - -25 +25 -2S +50 -10 
16 - -2S· 1 SO -25 +so -10 
17 - -25 150 -25 150 -10 
J8 - -25 I50 -2S ISO -10 
19 - -2S +25 -2S +50 -10 
20 - -25 +-2S -2S +SO -10 
21 - -2S +25 -25 +SO -10 
22 - -2S .I 50 -25 +SO -10 
23 - -25 J 50 -25 +50 -10 
24 - -25 I 50 -25 +50 -10 
25 - -25 +2S -25 IlOO -10 
26 w -2S +SO -25 +50 -10 
27 - -25 +2S -2S ISO -10 
28 w '-2S I 50 -2s 1100 -10 
30 w -2S .1100 -2S .+100 . -10 
32 w -2S +so· -2S +100 -10 
34 w -2S +50 -2S +100 -JO 
36 - -25 +SO '-2S 1100 -10 
38 - -2S +SO -25 +SO -10 
40 - -2S +SO -'2s +SO -10 
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BRUCELLOSIS SEROLOGY FOR GROUP VC-4 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CA Rb ME PLATE RlV TUBE CF 
95 0 - -.25 -25 -25 -25 -10 
l + -25 [400 -25 +200 -10 
2 + -25 1200 . -25 +400 -10 
3 + -25 +100 I 25 1200 3+20 
4 w -25 I 100 125 +100 2t-l 0 
5 w -25 +50 -25 +50 -10 
6 T -25 I 25 -25 t-25 -10 
7 - -25 +25 -25 t-25 -10 
8 - -25 125 -25 +25 -10 
10 - -25 125 -25 125 -10 
12 - -25 -25 -25 125 -10 ' . 14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 +25 -10 
1 7. - -25 -25 -25 125 -10 
18 - -25 -25 -25 125 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 +25 -10 
21 - -25 -25 -25 125 -10 
22 - -25 -25 -25 125 -10 
23 - -25 -25 -25 125 -10 
24 - -25 -25 -25 -25 -10 
25 ~ -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - I25 -25 -25 -25 -10 
28 - -25 -25 -25 125 -10 
30 - -25. +25 -25 +25 -1.0 
32 - -25 125 -25 125 -10 
·34 - -25 -25 -25 ISO -10 
36 - -25 -25 -25 125 -10 
38 
40 
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BRUCELLOSIS SEROLOGY FDR GROUP V-4 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUSE CF 
120 0 - -25 -25 -25 -25 -10 
1 T -25 +SO -2S +100 -10 
2 + -2S +100 +2S +200 -10 
3 .. 125 +LOO 150 +200 -10 
4 w I2S + 100 ISO +200 1 +10 
5 w -2S +so I2S +so -to 
6 w -2S +SO I.2S +so -10 
7 T -2S +so -2S +SO -to 
8 - -2S ISO -25 +SO -to 
to - -2S ISO -2S -2S -to 
12 - -2S +25 -25 -25 -1 o· 
14 - -25 +2S -25 125 -to 
16 - -25 +2S -25 -25 -10 
17 
18 - -25 +25 -25 150 -10 
19 
20 - -25 +25 -25· [50 -10 
21 
22 - -25 +25 -2S 125 -to 
23 
24 - -25 +2S -25 +50 -10 
25 
26 - -25 +2S -25 +50 -10 
27 
28 - -2S· +25 -25 +50 -10 
30 
32 - -25 150 -25 -25 -10 
34 
36 ·- -25 ISO -25 I50 -10 
38 
40 
121 0 - -25 -25 -25 -25 -10 
1 T -25 125 -25 -25 -10 
2 .T -25 +50 -25 1200 -10 
3 w -25 +SO -25 IlOO -10 
4 Ill -25 [ 100 -25 1100 -10. 
5 w -25 I 50 -25 +25 -10 
6 T -25 +25 -25 +25 -10 
7 - -25 +25 -25 -25 -10 
8 - -25 +25 -25 I25 -10 
10 - -25 125 -25 -25 -10 
12 - -25 125 -25' -25 -10 
14 - -25 -25 ~25 -25 -10 
16 - -25· 125 -25 -25 -10 
17 
18 - -25 I.25 -25 I25 -10 
19 
20 - -25 125 -25 -25 -10 
21 
22 - -2S 125 -25 125 -10 
23 
24 - -25 
25 
-25 -25 125 -10 
26 ~ -25 125 -25 -25 -10 
27 
28 - -25 -25 -25 -25 -10 
.30 
32 - -25 125 -25 125 -10 
3.4 
36 - -25 -25 -25 -25 -10 
38 
40 - -25 125 -25 125 -10 
( 
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BRUCELLOSIS SEROLOGY FOR GROUP V-4 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARO ME PLATE RIV TUBE CF 
122 0 -25 -25 -25 -25 -10 
1 + -25 I 1 00 -25' +!OP -10 
2 + 125 1200 125 1200 -10 
3 + +25 +50 -25 +50 -10 
4. w -25 +50 -25 +50 -10 
5 T -25' +25 -25 +25 -10 
6 -25 150 -25 +25 -10 
7 -25 +25' -25 125 -10 
8 -25 '+25 -25 +25 -10 
10 -25 125 -25 125 -10 
12 -25 I 25 -25 -25 -10 
14 -25 125 ,-25 -25 -10 
16 -25 +25 -25 +25 -10 
17 
18 -25 I 25 -25 +25 -10 
19 
20 -25 +25 -25 +25 -10 
21 
22 -25 +25 -25 I 25 -10 
23 
24 -25 125 -25 125 -10 
25 
26 -25 +25 -25 -25 -10 
27 
28 -25 125 -25 125 -10 
30 
32 -25 +25 -25 I 25 -10 
34 
36 -25 -25 -25 -25 -10 
38 
40 
123 0 -25 -25 -25 -25 -IO 
I -25 +25 -25 -25 -10 
2 -25 I 50 -25 +50 -10 
3 -25 150 -25 +50 -10 
4 w -25 I 50 -25 +50 -10 
5 T -25 125 -25 150 -10 
6 -25 +25 -25 +25 -10 
7 -25 +25 -25 125 -10 
8 -25 125 -25 -25 -10 
10 -25 125 -25 -25 -10 
12 -25 -25 -25 -25 -10 
14 -25 -25 -25 125 -10 
16 -25 -25 -25 +25 -10 
17 
18 -25 -25 -25 +25 -10 
19 
20 -25 125 
21 
-25 .125 ·-10 
22 -25 l 25 -25 1.25 -10 
23 
24 -25 I 25 
25 
-25 125 -10 
26 -25, +25 
27 
-25 +25 -10 
28 -25 I 25 -25 +25 -10 
,30 
32 -25 +25 
34 
-25 +25 -10 
36 ~25 125 -25 +25 -10 
38 
40 
220 
\ BRUCELLOSIS SEROLO:iY FOR GROUP V-4 / 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
18 .. 0 - -25 -25 -25 -25 -10 
l - -25 +50 -25 150 -10 
2 T -25 +100 -25 .+100 -10 
3 - -25 I mo -25 +100 -10 
4 - -25 +50 -25 +50 -10 
5 - -25 +50 -25 150 -10 
6 - -25 150 -25 +25 -10 
7 - -25 +25 -2.5 125 -10 
8 - -25 +25 -25 +25 -10 
10 - -25 125 -25 +25 -10 
12 - -25 !25 -25 -25 -10 
14 - -25 I 25 -25 -25 -10 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
30 
32 
I 34 
36 
38 
40 
125 0 - -25 -25 -25 -25 - IO· 
l T -25 1200 -25 +40() -10 
2 + -25 +200 +25 140() -10 
3 + +25 I 400 150 1400 2+20 
4 .+ 125 1 200 150 +400 3+10 
5 w -25 IlOO 125 1200 -10 
6 W· -25 +50 125 +100 -10 
7 - -25 +50 125 150 -10 
8 - -25 +25 -25 +50 -10 
10 - -25 150 -25 150 -10 
12 - -25 +25 -25 150 -10 
14 - -.25 125 -25 +25 -10 
16 - -25 
17 
+25 -25 +25 -10 
18 - -25 125 -25 +25 -10 
19 
20 - -25 +25 -25 +25 -10 
21 
22 - -25 
23 
125 -25 -25 -10 
24 - -25 .. 25 -25 125 -10 
25 
26 - -25 
27 
+25 -25 +25 -10· 
28 - -25 -25 -25 150 -10 
30 -25 
32 - -25 
34 
+25 -25 125 -10 
36 - -25 
38 
+25 -25 +25 -10 
40 
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BRUCELLOSIS SEROLOGY FOR GROUP V-4 
ANIMAL Ill.EEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
126 0 - -25 -25 -25 -25 -10 
I + -25 +100 -25 +200 -10 
·2 + -25 +100 125 +100 -10 
3 + I 25 1100 +25 +100 3+10 
4 w 125 +50 125 +50 2+10 
5 w 125 +50 -25 +50 -10 
6 - -25 I 50 125 150 -10 
7 - -25 l 50 -25 -25 -10 
8 - -25 +25 -25 -25 -10 
10 - -25 150 -25 -25 -10 
12 - -25 I'25 -25 -25 -10 
14 - -25 l 25. -25 -25 -10 
16 - -25 +25 -25 -25 -10 
17 
18 - -25 125 ...,25 +25 -10 
19 
20 - -25 125 -25 125 -10 
21 
22 - -25 +25 -25 +25 -10 
23 
24 - -25 +25 -25 +25 -10 
25 
26 - -25 I 25 -25 +25 -10 
27 
28 - -2 .. 5 150 -25 !25 -10 
30 
32 - -25 +25 --:25 +25 -10 
34 
36 - -25 l 50 -23 +25 -10 
38 
40 
127 0 - -25 -25 -25 -25 -10 
1 - -25 l 50 -25 +50 -10 
2 - -25 +50 -25 +50 -10 
3 - ~25 I 50 -25 +50 -10 
4 T -25 I 50 -25 150 3+10 
5 T .. 25 .. 25 -25 +25 -10 
6 T -25 .. 25 125 -25 -10 
7 - -25 +25 -25 -25 -10 
8 - -25 .. 25 -25 I 2!; -10 
10 - -25 l 50 -25 I 25. -10 
12 - -25 125 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 I 25 . -25 -25 -10 
17 
18 - -25 -25 -25 125 -10 
19 
20 - -25 -25 -25 !25 -10 
21 
22 - -25 -25 -,25 -25 -10 
23 
24 - -25 I 25 
25 
-25 +25 ~10 
26 - -25 125 -25 !25 -10 
27· 
28 - -25 -25 -25 -25 -10 
30 
32 - -25 
34 
-25 -25 -25 -10 
36 - -25 
38 
125 -25 -25 -10 
40 
222 
BRUCELLOSIS SEROL,OGY FOR GROUP VC-5 
ANIMAL II/EEK ·VSL VSL VSL VSL ·vsL VSL 
CARD ME PLATE RIV TUBE CF 
l 0 - -25 -25 -25 -25 -10 
1 T -25 I 50 -25 -25 -10 
2 - -25 +50 -25 -25 -10 
3 - -25 +25 ~25 125 -10 
4 - -25 -25 -25 125 -10 
5 - -25 125 -25 125 -10 
6 - -25 -25 -25 -25 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 -25 -10 
l 0 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 [25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 125 -25 +25 -10 
17 - .-25 -25 -25 125 -10 
18 - -25 I 25 -25 +25 -10 
19 - -25 -25 -25 125 -10 
20 - -25 -25 -25 [25 -10 
21 - -25 I 25 -25 +25 -10 
22 - -25 -25 -25 125 -lO 
23 - -25 I 25 -25 +25 -10 
24 - -25· -25 -25 +25 -lO 
25 - -25 125 -25 +25 -10 
26 - -25. l 25 -25 +25 -10 
27 - -25 125 -25 125 -10 
28 - -25 125 -25 +25 -10 
30 - -25 I 25 -25 +25 -10 
32 - -25 125 -25 +25 -10 
34 - -25 I 25 -25 +25 -lO 
36 - -25 125 -25 +25 - lO . 
38 ·- -25 l 25 -25 125 -10 
40 
2 0 - -25 -25 -25 -25 -10 
1 - -2s -25 -25 -25 -10 
2 - -25 l 50 -25 150 -10 
3 - -25 l 50 -25 +25 -10 
4 ·- -25 125 -25 125 -10 
5 - -25 -25 -25 I 25 -10 
6 - -25 -25 -25 -25 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 -25 -10 
1 0 - -25 -25 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 125 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 -25 -25 -25 -10 
22 - -25 -25 '-25 -25 -10 
23 - -25 -25 -25 -25 -10 
24 - -25 -25 -25 -25 -10 
25 - -25 -25 -25 .-25 -10 
26 - -25 -25 -.25 -25 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 - -25 -25 -25 -2:> -10 
32 - -25 -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 -25 -25 -25 -10 4o - -25 -25 -25 -25 -10 
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BRUCELLOSIS SEROLOGY FUR GROUP VC-5 
AN I MAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE ill v TUBE CF 
3 0 - -2s l2S -2S +2S -10 
1 - -2S llOO -2!') +100 -10 
2 - -2S I 100 -2S 1200 -10 
3 w -2S +200 -2S 1400 -10 
4 T -2s +100 -2S +200 -10 
s - -2s I 100 -2S + 1.00 -10 
6 - -2S +SO -2S lSO -10 
7 ·- -2S l.SO -2S +2S -10 
8 - -2s ISO -2S l2S -10 
10 - -2S ISO -2S I2S -10 
12 - -2S +2s -2S . +2S -10 
14 - -2S +2S -2S +2S -10 
16 - -2S +2S -2S ·+2s -1.0 
17 - -2S +2S -2S +2s -10 
18 - -2S +2S -2S I2S -10 
19 T -2s +2S -2s ISO -10 
20 - -2s +2S -2s +SO -10 
21 - -2s l 50 -2S +SO -10 
22 - -2s 12S -2S +2S -10 
23 - -25 +2S -2S +2S -10 
24 - -2S +2S -2S +25 -10 
2S - -2S +2S -2S ISO -10 
26 - -2S +2S -2S +so -10 
27 - -2S l SO -2S ISO -10 
28 - -2s l SO -2S . I SO -10 
30 - -2s I SO -2S .. so -10 
32 - ·-2S I l 00 -2S +100 -10 
34 - -25 +50 -2S +100 -10 
.36 - -2S +2S -2S +SO -10 
38 - -2S I SO -2S lSO -10 
40 - -2S l2S -2S I 2S -10 
4 0 - -25 -2S -2S -25 -10 
1 Ill -2s +SO -2S +100 -10 
2 T -2S I 100 -2S +100 -10 
3 + -2S I 200 l2S +100 -10 
4 w -2s +100 -2S +100 -10 
s w -2S +SO -·25 +SO -10 
6 Ill -2S +SO -25 +SO -10 
7 - -25 +2S -2S +2S -10 
8 - .-2s +2S -2s +2S -10 
10 - -2S +2S -2S I2S -10 
12 - -2s . l 2S -25 12S -10 
14 - -25 12S -2S -25 -10 
16 - -2S 12S -25 -2s -10 
17 - -2s I 2S -2S -2S -10 
18 - :-2S 12S -2S 12S -10 
19 - -2S -2S -25 I2S -10 
20 - -2S -25 -2s 12S -1·0 
21 - -2S I 25 -2S I 25 -10 
22 - -2S -25 -2S 125 -10 
.23 - -25 125 -25 12S -10 
24 - -2S -25 -2S 12S -10 
·25 - -2S ·-2S -25 +2S -10 
26 - -2S I 2S -2S +25 -10 
27 - -2S · I 2S -2S 12S ~10 
28 - -2S l 2S -2s +25 -10 
30 - -25 !25 -25 l2S -10 
32 - -2S I2S -25 -2S -10 
.34 - -25 +2S -2S +2S -10 
36 - -2s +2.5 .-2s 12S -10 
38 - -25 -2S -2S -2S -10 
4.0 - -25 -2S -2s -2S -10 
224 
BRUCELLOSIS SEROLOGY FOR GROUP VC-5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
5 0 - -25 -25 -25 -25 -10 
1 - -25 +-25 -25 +-25 -10 
2 - -25 150 -25 +-25 -10 
3 - -25 ( 50 -25 150 -10 
4 - -25 +25 -25 +25 -10 
5 - -25 125 -25 +25 -10 
6 - -25 +25 -25 +25 -10 
7 - -25 +25 -25 . +25 -10 
8 - -25 +25 -25 150 -10 
10 - -25 +25. -25 I50 -10 
12 - -25 125 -25 +25 -10 
14 - -25 +25 -25 +25 -10 
16 - -2S 12S -25 +2S -10 
17 - -25 +25 -2S +25 -10 
18 - -25 +25 -25 +25 -10 
19 - -25 +25 -25 +2S -10 
20 - -25 +2S -2S +25 ~10 
2i - -25 +25 -25 ISO -10 
22 - -25 +25 -2S ISO -10 
23 - -2S ·1 50 -2S +SO -IO 
24 - 12S +so -25 +so -10 
2S - -2S 150 -25 IlOO -10 
26 - -25 +50 -25 +50 -10 
27 - -25 +so -25 +50 -IO 
28 - -25 I I 0 0 -2S +SO -10 
30 - -25 l SO -25 +50 -10 
32 - -25 I SO -2S ISO -10 
34 - -25 l 50 -25 +50 -10 
36 - -25 +50 -25 1100 -10 
38 
40 
6 0 - -25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - -25 150 -25 125 -10 
3 w -25 +SO -25 150 -10 
4 w -25 +100 -25 +50 -10 
5 w -25 +50 -25 +50 -10 
6 w I 2S +50 -25 +25 -10 
7 "' -25 I 50 -25 +25 -10 B - -25 +25 -25 125 -10 
10 - -25 +2S -25 -25 -10 
12 - -25 +25 -25 I25 -10 
14 - -25 I 25 -25 -25 -10 
16 - -25 125 -25 -25 -10 
17 - -2S 125 -25 -25 -10 
18 - -2s 12S -25 125 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 -2S -25 -25 -10 
22 - -25 -2s -2S -25 -10 
23 - -2S -25 -25 -25 -10 
24 - -25 125 -25 -25 -10 
25 - -25 125 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 ·-25 -25 -25 -10 
28 - -25 -25 -25 -25 -IO 
30 - -25 -25 -25 +25 -10 
32 - -25 · 125 -25 I25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 -25 -25 -25 -10 
40 
225 
BRUCELLOSIS SEROLO-iY FOR GROUP vc~5 
ANIMAL II/EEK VSL VSL. VSL VSL VSL VSL 
CARD ME PLATE RlV TUBE CF 
7 0 - -25 -25 -25 -25 -10 
1 - -25 -'25 -25 125 -10 
2 - ~25 I 25 -25 -25 -10 
3 - -25 . 125 -25 -25 -10 
4 - -25 +25 -25 125 -10 
5 - -25 125 -25 125 -10 
6 - -25 +25 -25 125 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 -25 -10 
10 - -25 -25 -25 -25 -to 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 ·- -25 -25 -25 -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 125 -25 -25 -10 
22 - -25 .,. 25 -25 -25 -10 
23 - -25 125 -25 -25 -10 
24 - -25 125 -25 -25 -10 
25 - -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 - ·-' 25 -25 -25 -25. -10 
32 - -25 -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 -25 -25 -25 -10 
38 
40 
B 0 - -25 -25 -25 -25 -10 
1 - -25 150 -25 +25 -10 
2 - -25 [ 50 -25 +25 -10 
3 T -.25 I 50 -25 ISO -10 
4 - -25 +50 -25 +25 -10 
5 - -25 +25 -25 +25 -10 
6 - -25 J 50 -25 125 -10 
7 - -25 I 25 -25 -25 -10 
8 - -25 -25 ~2s -25 -10 
10 - -25 ~25 -25 -25 -10 
12 - -25 ~25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25. -25 -10 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
21 - -25 -25 -25 ·-25 -10 
22 - -25 -25 -25 -25 ~10 
23 - -25 -25 -25 -25 -10 
24 - ...:.25 -25 -25 -25 -10 
25 - -25 -25 -25 -25 -10 
26 - -25 -25 -25 -25 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 - -25 -25 -25 -25 -1.0 
32 - -25 -25 -25 ~25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 125 -25 -25 -10 
38 - -25 -25 -25 -25 -10 
40 - -25 -25 -25 -25 -10 
226 
BRUCELLOSIS SEROLOGY FOR GROUP VC-_5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
9 0 ·- -25 -25 -25 125 -10 
l - -25. l l 00 -25 ISO -' 10 
2 - -25 +50 -25 1100 -10 
3 T -25 +50 -25 +50 -10 
4 - -25 I 50 -25 150 -10 
5 - -25 +25 -25 +25 .. -10 
6 - -25 +25 -25 150 -10 
7 - -25 +25 -25 +25 -10 
8 - -25 +25 -25 +25 -10 
10 - -25 125 -25 +25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - '-25 -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 125 -10 
19 - -25 125 -25 125 -10 
20 - -25 -25 -25 125 -10 
2.1 - -25 I 25 -25 +25 -10 
22 - -25 -.25 -25 125 -10 
23 - -25 -25 -25 125 -10 
24 - -25 I 25 -25 125 -10, 
25 - -25 l 25 -25 -25 -10 
26 - -25 l 25 -25 -25 -10 
27 - -25 I 25 -25 -25 -10 
28 - -25 -25 -25 -25 -10 
30 - -25 -25 -25 125 -10 
32 - -25 -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 -25 -25 -25 -10 
40 
10 0 - -25 -25 -25 -25 -10 
1 - -25 I 50 -'25 -25 -to 
2 - -25 +50 -25 +50· -10 
3 - -25 +50 -25 +25 -10 
4 - -25 I 50 -25 +25 -10 
5 - -25 +25 -25 +25 -10 
6 - -25 150 -25 I 25 -10 
7 - -25 +25 -25 +25 -10 
8 - -25 -25 -25 125 -10 
10 - -25 -25 -25 125 -10 
12 - -25 +25 -25 -25 -10 
14 - -25 I 25 -25 -25 -10 
16 - -25 -25 -25 +25 -10 
17 - ·-25 125 -25 -25 -10 
18 - -25 125 -25 125 -10 
19 - -25 125 -25 125 -10 
20 - -25 125 -25 125 -10 
21 - -25 -25 -25 125 -10 
22 - '-25 125 -25 125 -10 
23 - -25. 1.25 -25 ·+25 -10 
24 - -25 125 -25 I 25 -10 
25 - -25 I 25 -25 125 -10 
26 - -25 125 -25 125 -10 
27 - -25 125 -25 125 -10 
28 - -25 125 -25 125 -10 
30 - -25 +25 -25 +25 -1.0 
32 - -25 150 -25 +25 -10 
34 - -25 125 -25 +50 -10 
36 ·- -25 +25 -25 125 -10 
38 - -25 l 25 -25 +25 -10 
40 
227 
BRUCELLOSIS SEROLOGY FOR GROUP VC-5 
AN n.1.\L WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
1 l 0 - -25 -25 -25 1.25 -10 
1 - -25 I 25 -25 [25 -10 
2 - -25 +25 -25 +25 -10 
3 - -25 .125 -2$ 125 -10 
4 - ' -25 l 25 -25 +25 -10 
5 - -25 -25 -25 +25 -10 
6 - -25 ~25 -25 +25 -10 
7 - -25 -25 -25 +25 -10 
8 - -25 125 -25 +25 -10 
10 - -25 125 -25 125 -10 
12 - -25 -25 -25 -2·5 -10 
1.4 - -25 125 -25 125 -10 
16 - -25 -'25 -25 l 25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 125 -10 
'19 - -25 -25 -25 +25 -1 () 
20 - -25 125 -25 125 -10 
21 - -25 -' 25 -25 +.25 -10 
22 - -25 -25 ,-25 125 -.10 
23 - -25 125 -25 +25 -10 
24 - -25 -25 -25 +25 -1 o· 
25 - -25, -25 -25 +25 -10 
26 - -25 -25 -25 125 -10 
27 - -25 -25 -25 -25 -10 
28 - -25 -25 -25 125 -10 
'30 ' - -25 -25 -25 125 -1.0 
32 - -25 -25 ·-25 -25 -10 
34 - -25 125 -25 ·+25 -10 
36 - -25 l 25 125 125 -10 
38 - -25 125 -25 125 -10 
40 - - --25 125 -25 125 -10 
12 0 - -25 -25 -25 -25 -10 
I - -25 l 25 -25 -25 -10 
2 - -2·5 +2°5 -25 -25 -10 
3 - -25 +25 "-25 125 -10 
4 - -25 1 50 -25 +25 -10 
5 - -25 125 -25 -25 -10 
6 - -25 l 25 -25 -25 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 ~-25 -10 
10 - -25 -25 -25 -25 -10 
12 - '-25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 ~25 -io 
19 - -25 -25 -25 -25 -10 
20 - -25 -25 -25 -25 -10 
2.l - -25 -25 -25 -25 -10 
22 ~ -25 -25 -25 -25 -10. 
23 - -25 -25 -25 -25 -10 
24 - -25 -25 ~2·5 -25 -'-10 
25 - -'-25 -25 -25 -25 -io 
26 - -25 -25 -25 -25 -10 
27· - -25 -25 -25 '-25 --10 
28 - ~25 ·-25 -25 -25 -10 
30 - -25 -'-25 -25 -25 -10 
32 - ~z5 -25 -25 -25 -10 
34 - -25 -25 -25 -25 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 -25 -25 -25 -10 
40 
'228 
BRUCELLOSIS SEROLOGY FOR GROUP VC-5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
13 0 -25 -25 -25 ~25 -10 
l -25 +50 -25 I 50 -10 
2 -25 +50 -25 +100 -10 
3 "' -25 +50 -25 -25 -10 4 w -25 !50 -25 +50 -10 
5 -25 125 -25 +25 -10 
6 -25 +25 -25 I25 ~10 
:7 -25 125 -25 +25 -IO 
8 -25 -25 -25 -25 -10 
10 -25 -25 -25 -25 -10 
12 -25 -25 -25 -25 -10 
14 -25 -25 -25 -25 -10 
16 -25 -25 -25 -25 -10 
17 -25 -25 -25 -25 -10 
18 -25 -25 '-25 ~25 -10 
19 -25 -25 -·25 -25 -10 
20 -25 -25 -25 -25 -10 
21 -25 -25 -25 -25 -IO 
22 -25 -25 -25 -25 -10 
23 -25 -25 -25 -25 -10 
24 -25 -25 -25 -25 -10 
25 -25 -25 -25 -25 -10 
26 -25 -25 -25 -25 -10 
27 -25 -25 -25 -25 -IO 
28 -25 -25 -25 -25 -10 
30 -25 -25 -25 -25 -10 
32 -25 -25 -25 -25 -10 
34 -25 -25 -25 -25 -10 
36 -25 -25 -25 -25 -10 
38 -25 125 -25 -25 -10 
40 
14 0 -25 -25 -25 -25 -10 
l -25 125 -25 +25 -10 
2 T -25 -25 -25 -25 -10 
j -25 +25 -25 '-25 -10 
4 -25 +25 -25 +25 -10 
5 -25 -25 -25 ISO -10 
6 -25 ~25 -25 +25 -10 
7 -25 -25 -25 +25 -10· 
8 -25 I 25 -25 125 -10 
10 -25 -25 -25 -25 -10 
12 -25 -25 -25 -25 -10 
14 -25 125 -25 -25 -10 
16 -25 -25 -25 125 -10 
17 -25 -25 -25 -25 -10 
18 -25 -25 -25 -25 -10 
19 -'-25 125 -25 !25 -10 
20 -25 125 -25 !25 -10 
21 -25 -25 .·-25 125 -10 
22 -25 -25 ~25 +25 -10 
23 -25 -25 -25 !25 -10 
24 -25 -25 -25 -25 -10 
25 -25 -25 ·-25 -25 -10 
26 -25 -25 -25 -25 -10 
27 -25 ·-25 -25 -25 -10 
28 -25 -25 -25 125 -10 
30 -25 -25 -25 125 -10 
32 -25 125 -25 +25 -1·0 
34 -25 t 25 -25 +25 -10 
36 -25 125 -25 125 -10 
38 -25 125 -25 125 ~10 
40 
229 
BRUCELLOSIS SEROLOGY FOR GROUP vc-5· 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME !'LATE RIV TUBE CF 
1,5 0 - -25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - .,,-25 +25 -25 -25 -10 
3 - -25 150 -25 150 -10 
4 - -25 +25 -25 125 -10 
5 - -25 -25 -25 -25 -10 
6 - -25 -25 -25 125 -10 
7 - -25 -25 -25 -25 -10 
8 - -25 -25 -25 -25 -10 
10 - -25 -25 -25 -25 -10 
12 - -25 I 25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 125 -10 
17 - -25 -25 -25 -25 -10 
18 - -25 -25 -25 125 -10 
19 - -25 +25 -25 +25 -10 
20 - -25 I 25 -25 +25 -10 
21 - -25 [ 25 -25 +25 -10 
22 - -25 -25 -25 125. -10 
23 - -25 l 25 -25. +25 -10 
24 - -25 -25 -25 l 25 -10 
25 - -25 I 25 -25 -25 -10 
26 - . -25 125 -25 125 -10 
27 - -25 -25 -25 125 -10 
28 - -25 -25' -25 125 -10 
30 - -25 I 25 -25 150 -10 
. 32 - -25 -25 -25 .+25 -10 
34 - -25 -25 -25 125 -10 
36 - -25 -25 -25 -25 -10 
38 - -25 I 25 . -25 -25 -10 
40 
230 
BRUCELLOSIS SEROLOGY FOR GROUP V-5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
128 0 -25 -25 -25 -25 -10 
1 -25 +25 -25 +50 -10 
2 -25 +50 -25 l 200 -10 
3 T -25 +50 -25 +50 -10 
4 T -25 l 50 -25 +50 -10 
5 T -25 +25 -25 ISO -10 
6 -25 +25 -25 +25 -10 
7 -25 +25 -25 +25 -10 
8 -25 ! 25 -25 -25 -10 
10 -25 -25 -25 -25 -10 
12 -25 l 25 -25 -25 -10 
14 -25 -25 -25 -25 -10 
16 -25 -25 -25 -25 -10 
17 
18 -25 -25 -25 -25 -10 
19 
20 -25 -25 -25 125 -10 
21 
22 -25 -25 -25 -25 -10 
23 
24 -25 -25 -25 -25 -10 
25 
26 -25 -25 -25 -25 -10 
27 
28 -25 -25 -25 -25 ~10 
30 
32 -25 +25 -25 -25 -10 
34 
36 -25 125 -25 -25 -10 
38 
40 -25 125 -25 -25 -10 
129 0 -25 -25 -25 -25 -10 
I -25 125 -25 +25 -10 
2 T -25 +50 -25 +100 -10 
3 -25 +50 -25 +50 -10 
4 -25 +25 -25 +50 -10 
5 -25 +25 -25 150 -10 
6 -25 +25 -25 +25 -10 
.7 -25 +25 -25 -25 -10 
8 -25 +25 -25 -25 -10 
10 -25 +25 -25 125 -10 
12 ~25 +25 -25 -25 -10 
14 -25 +25 -25 -25 -10 
16 -25 +25 ~25 +25 -10 
17 
18 -25 125 -25 +25 -10 
19 
20 -25 +25 -25 +25 -10 
21 
22 ·-25 +25 
23 
-25 +25 -10 
24 -25 +25 
25 
-25 +25 -10 
26 -25 +25 
27 
-25 +50 -10 
28 -25 I 50 
30 
-25 150 -10 
32 -25 +25· -25 +25 -10 
34 
36 -25 +25 -25 l 25 -10 
38 
40 
231 
9RUCELLOSIS SEROLOGY FOR GROUP V-5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
130 0 - -25 -25 -25 -25 -10 
1 - -25 I 50 -25 1100 -10 
2 + -25 I 100 125 1400 -10 
3 w -25 +50 -25 +50 2+20 
4 w -25 l 50 -25 +100 2+10 
5 w ·-25 +50 -25 +50 -10 
6 w -25 +25 -25 +25 -10 
7 w -25 +25 -25 +25 -10 
8 - -25 +25 -25 125 -10 
10 - -25 +25 -25 I25 -10 
12 - -25 +25 -25 +25 -10 
14 - -25 +25 -25 +25 -10 
16 - -25 +25 -25 +25 -10 
17 
18 - -25 125 -25 +25 -10 
19 
20 - -25 +25 -25 +25 -10 
21 
22 - ~25 l 25 -25 +25 -10 
23 
24 - -25 +25 -25 +25 -10 
25 
26 - -25 +25 -25 +50. -10 
27 
28 - -25 +25 -25 150 -10 
30 
32 - -25 +25 -25 +25 -10 
34 
36 - -25 125 -25 125 -10 
38 
40 
131 0 - -25 -25 -25 125 -10 
l - -25 125 -25 125 -10 
2 - -25 I 50 -25 150 -10 
3 - -25 +25 -25 150 -10 
4 - -25 +25 -25 +25 -10 
5 - -25 I 25 -25 +25 -10 
6 - -25 -25 -25 125 -10 
7 - -25 -25 -25 +25 -10 
8 - -25 -25 -25 I25 -10 
10 - -25 I 25 -:-25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 125 -25 -25 -10 
16 - -25 +25 -25 +25 -10 
17 
18 - -25 +25 -25 +25 ·-10 
19 
20 - -25 
21 
+25 -25 +25 -10 
22 - -25 
23 
+25 -25 +25 -10 
24 - -25 
25 
+25 -25 +25 -10 
26 ·- -25 +25 -25 ISO -10 
27 
28 - -25 +25 -25 150 -10 
30 
·32 - -25 +25 
3lj. 
-25 +25 -10 
36 - -25 125 -25 -25 -10 38 
40 - -25 -25 -25 -25 -10 
232 
BRUCELLOSIS SEROLOGY FOR GROUP V-5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
132 0 ~25 -25 -25 125 -10 
1 -25 I l 00 -25 +200 -10 
2 T -25 +100 -25 +200 -1.0 
3 + -25 1100 i25 +400 3+20 
4 + +25 I 100 125 I400 3+10 
5 w 125 I l 0 0 125 +50 2+20A 
6 w -25 +50 -25 +50 2+10 
7 -25 +50 -25 +25 -10 
8 T -25 +25 -25 150 -10 
10 -25 +25 -25 +25 -10 
12 -25 ISO -25 +50 -10 
14 -25 +25 -25 +25 -10 
16 -25 +25 -25 +50 -1 () 
17 
18 -25 +25 -25 +50 -10 
19 
20 -25 +25 -25 +25 -10 
21 
22 -25 +25 -25 +25 -10 
23 
24 -25 +25 -25 +25 -10 
25 
26 -25 +25 -25 +25 -10 
27 
~8 -25 +25 -25 150 -10 
30 
32 -25 I 50 -25 125 -10 
34 
36 -25 +25 -25 125 -I 
38 
40 
133 0 -25 -25 -25 -25 -10 
l -.25 125 -25 -25 -10 
2 -25 125 -25 I 25 -10 
3 -25 -25 ~25 -25 -10 
4 -25 -25 -25 -25 ~10 
5 ·-25 125 -25 -25 -10 
6 -25 -25 -25 125 -10 
7 -25 -25 -25 +25 -10 
8 -25 -25 -25 -25 -10 
10 ~ -25 -25 -25 -25 -10 
12 -25 -25 -25 -25 -10 
14 -25 -25 -25 -25 -10 
16 -25 -25 -25 -25 - l () 
17 
18 
19 
20 
2.1 
22 
23 
24 
25 
26 
27 
28 
30 
32 
34 
36 
38 
40 
233 
BRUCELLOSIS SEROLOGY FOR GROUP V-5 
ANIMAL WEEK VSL VSL VSL VSL VSL VSL 
CARD ME PLATE RIV TUBE CF 
134 0 - -25 -25 -25 -25 -10 
1 - -25 125 -25 -25 -10 
2 - -25 125 -25 -25 -10 
3 - -25 l 25 -25 -25 -10 
4 - -25 125 -25 +25 -10 
5 - -25 .+25 -25 125 -10 
6 - -25 -25 -25 +25 -10 
7 - -25 125 -25 125 -10 
8 - -25 125 -25 -25 -10 
10 - -25 125 -25 -25 -10 
12 - -25 -25 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 
18 - -25 +25 -25 +25 -10 
19 
20 - -25 +25 -25 +25 -10 
21 
22 - -25 +25 -25 +25 -1 0 
23 
24 - -25 150 -25 +50 -10 
25 
26 - -25 I 50 -25 150 -10 
27 
28. - -25 125 -25 150 -10 
30 
32 + -25 +100 -25 1400 -10 
34 
36 - -25 +50 -25 1100 -10 
38 
40 + -25 +50 -25 1100 -10 
l 35 0 - -25 -25 -25 -25 -10 
1 - -25 -25 -25 -25 -10 
2 - -25 125 -25 +25 -10 
3 - -25 +so -25 +25 ~10 
4 T -25 150 -25 +25 -10 
5 T -25 +25 -25 +25 -10 
6 T -25 +25 -25 -25 -IO 
7 - -25 +25 -25 125 -10 
8 - -25 125 -25 125 -10 
1 0 - -25 -25 -25 -25 -10· 
12 - -25 125 -25 -25 -10 
14 - -25 -25 -25 -25 -10 
16 - -25 -25 -25 -25 -10 
17 
18 - -25 -25 -25 -2:; -10 
19 
20 - -25 -25 -25 -25 -10 
21 
22 - -25 -25 :,.25 -25 -10 
23 
24 - -25 +25 -25 -25 -10 
25 
26 - -25 125 -25 -25 -10 
27 
28 - -25 
30 
-25 -25 -25 -10 
32 - -25 
34 
+25 -25 -25 -10 
36 - -25 i25 -25 -25 -10 
38 
40 
